Edgar Filing: BRAVO FOODS INTERNATIONAL CORP

As filed with the Securities and Exchange
Commission on March 30, 2005 An Exhibit List
can be found on page II-11.

Registration No. 333-_______

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON D.C. 20549
-----------------------------

AMENDMENT NO. 1 TO THE

FORM SB-2
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
-----------------------------

BRAVO! FOODS INTERNATIONAL CORP.
(Name of small business issuer in its charter)

Delaware 2020 62-1681831
(State or other (Primary Standard Industrial (I.R.S. Employer
Jurisdiction of Classification Code Number) Identification No.)
Incorporation or
Organization)

11300 US Highway 1
North Palm Beach, Florida 33408
(561) 625-1411
(Address and telephone number of principal executive offices and principal place
of business)

Roy G. Warren, Chief Executive Officer
BRAVO! FOODS INTERNATIONAL CORP.
11300 US Highway 1
North Palm Beach, Florida 33408
(561) 625-1411
(Name, address and telephone number of agent for service)

Copies to:
Marc Ross, Esq.
Stephen Fleming, Esq.
Sichenzia Ross Friedman Ference LLP
1065 Avenue of the Americas, 21st Flr.
New York, New York 10018
(212) 930-9700
(212) 930-9725 (fax)

APPROXIMATE DATE OF PROPOSED SALE TO THE PUBLIC:
From time to time after this Registration Statement becomes effective.

If any securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or
interest reinvestment plans, check the following box: [X]

If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, check the following box and
list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. ________

If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. _________

If this Form is a post-effective amendment filed pursuant to Rule 462(d)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. _________

If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. _________

CALCULATION OF REGISTRANT FEE

Proposed
maximum Proposed
offering maximum
Title of each class of Amount to be price per aggregate Amount of
securities to be registered registered (1) share offering price registration fee
--------------------------------------------------------------------------------------------

Common Stock issuable upon
conversion of convertible
debentures 28,212,500 $ 0.15(2) $ 4,231,875.00 $ 498.09
--------------------------------------------------------------------------------------------
Common Stock issuable upon
exercise of warrants at $.15
per share 6,200,000 $ 0.15(3) $ 930,000.00 $ 109.47
--------------------------------------------------------------------------------------------
Common Stock issuable upon
exercise of warrants at $.25
per share 2,000,000 $ 0.25(3) $ 500,000.00 $ 58.85
--------------------------------------------------------------------------------------------
Common Stock issuable upon
exercise of warrants at
$2.00 per share 13,000,000 $ 2.00(3) $26,000,000.00 $3,060.20
--------------------------------------------------------------------------------------------

--------------------------------------------------------------------------------------------
Total 49,412,500 $3,726.60(4)

--------------------------------------------------------------------------------------------

(1) Includes shares of our common stock, par value $0.001 per share, which may
be offered pursuant to this registration statement, which shares are issuable
upon conversion of convertible debentures and the exercise of warrants held by
the selling stockholders. In addition to the shares set forth in the table, the
amount to be registered includes an indeterminate number of shares issuable upon
conversion of the debentures as such number may be adjusted as a result of stock
splits, stock dividends and similar transactions in accordance with Rule 416.
The number of shares of common stock registered hereunder represents a good
faith estimate by us of the number of shares of common stock issuable upon
conversion of the debentures. For purposes of estimating the number of shares of
common stock to be included in this registration statement, we calculated a good
faith estimate of the number of shares of our common stock that we believe will
be issuable upon conversion of the debentures to account for market
fluctuations. Should the conversion ratio result in our having insufficient
shares, we will not rely upon Rule 416, but will file a new registration
statement to cover the resale of such additional shares should that become
necessary. In addition, should a decrease in the exercise price as a result of
an issuance or sale of shares below the then current market price, result in our
having insufficient shares, we will not rely upon Rule 416, but will file a new
registration statement to cover the resale of such additional shares should that
become necessary.

(2) Estimated solely for purposes of calculating the registration fee in
accordance with Rule 457(c) under the Securities Act of 1933, using the average
of the high and low price as reported on the Over-The-Counter Bulletin Board on
January 14, 2005, which was $.15 per share.

(3) Estimated solely for purposes of calculating the registration fee in
accordance with Rule 457(g) under the Securities Act of 1933, using the higher
of the exercise price of such warrants or the average of the high and low price
as reported on the Over-The-Counter Bulletin Board on January 14, 2005, which
was $.15 per share.

(4) Previously paid.

The registrant hereby amends this registration statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that this registration
statement shall thereafter become effective in accordance with Section 8(a) of

iii

the Securities Act of 1933 or until the registration statement shall become
effective on such date as the commission, acting pursuant to said Section 8(a),
may determine.

PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION, DATED MARCH 30, 2005

BRAVO! FOOD INTERNATIONAL CORP.
49,412,500 SHARES OF
COMMON STOCK

This prospectus relates to the resale by the selling stockholders up to
49,412,500 shares of our common stock, including the following:

o up to 28,212,500 shares of common stock underlying convertible
debentures,
o up to 6,200,000 shares issuable upon the exercise of common
stock purchase warrants at $.15,
o up to 2,000,000 shares issuable upon the exercise of common
stock purchase warrants at $.25, and
o up to 13,000,000 shares issuable upon the exercise of common
stock purchase warrants at $2.00.

The convertible debentures issued in connection with our private placement
dated June 2004 are convertible into our common stock at $0.15 and the
convertible debentures issued in connection with our private placement dated
October 2004 and December 2004 are convertible into our common stock at $.10.
The selling stockholders may sell common stock from time to time in the
principal market on which the stock is traded at the prevailing market price or
in negotiated transactions. The selling stockholders may be deemed underwriters
of the shares of common stock, which they are offering. We will pay the expenses
of registering these shares.

Our common stock is registered under Section 12(g) of the Securities
Exchange Act of 1934 and is listed on the Over-The-Counter Bulletin Board under
the symbol "BRVO". The last reported sales price per share of our common stock
as reported by the Over-The-Counter Bulletin Board on March 24, 2005, was $.16.

Investing in these securities involves significant risks. See "Risk
Factors" beginning on page 4.

Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
Prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.

The date of this prospectus is _______, 2005.

The information in this Prospectus is not complete and may be changed.
This Prospectus is included in the Registration Statement that was filed by
Bravo! Foods International Corp., with the Securities and Exchange Commission.
The selling stockholders may not sell these securities until the registration
statement becomes effective. This Prospectus is not an offer to sell these
securities and is not soliciting an offer to buy these securities in any state
where the sale is not permitted.

PROSPECTUS SUMMARY

The following summary highlights selected information contained in this
prospectus. This summary does not contain all the information you should
consider before investing in the securities. Before making an investment
decision, you should read the entire prospectus carefully, including the "risk
factors" section, the financial statements and the notes to the financial
statements.

BRAVO! FOODS INTERNATIONAL CORP.

We are involved in the development and marketing of our Slammers(R)
trademarked brand, the obtaining of license rights from third party holders of
intellectual property rights to other trademarked brands, logos and characters,
and the granting of production and marketing rights to processor dairies to
produce branded flavored milk and generating revenue through the sale of "kits"
to these dairies outside of the United States and through wholesale sales within
the United States. The price of the "kits" consists of an invoiced price for a
fixed amount of flavor ingredients per kit used to produce the flavored milk and
a fee charged to the diaries for the production, promotion and sales rights for
the branded flavored milk. In the United States, we also generate revenue from
the unit sales of finished branded flavored milks to retail consumer outlets.

Our new product introduction and growth expansion continue to be expensive
and we reported a net loss of $3,016,987 for the year ended December 31, 2003
and a net loss of $3,799,926 for the year ended December 31, 2004. We have
suffered operating losses and negative cash flows from operations since
inception and, at December 31, 2004, we had an accumulated deficit, a capital
deficit, are delinquent on certain debts and have negative working capital.
These conditions give rise to substantial doubt about our ability to continue as
a going concern.

Our principal offices are located at 11300 US Highway 1, North Palm Beach,
Florida 33408, and our telephone number is (561) 625-1411. We are a Delaware
corporation.

The Offering

Common stock offered by selling stockholders........Up to 49,412,500 shares,
which would represent 45.19%
of our then current
outstanding shares of common
stock (assuming the full
conversion of all debentures
and exercise of warrants
being registered herewith),
including

o up to 28,212,500 shares
of common stock
underlying convertible
debentures in the
aggregate amount of
$2,250,000 based on
current conversion prices
and assuming full
conversion of the
convertible debentures
(includes a good faith
estimate of the shares
underlying the
convertible debenture to
account for a decrease in
the conversion price);
o up to 6,200,000 shares
issuable upon the
exercise of common stock
purchase warrants at an
exercise price of $.15
per share, assuming full
exercise of the warrants;
o up to 2,000,000 shares
issuable upon the
exercise of common stock
purchase warrants at an
exercise price of $0.25
per share, assuming full
exercise of the warrants;
o up to 13,000,000
issuable upon the
exercise of common stock
purchase warrants at an
exercise price of $2.00
per share, assuming full
exercise of the warrants.

Common stock to be outstanding after the offering...Up to 109,330,297 shares

Use of proceeds.....................................We will not receive any
proceeds from the sale of
the common stock.

Over-The-Counter Bulletin Board Symbol..............BRVO

The above information regarding common stock to be outstanding after the
offering is based on 59,917,797 shares of common stock outstanding as of March
4, 2005 and assumes the subsequent conversion of our issued convertible
debentures, with interest, and exercise of warrants by our selling stockholders.

To obtain funding for our ongoing operations, we entered into the
following two financing transactions.

June 2004

In June 2004, we entered into a Subscription Agreement with Longview Fund,
LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited, Stonestreet
Limited Partnership and Mid-Am Capital L.L.C for the issuance of convertible 10%
notes in the aggregate amount of $1,300,000 and five-year "A" warrants for the
purchase of, in the aggregate, 5,200,000 shares of common stock, at $0.25 per
share, and five-year "B" warrants for the purchase of, in the aggregate,
13,000,000 shares of common stock, at $2.00 per share. In connection with the
October 2004 financing, we subsequently amended the exercise price to $.15 for
the "A" warrants issued to Longview Fund, LP, Alpha Capital Aktiengesellschaft,
Whalehaven Funds Limited and Stonestreet Limited Partnership. The notes are
convertible into shares of common stock of the Company at $0.15 per common
share. The notes are payable in twelve equal monthly installments, commencing
January 1, 2005. The installment payments consist of principal and a "premium"
of 20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on December 1, 2005, if our common stock
trades above $0.20 for the five trading days prior to the due date of an
installment payment. In connection with this transaction, we issued additional
notes in the aggregate amount of $40,000 to Gem Funding, LLC, Bi-Coastal
Consulting Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon
identical terms as the principal notes, as a finder's fee, and paid $12,500 in
legal fees. The common stock underlying all notes and warrants carry
registration rights.

The selling stockholders have contractually agreed to restrict their
ability to convert or exercise their warrants and receive shares of our common
stock such that the number of shares of common stock held by them and their
affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.

This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.

October 2004

the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.

December 2004

In December 2004, we entered into Subscription Agreements with Momona
Capital Corp. and Ellis International Ltd. for the issuance of convertible 10%
notes in the aggregate amount of $400,000 and five-year "C" warrants for the
purchase of, in the aggregate, 800,000 shares of common stock, at $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $10,000 to Momona Capital Corp. and Ellis International
Ltd. upon identical terms as the principal notes, as a finder's fee. The common
stock underlying all notes and warrants carry registration rights.

This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.

RISK FACTORS

This investment has a high degree of risk. Before you invest you should
carefully consider the risks and uncertainties described below and the other
information in this prospectus. If any of the following risks actually occur,
our business, operating results and financial condition could be harmed and the
value of our stock could go down. This means you could lose all or a part of
your investment.

Risks Relating to Our Business:

We Have a History Of Losses Which May Continue, Requiring Us To Seek
Additional Sources of Capital Which May Not Be Available, Requiring Us To
Curtail Or Cease Operations.

We incurred net losses of $3,799,926 for the year ended December 31, 2004
and $3,016,987 for the year ended December 31, 2003. We cannot assure you that
we can achieve or sustain profitability on a quarterly or annual basis in the
future. If revenues grow more slowly than we anticipate, or if operating
expenses exceed our expectations or cannot be adjusted accordingly, we will
continue to incur losses. We will continue to incur losses until we are able to
establish significant sales. Our possible success is dependent upon the
successful development and marketing of our services and products, as to which
there is no assurance. Any future success that we might enjoy will depend upon
many factors, including factors out of our control or which cannot be predicted
at this time. These factors may include changes in or increased levels of
competition, including the entry of additional competitors and increased success
by existing competitors, changes in general economic conditions, increases in
operating costs, including costs of supplies, personnel, marketing and
promotions, reduced margins caused by competitive pressures and other factors.
These conditions may have a materially adverse effect upon us or may force us to
reduce or curtail operations. In addition, we will require additional funds to
sustain and expand our sales and marketing activities, particularly if a
well-financed competitor emerges. We anticipate that we will require up to
approximately $1,500,000 to fund our continued operations for the next twelve
months, depending on revenue from operations. There can be no assurance that
financing will be available in amounts or on terms acceptable to us, if at all.
The inability to obtain sufficient funds from operations or external sources
would require us to curtail or cease operations.

If We Are Unable to Obtain Additional Funding Our Business Operations Will be
Harmed and If We Do Obtain Additional Financing Our Then Existing
Shareholders May Suffer Substantial Dilution.

Additional capital will be required to effectively support the operations
and to otherwise implement our overall business strategy. However, there can be
no assurance that financing will be available when needed on terms that are
acceptable to us. The inability to obtain additional capital will restrict our
ability to grow and may reduce our ability to continue to conduct business
operations. If we are unable to obtain additional financing, we will likely be
required to curtail our marketing and development plans and possibly cease our
operations. Any additional equity financing may involve substantial dilution to
our then existing shareholders.

Our Independent Auditors Have Expressed Substantial Doubt About Our Ability
to Continue As a Going Concern, Which May Hinder Our Ability to Obtain Future
Financing.

In their report dated March 4, 2005, our independent auditors stated that
our financial statements for the year ended December 31, 2004 were prepared
assuming that we would continue as a going concern. Our ability to continue as a
going concern is an issue raised as a result of a net loss for the year ended
December 31, 2004 in the amount of $3,799,926. We continue to experience net
operating losses. Our ability to continue as a going concern is subject to our
ability to generate a profit and/or obtain necessary funding from outside
sources, including obtaining additional funding from the sale of our securities,
increasing sales or obtaining loans and grants from various financial
institutions where possible. Our continued net operating losses increases the
difficulty in meeting such goals and there can be no assurances that such
methods will prove successful.

Since we depend upon key personnel having significant business contacts in the
US and internationally, the loss of one or more of our management team may have
a negative effect on our business.

The unexpected loss of the services of any member of the management team could
have a material adverse effect on our ability to conduct and grow both our US
and international business. We are and will be dependent on our current
management teams for the foreseeable future

o to obtain needed additional financing

o to develop and maintain critical business contacts for the
production of our branded milk products

o to develop and maintain third party licensor and brand development
contacts for the formulation of new brand development and branded
food products

We face intense competition in our US market that could negatively impact our
results of operations

Since we are smaller than our competitors in the US market and since we
have limited resources and sell our branded products at premium prices, we have
had difficulty in developing and maintaining our market share in the consumer
milk market. This difficulty could adversely affect our ability to achieve our
business goals to develop and increase the awareness of our branded products in
an effort to increase sales, while maintaining a premium price structure.

The ability of our competition to sell dairy and other food products at
prices below prices charged by us for our products may represent an obstacle to
our ability to secure a market share at revenue levels sufficient to achieve
profitability.

In our foreign business, we grant the rights to produce and sell branded
milk products to processor dairies under production agreements. Our role in
these agreements, in addition to granting the rights to produce the branded
milks as part of the sale of flavor ingredient packages to dairies, is limited
to marketing and promotion assistance and control over packaging and advertising
design issues. Such processors dairies have significant control over sales and
distribution of the branded milk products.. A reduction in sales effort or
discontinuance of sales of our products by our co-producers could lead to
reduced sales.

Risks Relating to Our Current Financing Arrangement:

There Are a Large Number of Shares Underlying Our Convertible Debentures and
Warrants That May be Available for Future Sale and the Sale of These Shares May
Depress the Market Price of Our Common Stock.

As of March 4, 2005, we had 59,917,797 shares of common stock issued and
outstanding and convertible debentures outstanding that may be converted into an
estimated 41,700,000 shares of common stock at current market prices,
outstanding warrants to purchase 43,900,227 shares of common stock and options
to purchase 3,571,086 shares of common stock. Furthermore, there are currently
outstanding shares of Preferred Stock that are convertible into approximately
41,500,000 shares of common stock. In addition, the number of shares of common
stock issuable upon conversion of the outstanding convertible debentures may
increase if the market price of our stock declines. All of the shares, including
all of the shares issuable upon conversion of the debentures and upon exercise
of our warrants, may be sold without restriction. The sale of these shares may
adversely affect the market price of our common stock.

The Issuance of Shares Upon Conversion of the Convertible Debentures and
Exercise of Outstanding Warrants May Cause Immediate and Substantial Dilution to
Our Existing Stockholders.

The issuance of shares upon conversion of the convertible debentures and
exercise of warrants may result in substantial dilution to the interests of
other stockholders since the selling stockholders may ultimately convert and
sell the full amount issuable on conversion. Although the selling stockholders
may not convert their convertible debentures and/or exercise their warrants if
such conversion or exercise would cause them to own more than 9.99% of our
outstanding common stock, this restriction does not prevent the selling
stockholders from converting and/or exercising some of their holdings, selling
these shares and then converting the rest of their holdings. In this way, the
selling stockholders could sell more than this limit while never holding more
than this limit. There is no upper limit on the number of shares that may be

issued which will have the effect of further diluting the proportionate equity
interest and voting power of holders of our common stock, including investors in
this offering.

If We Are Required for any Reason to Repay Our Outstanding Convertible
Debentures, We Would Be Required to Deplete Our Working Capital, If
Available, Or Raise Additional Funds. Our Failure to Repay the Convertible
Debentures, If Required, Could Result in Legal Action Against Us, Which Could
Require the Sale of Substantial Assets.

In November 2003, April 2004, June 2004, October 2004 and December 2004,
we entered into financing arrangements for the sale of $3,150,000 principal
amount of convertible debentures. The convertible debentures issued in November
2003 are due and payable, with 8% interest, two years from the date of issuance,
unless sooner converted into shares of our common stock. In April 2004, we
entered into a Subscription Agreement with two accredited investors for the sale
of $500,000 in convertible debentures. The debentures issued in connection with
the April 2004 financing bear interest at 10%. The principal on the notes is due
in equal monthly installments commencing on November 1, 2004 until October 1,
2005. On October 1, 2005, all principal and interest shall become due. In June
2004, we issued convertible 10% notes in the aggregate amount of $1,300,000. The
notes are payable in twelve equal monthly installments, commencing January 1,
2005. The installment payments consist of principal and a "premium" of 20% of
the principal paid per installment. We have the option to defer such payment
until the note's maturity date on December 1, 2005, if our common stock trades
above $0.20 for the five trading days prior to the due date of an installment
payment. In October 2004, we issued convertible 10% notes in the aggregate
amount of $500,000. The notes are payable in twelve equal monthly installments,
commencing May 1, 2005. The installment payments consist of principal and a
"premium" of 20% of the principal paid per installment. We have the option to
defer such payment until the note's maturity date on April 30, 2006, if our
common stock trades above $0.20 for the five trading days prior to the due date
of an installment payment. In December 2004, we issued convertible 10% notes in
the aggregate amount of $400,000. The notes are payable in twelve equal monthly
installments, commencing May 1, 2005. The installment payments consist of
principal and a "premium" of 20% of the principal paid per installment. We have
the option to defer such payment until the note's maturity date on April 30,
2006, if our common stock trades above $0.20 for the five trading days prior to
the due date of an installment payment.

Any event of default could require the early repayment of the convertible
debentures, including a default interest rate if the default is not cured with
the specified grace period. We anticipate that the full amount of the
convertible debentures, together with accrued interest, will be converted into
shares of our common stock, in accordance with the terms of the convertible
debentures. If we are required to repay the convertible debentures, we would be
required to use our limited working capital and raise additional funds. If we
were unable to repay the debentures when required, the debenture holders could
commence legal action against us to recover the amounts due. Any such action
would require us to obtain additional financing or curtail or cease operations.

Risks Relating to Our Common Stock:

If We Fail to Remain Current on Our Reporting Requirements, We Could be Removed
From the OTC Bulletin Board Which Would Limit the Ability of Broker-Dealers to
Sell Our Securities and the Ability of Stockholders to Sell Their Securities in
the Secondary Market.

Companies trading on the OTC Bulletin Board, such as us, must be reporting
issuers under Section 12 of the Securities Exchange Act of 1934, as amended, and
must be current in their reports under Section 13, in order to maintain price
quotation privileges on the OTC Bulletin Board. If we fail to remain current on
our reporting requirements, we could be removed from the OTC Bulletin Board. As
a result, the market liquidity for our securities could be severely adversely
affected by limiting the ability of broker-dealers to sell our securities and
the ability of stockholders to sell their securities in the secondary market.

Our Common Stock is Subject to the "Penny Stock" Rules of the SEC and the
Trading Market in Our Securities is Limited, Which Makes Transactions in Our
Stock Cumbersome and May Reduce the Value of an Investment in Our Stock.

with an exercise price of less than $5.00 per share, subject to certain
exceptions. For any transaction involving a penny stock, unless exempt, the
rules require:

o that a broker or dealer approve a person's account for transactions
in penny stocks; and
o the broker or dealer receive from the investor a written agreement
to the transaction, setting forth the identity and quantity of the
penny stock to be purchased.

In order to approve a person's account for transactions in penny stocks, the
broker or dealer must:

o obtain financial information and investment experience objectives of
the person; and
o make a reasonable determination that the transactions in penny
stocks are suitable for that person and the person has sufficient
knowledge and experience in financial matters to be capable of
evaluating the risks of transactions in penny stocks.

The broker or dealer must also deliver, prior to any transaction in a penny
stock, a disclosure schedule prescribed by the Commission relating to the penny
stock market, which, in highlight form:

o sets forth the basis on which the broker or dealer made the
suitability determination; and
o that the broker or dealer received a signed, written agreement from
the investor prior to the transaction.

Generally, brokers may be less willing to execute transactions in securities
subject to the "penny stock" rules. This may make it more difficult for
investors to dispose of our common stock and cause a decline in the market value
of our stock.

Disclosure also has to be made about the risks of investing in penny
stocks in both public offerings and in secondary trading and about the
commissions payable to both the broker-dealer and the registered representative,
current quotations for the securities and the rights and remedies available to
an investor in cases of fraud in penny stock transactions. Finally, monthly
statements have to be sent disclosing recent price information for the penny
stock held in the account and information on the limited market in penny stocks.

USE OF PROCEEDS

This prospectus relates to shares of our common stock that may be offered
and sold from time to time by the selling stockholders. We will not receive any
proceeds from the sale of shares of common stock in this offering. In the event
that we received proceeds from the exercise of the Class A, Class B Warrants and
other warrants, we will use these funds for working capital.

MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

Our common stock is quoted on the OTC Bulletin Board under the symbol
"BRVO".

For the periods indicated, the following table sets forth the high and low
bid prices per share of common stock. These prices represent inter-dealer
quotations without retail markup, markdown, or commission and may not
necessarily represent actual transactions.

--------------------------------------------------------------------------------
High Low
--------------------------------------------------------------------------------

2001 $ $

--------------------------------------------------------------------------------
First Quarter .59 .27
--------------------------------------------------------------------------------
Second Quarter .51 .32
--------------------------------------------------------------------------------
Third Quarter .51 .20
--------------------------------------------------------------------------------
Fourth Quarter .50 .31
--------------------------------------------------------------------------------

2002

--------------------------------------------------------------------------------
First Quarter .52 .37
--------------------------------------------------------------------------------
Second Quarter .39 .21
--------------------------------------------------------------------------------
Third Quarter .38 .22
--------------------------------------------------------------------------------
Fourth Quarter .40 .24
--------------------------------------------------------------------------------

2003

--------------------------------------------------------------------------------
First Quarter .28 .19
--------------------------------------------------------------------------------
Second Quarter .23 .08
--------------------------------------------------------------------------------
Third Quarter .16 .09
--------------------------------------------------------------------------------
Fourth Quarter .14 .05
--------------------------------------------------------------------------------

--------------------------------------------------------------------------------

2004

--------------------------------------------------------------------------------
First Quarter .17 .06
--------------------------------------------------------------------------------
Second Quarter .34 .14
--------------------------------------------------------------------------------
Third Quarter .27 .13
--------------------------------------------------------------------------------
Fourth Quarter .22 .09
--------------------------------------------------------------------------------

HOLDERS

As of March 4, 2005, we had approximately 1,900 holders of our common
stock. The number of record holders was determined from the records of our
transfer agent and does not include beneficial owners of common stock whose
shares are held in the names of various security brokers, dealers, and
registered clearing agencies. The transfer agent of our common stock is American
Stock Transfer & Trust Company, 59 Maiden Lane, Plaza Level, New York, NY 10038.

We have not paid dividends on our common stock and do not anticipate
paying dividends. Management intends to retain future earnings, if any, to
finance working capital, to expand our operations and to pursue our acquisition
strategy.

The holders of common stock are entitled to receive, pro rata, such
dividends and other distributions as and when declared by our board of directors
out of the assets and funds legally available therefor. The availability of
funds is dependent upon dividends or distribution of profits.

We have accrued dividends for our convertible preferred stock in the
amount of $339,904 at December 31, 2003 and $388,632 for the period ended
December 31, 2004.

Securities authorized for issuance under equity compensation plans

The equity compensation reported in this section has been and will be
issued pursuant to individual compensation contracts and arrangements with
employees, directors, consultants, advisors, vendors, suppliers, lenders and
service providers. The equity is reported on an aggregate basis as of December
31, 2004. Our security holders have not approved the compensation contracts and
arrangements underlying the equity reported.

-------------------------- -------------------------- ------------------------------ ---------------------------------
Number of securities to Weighted average price of
be issued upon exercise outstanding options, Number of securities remaining
Compensation Plan of options, warrants and warrants and rights for future issuance under
Category rights equity compensation plans

-------------------------- -------------------------- ------------------------------ ------------ --------------------

Directors (former) 335,000 $0.71 0 individual plans
-------------------------- -------------------------- ------------------------------ ------------ --------------------
Employees (former) 591,167 $0.87 60,000 individual plans
-------------------------- -------------------------- ------------------------------ ------------ --------------------
Consultants 1,460,714 $0.30 0 individual plans
-------------------------- -------------------------- ------------------------------ ------------ --------------------
Lender 25,000 $0.40 0 individual plan
-------------------------- -------------------------- ------------------------------ ------------ --------------------
Total 2,412,381 $0.77 60,000
-------------------------- -------------------------- ------------------------------ ------------ --------------------

Compensation Plans

Directors

On March 27, 2001, we issued options to our directors to purchase an
aggregate of 925,000 shares of our common stock. The options have an exercise
price of $0.75 and expire March 26, 2006. Directors received options for 35,000
shares for each full year of service and an additional 40,000 shares for service
on a board committee. On August 14, 2001, we issued 250,000 options to the Board
of Directors for services rendered as directors. Each director received options
for 25,000 shares of common stock at an exercise price of $0.60. The options can
be exercised for five years.

On January 13, 2004, the Board of Directors adopted a plan to convert on a
one for one basis the options granted to our present employees and the directors
currently serving on the Board into a like number of our restricted shares of
common stock at the then market value of $0.08 per share. The conversion of the
options to common stock for any individual director or employee was conditioned
upon a "lockup" agreement by such director or employee, pursuant to which the
recipients of such common stock could not sell, transfer, pledge or hypothecate
such common stock for a six-month period.

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS

Some of the information in this Form SB-2 contains forward-looking
statements that involve substantial risks and uncertainties. You can identify
these statements by forward-looking words such as "may," "will," "expect,"
"anticipate," "believe," "estimate" and "continue," or similar words. You should
read statements that contain these words carefully because they:

o discuss our future expectations;
o contain projections of our future results of operations or of our
financial condition; and
o state other "forward-looking" information.

We believe it is important to communicate our expectations. However, there
may be events in the future that we are not able to accurately predict or over
which we have no control. Our actual results and the timing of certain events
could differ materially from those anticipated in these forward-looking
statements as a result of certain factors, including those set forth under "Risk
Factors," "Business" and elsewhere in this prospectus.
See "Risk Factors."

OVERVIEW

Our business model includes the development and marketing of our company
owned Slammers(R) trademarked brand, the obtaining of license rights from third
party holders of intellectual property rights to other trademarked brands, logos
and characters and the granting of production and marketing rights to processor
dairies to produce branded flavored milk. We generate revenue in our
international (non-US) business through the sale of "kits" to these dairies. The
price of the "kits" consists of an invoiced price for a fixed amount of flavor
ingredients per kit used to produce the flavored milk and a fee charged to the
dairy processors for the production, promotion and sales rights for the branded
flavored milk. In the United States, we generate revenue from the unit sales of
finished branded flavored milks to retail consumer outlets.

Our new product introduction and growth expansion continues to be
expensive, and we reported a net loss of $3,799,926 for the year ended December
31, 2004. As shown in the accompanying financial statements, we have suffered
operating losses and negative cash flows from operations since inception and at
December 31, 2004 have an accumulated deficit, a capital deficit, are delinquent
on certain debts and have negative working capital. These conditions give rise
to substantial doubt about our ability to continue as a going concern. As
discussed herein, we plan to work toward profitability in our U.S. and
international business and obtain additional financing. While there is no
assurance that funding will be available or that we will be able to improve our
operating results, we are continuing to seek equity and/or debt financing. We
cannot give any assurances, however, that management will be successful in
carrying out our plans.

CORPORATE GOVERNANCE

The Board of Directors

Our board has positions for nine directors that are elected as Class A or
Class B directors at alternate annual meetings of our shareholders. We presently
have two mid-term vacancies on the board. Six of the seven current directors of
our board are independent. Our chairman and chief executive officer are
separate. The board meets regularly either in person or by telephonic conference
at least four times a year, and all directors have access to the information
necessary to enable them to discharge their duties. The board, as a whole, and
the audit committee in particular, review our financial condition and
performance on an estimated vs. actual basis and financial projections as a
regular agenda item at scheduled periodic board meetings, based upon separate
reports submitted by our chief executive officer and chief financial officer.
Our shareholders elect directors after nomination by the board or the board
appoints directors when a vacancy arises prior to an election. This year we have
adopted a nomination procedure based upon a rotating nomination committee made
up of those members of the director Class not up for election. The board
presently is examining whether this procedure, as well as the make up of the
audit and compensation committees, should be the subject of an amendment to the
by-laws.

Audit Committee

Our audit committee is composed of three independent directors and
functions to assist the board in overseeing our accounting and reporting
practices. Our financial information is booked in house by our CFO's office,
from which we prepare financial reports. Lazar Levine & Felix LLP, independent
registered public accountants and auditors, audit or review these financial
reports. Our chief financial officer reviews the preliminary financial and
non-financial information prepared in house with our securities counsel and the
reports of the auditors. The committee reviews the preparation of our audited
and unaudited periodic financial reporting and internal control reports prepared
by our chief financial officer. The committee reviews significant changes in
accounting policies and addresses issues and recommendations presented by our
internal and external certified accountants as well as our auditors. Currently,
there is one vacancy on the audit committee.

Compensation Committee

Our compensation committee is composed of three independent directors and
reviews the compensation structure and policies concerning executive
compensation. The committee develops proposals and recommendations for executive
compensation and presents those recommendations to the full board for
consideration. The committee periodically reviews the performance of our other
members of management and the recommendations of the chief executive officer
with respect to the compensation of those individuals. Given the size of our
company, the board periodically reviews all such employment contracts. The board
must approve all compensation packages that involve the issuance of our stock or
stock options. Currently, there is one vacancy on the compensation committee.

Nominating Committee

The nominating committee was established in the second quarter 2002 and
consists of those members of the director Class not up for election. The
committee is charged with determining those individuals who will be presented to
the shareholders for election at the next scheduled annual meeting. The full
board fills any mid term vacancies by appointment.

CRITICAL ACCOUNTING POLICIES

Estimates

This discussion and analysis of our consolidated financial condition and
results of operations are based on our consolidated financial statements, which
have been prepared in accordance with accounting principles generally accepted
in the United States of America. The preparation of these financial statements
requires us to make estimates and disclosure of contingent assets and
liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting period. On an on-going basis, we
evaluate our company's estimates, including those related to reserves for bad
debts and valuation allowance for deferred tax assets. We base our estimates on
historical experience and on various other assumptions that are believed to be
reasonable under the circumstances, the result of which forms the basis for
making judgments about the carrying values of assets and liabilities that are
not readily apparent from other sources. Actual results may differ materially
from these estimates under different assumptions or conditions. Our use of
estimates, however, is quite limited as we have adequate time to process and
record actual results from operations.

Revenue recognition

United States

We recognize revenue in the United States at the gross amount of our
invoices for the sale of finished product to wholesale buyers. We take title to
our branded flavored milks when they are shipped by our third party processors
and recognize as revenue the gross wholesale price charged to our wholesale
customers. Our gross margin is determined by the reported wholesale price less
the cost charged by Jasper Products, our third party processor, to produce the
branded milk products.

Prior to 2004, we reported revenue in the United States from our sale of
"kits" to third party processors and from the differential between the cost of
producing our finished product and the wholesale price of our finished product.
Commencing in the first quarter 2004, we report revenue from our sale of
finished product on the wholesale level. We report the cost of producing the
product charged by a third party processor as the cost of goods sold. This
change in revenue recognition has resulted in materially higher reported revenue
for our company, with a corresponding material increase in reported costs of
goods sold.

In certain circumstances in our U.S. business, we are required to pay
slotting fees, give promotional discounts or make marketing allowances in order
to secure wholesale customers. These payments, discounts and allowances reduce
our reported revenue in accordance with the guidelines set forth in EITF 01-9
and SEC Staff Accounting Bulletin No. 101.

International Sales

We recognize revenue in our international (non US) business at the gross
amount of our invoices for the sale of kits at the time of shipment of flavor
ingredients to processor dairies with whom we have production contracts for
extended shelf life and aseptic long life milk. We base this recognition on our
role as the principal in these transactions, our discretion in establishing kit
prices (including the price of flavor ingredients and production right fees),
our development and refinement of flavors and flavor modifications, our
discretion in supplier selection and our credit risk to pay for ingredients if
processors do not pay ingredient suppliers. The revenue generated by the
production contracts under this model consists of the cost of the processors'
purchase of flavor ingredients and fees charged by us to the processors for
production rights. We formulate the price of production rights to cover our
intellectual property licenses, which varies by licensor as a percentage of the
total cost of a kit sold to the processor dairy under the production agreement.
We recognize revenue on the gross amount of "kit" invoices to the dairy
processors and simultaneously record as cost of goods sold the cost of flavor
ingredients paid by the processor dairies to ingredients supplier. The
recognition of revenue generated from the sale of production rights associated
with the flavor ingredients is complete upon shipment of the ingredients to the
processor, given the short utilization cycle of the ingredients shipped.

Pursuant to EITF 99-19, international sales of kits made directly to
customers by us are reflected in the statements of operations on a gross basis,
whereby the total amount billed to the customer is recognized as revenue.

RESULTS OF OPERATIONS

Financial Condition at December 31, 2004

As of December 31, 2004, we had an accumulated deficit of $33,737,029,
cash on hand of $113,888 and reported total capital deficit of $3,029,694.

For this same period of time, we had revenue of $3,344,699 and general and
administrative expense of $2,639,085.

After interest expenses of $240,447, cost of goods sold of $2,374,805,
product development costs of $85,671 and selling expenses of $1,804,617 incurred
in operations, we had a net loss of $3,799,926.

Year Ended December 31, 2004 Compared to Year Ended December 31, 2003

Consolidated Revenue

We had revenue for the year ended December 31, 2004 of $3,344,699, with
cost of sales of $2,374,805, resulting in a gross margin of $969,894. This
revenue and resultant gross margin are net of slotting fees, promotional
discounts and marketing allowances for this period in the amount of $204,755. Of
the reported $3,344,699, U.S. sales accounted for $2,771,081 with an additional
$573,618 from international sales in Mexico and the Middle East. Our reported
revenue for the year ended December 31, 2004 increased by $2,144,557, a 178.69%
increase compared to revenue of $1,200,142 for the same period in 2003. This

increase is the result of a change in our method of revenue recognition in the
United States, commencing January 1, 2004, when we began to act as the principal
in these transactions, rather than as an agent. In addition, in the first
quarter of 2004, we began to phase out our Looney Tunes(TM) flavored milk
products and to develop four new branded product lines in the United States,
including the launch of our Slammers(R) line of Marvel Comics Super Heroes(R)
branded flavored milks during the second quarter 2004. We also began to ship
kits to our third-party Middle East dairy processor during the second quarter
2004.

Consolidated Cost of Sales

We incurred cost of goods sold of $2,374,805 for the year ended December
31, 2004, $2,262,055 of which was incurred in our U.S. business, and $112,750 in
connection with out international sales. Cost of goods sold in 2004 increased by
$2,182,307, a 1133.68% increase compared to $192,498 for the same period in
2003. The increase in cost of goods sold reflects an increase in sales, the
change in our role from agent to principal during this period and the
concomitant increase in reported cost of goods sold associated with that change.

In countries except the United States, our revenue is generated by the
sale of kits to dairy processors. Each kit consists of flavor ingredients for
flavored milks and production rights to manufacture and sell the milks. In line
with our revenue recognition policies, we recognize the full invoiced kit price
as revenue, less the cost of production charged by the processor, which we
record as cost of goods sold.

In the United States, we are responsible for the sale of finished
Slammers(R) flavored milk (referred to as "unit sales") to retail outlets. For
these unit sales, we recognize as revenue the invoiced wholesale prices that we
charge to the retail outlets that purchase the Slammers(R) flavored milks. We
report, as cost of goods sold, the price charged to us by Jasper Products, a
third party processor under contract with our company, for producing the
finished Slammers(R) products.

Segmented revenues and costs of sales

The following table presents revenue by source and type against costs of
goods sold, as well as combined gross revenues and gross margins. In countries
other than the United States, revenues for the period ended December 31, 2004
were generated by kit sales to third party processors. Our revenue from the sale
of finished product to retail outlets is recorded as "unit sales" on the
following table.

United Middle
2004 States Canada Mexico East Total Company
----------- -------- --------- --------- -------------

Revenue - unit sales $ 2,726,702 $ -- $ -- $ -- $ 2,726,702
Revenue - gross kit sales 44,379 -- 119,968 453,650 617,997
----------- -------- --------- --------- -----------
Total revenue 2,771,081 -- 119,968 453,650 3,344,699

Cost of goods sold (2,262,055) -- (55,609) (57,141) (2,374,805)
----------- -------- --------- --------- -----------

Gross margin $ 509,026 $ -- $ 64,359 $ 396,509 $ 969,894
=========== ======== ========= ========= ===========

United
2003 States Canada Mexico China Total Company
----------- -------- --------- --------- -------------
Revenue - unit sales $ 356,985 $ -- $ -- $ -- $ 356,985
Revenue - net kit sales 2,737 -- -- -- 2,737
Revenue - gross kit sales 629,999 43,745 145,362 21,314 840,420
----------- -------- --------- --------- -----------
Total revenue 989,721 43,745 145,362 21,314 1,200,142

Cost of goods sold (127,647) (10,403) (45,247) (9,201) (192,498)
----------- -------- --------- --------- -----------
Gross margin $ 862,074 $ 33,342 $ 100,115 $ 12,113 $ 1,007,644
=========== ======== ========= ========= ===========

United States

Revenues for the period ended December 31, 2004 in the United States
increased from $989,721 for the same period in 2003 to $2,771,081 in 2004, a
179.99% increase. The increase is the result of a change in revenue recognition
and the introduction of our new product lines during this period.

In the period ended December 31, 2004, our gross margin for U.S. sales of
$509,026 decreased by $353,048, or by 40.95%, from $862,074 for the same period
in 2003. The decrease in gross margin was the result of our role change from
agent to principal in our U.S. sales transactions, which required us to
recognize the entire cost of production of our milk products against revenues
from the wholesale sales for those products.

Foreign Sales

Revenues for the period ended December 31, 2004 from kit sales in foreign
countries increased from $210,421 for the same period in 2003 to $573,618, a
172.6 % increase. The increase is the result of sales growth in Mexico and the
Middle East during this period.

We recorded $112,750 in costs of kit sales in foreign countries for the
period ended December 31, 2004, an increase of $47,899 or 73.86% from $64,851
for the same period in 2003. As a percentage of sales, the costs of goods sold
decreased 19.7% for the period ended December 31, 2004, from 30.8% for the same
period in 2003. The decrease in cost of goods sold as a percentage of sales was
the result of the commencement of sales in the Middle East, which had
significantly lower costs of goods sold as a percentage of sales than occurred
China, Mexico and Canada.

For the period ended December 31, 2004, the gross profit of $460,868 for
kit sales in foreign countries increased by $315,298 or 216.6%, from $145,570
for the same period in 2003. The increase in gross profit was consistent with
the increase in sales volume and the decease in cost of goods sold for this
period.

Consolidated Operating Expenses

We incurred selling expenses of $1,804,617 for the period ended December
31, 2004, of which we incurred $1,664,520 in our United States operations. Our
selling expense for this period increased by $64,767, a 3.72% increase compared
to selling expense of $1,739,850 for the same period in 2003. The increase in
selling expenses in the current period was due to increased freight and
promotional charges associated with our transition away from our Looney
Tunes(TM) product line and the development of four new product lines, utilizing
newly licensed and directly owned branded trademarks.

Our incurred general and administrative expenses for the period ended
December 31, 2004 were $2,639,085, most of which we incurred in our United
States business operations. Our general and administrative expenses for this
period increased by $389,407, a 17.31% increase compared to $2,249,678 for the
same period in 2003. The increase in general and administrative expenses for the
current period in 2004 is the result of the accrual of the compensation value of
the conversion of management's and directors' options to common stock, in the
amount of $269,750 plus the recording of an additional payroll period in 2004.
This expense is a one-time charge.

As a percentage of total revenue, our general and administrative expenses
decreased from 187.5% in the period ended December 31, 2003, to 78.9% for the
current period in 2004. We anticipate a continued effort to reduce these
expenses as a percentage of sales through revenue growth, cost cutting efforts
and the refinement of business operations.

Interest Expense

We incurred interest expense for the period ended December 31, 2004 of
$240,447. Our interest expense increased by $210,914, a 714.16% increase
compared to $29,533 for the same period in 2003. The increase was due to

additional loans in 2004 and utilizing debt to finance our operations during
this period's transition in licensors of intellectual property utilized by our
company and the development and launch of new product lines.

Loss Per Share

We accrued dividends payable of $388,632 to various series of preferred
stock during the period ended December 31, 2004. Our accrued dividends increased
for this period by $48,728, or 14.33%, from $339,904 for the same period in
2003. The net loss before accrued dividends increased by $782,939, from
$3,016,987 for the period ended December 31, 2003 to $3,799,926 for the current
period, and the increase in accrued dividends was offset by the increase in the
weighted average number of common shares outstanding, resulting in a decrease in
our current period loss per share from $0.15 for the same period in 2003, to a
loss per share of $0.10 for the current period.

Liquidity and Capital Resources

Operations

As of December 31, 2004, we reported that net cash used in operating
activities was $4,122,830, net cash provided by financing activities was
$4,257,500 and net cash used in investing activities was $78,952. We had a
negative working capital of $2,365,969 as of December 31, 2004.

Compared to $1,562,389 of net cash used in operating activities in the
period ended December 31, 2003, our current year net cash used in operating
activities increased by $2,560,441 to $4,122,830. This increase was the result
of our utilization of cash rather than equity to pay service providers in this
current period and changes in deferred product development costs, prepaid
expenses, accounts payable and accrued expenses. Included in the net loss in
this current period were depreciation and amortization and stock compensation
for a finder's fee aggregating $974,847, compared to $194,635 for the same
period in 2003.

Changes in accounts receivable in this current period in 2004 resulted in
a cash decrease of $26,047, compared to a cash increase in receivables of
$210,228 for the same period in 2003, having a net result of a decrease of
$236,275. The changes in accounts payable and accrued liabilities in the period
ended December 31, 2003 contributed to a cash increase of $1,285,443, whereas
the changes in accounts payable and accrued liabilities for the current period
in 2004 amounted to a decrease of $593,475. We have adopted and will keep
implementing cost-cutting measures to lower our costs and expenses and to pay
our company's accounts payable and accrued liabilities by using cash and equity
instruments. Our cash flow generated through operating activities was inadequate
to cover all of our cash disbursement needs in the period ended December 31,
2004, and we had to rely on equity and debt financing to cover expenses.

Cash used in 2004 in investing activities for equipment was $78,952 for
software, computer equipment and leasehold improvements in the U.S., compared to
$31,323 for the same period in 2003.

Net cash provided by financing activities for the period ended December
31, 2004 was $4,257,500. Net cash provided by financing activities for the same
period in 2003 was $1,427,062, for a net increase of $2,830,438. The increase
was due primarily to issuing Series K preferred stock with gross proceeds of
$950,000 and debt in the aggregate amount of $3,427,500 in this current period.

We used the proceeds of the current period financing for working capital
purposes and to repay approximately $1,128,386 for a note to Jasper Products.

Going forward, our primary requirements for cash consist of the following:

o the continued development of our business model in the United States
and on an international basis;
o general overhead expenses for personnel to support the new business
activities;
o development, launch and marketing costs for our line of new branded
flavored milk products, and
o the payment of guaranteed license royalties.

We estimate that our need for financing to meet cash needs for operations
will continue through the fourth quarter of 2005, when we expect that cash
supplied by operating activities will approach the anticipated cash requirements
for operation expenses. We anticipate the need for additional financing in 2005
to reduce our liabilities, assist in marketing and to improve shareholders'
equity status. No assurances can be given that we will be able to obtain
additional financing, or that operating cash flows will be sufficient to fund
our operations.

We currently have monthly working capital needs of approximately $220,000.
We will continue to incur significant selling and other expenses in 2005 in
order to derive more revenue in retail markets, through the introduction and
ongoing support of our new products. Certain of these expenses, such as slotting
fees and freight charges, will be reduced as a function of unit sales costs as
we expand our sales markets and increase our sales within established markets.
Freight charges will be reduced as we are able to ship more full truckloads of
product given the reduced per unit cost associated with full truckloads versus
less than full truckloads. Similarly, slotting fees, which are paid to
warehouses or chain stores as initial set up or shelf space fees, are
essentially one-time charges per new customer. We believe that along with the
increase in our unit sales volume, the average unit selling expense and
associated costs will decrease, resulting in gross margins sufficient to
mitigate cash needs. In addition, we are actively seeking additional financing
to support our operational needs and to develop an expanded promotional program
for our products.

We are continuing to explore new points of sale for our branded flavored
milk. Presently, we are aggressively pursuing the school and vending market
through trade/industry shows and individual direct contacts. The implementation
of such a school base program, if viable, could have an impact on the level of
our revenue during 2004. Similarly, we expect that the greater control over
sales resulting from our refined business model and the anticipated expansion
into bodega stores as well as national chains, such as 7-Eleven, will have a
positive impact on revenues.

New Product Lines

In the third quarter 2003, we commenced an analysis of the Looney
Tunes(TM) brand performance within the context of the possible renewal of our
Warner Bros. licenses for United States, Mexico, China and Canada. In the fourth
quarter 2003, we concluded that, as a function of the sales of flavored milks,
the Looney Tunes(TM) brand has not supported the guaranteed royalty structure
required by Warner Bros. for its licenses. In the fourth quarter 2003, we
decided not to renew our license agreements with Warner Bros., and began to
develop new products in anticipation of the consummation of other license
relationships with Marvel Comics and MoonPie for co-branded flavored milk, as
well as a new single Slammers(R) brand. We have developed new aseptic products
in anticipation of these licenses and our own singular brand. We launched four
brands in 2004, beginning with Ultimate Slammers in April and achieved national
distribution of Ultimate Slammers through both retail grocers and convenience
stores by mid- summer. Roughly 10,000 retail supermarket stores carried this
brand nationwide in 2004. This was followed by the June launch of Slim
Slammers(R) and Moon Pie Slammers(R) and the July release of the
Pro-Slammers(TM).

Coincident with the Marvel license, we executed a production agreement
with Saudia Dairy & Foodstuff Company (SADAFCO), one of the largest Middle East
dairy processors, headquartered in Jeddah, Saudi Arabia. SADAFCO processes our
Slammers (R) branded flavored milks, including the Marvel line, for distribution
in nine Middle East countries. SADAFCO has the capacity to process our branded
milk products for distribution throughout the European Community. AsheTrade, our
international agent, facilitated our international business in 2004 with offices
in Miami, Florida and Jeddah, Saudi Arabia.

On September 21, 2004, we entered into a licensing agreement with
Masterfoods USA, a division of Mars, Incorporated, for the use of Masterfood's
Milky Way(R) Starburst(R) and 3 Musketeers(R) trademarks in connection with the
manufacture, marketing and sale of single serve flavored milk drinks in the
United States, our possessions and Territories, and US Military installations
worldwide. The license limits the relationship of the parties to separate
independent entities. The initial term of the license agreement expires December
31, 2007. We have agreed to pay a royalty based upon the total net sales value
of the licensed products sold and advance payments of certain agreed upon
guaranteed royalties. Ownership of the licensed marks and the specific milk
flavors to be utilized with the marks remains with Masterfoods. We have been
granted a right of first refusal for other milk beverage products utilizing the
Masterfoods marks within the license territory.

External Sources of Liquidity

Individual Loans

On November 6 and 7, 2001, respectively, we received the proceeds of two
loans aggregating $100,000 from two offshore lenders. The two promissory notes,
one for $34,000 and the other for $66,000, were payable February 1, 2002 and
bear interest at the annual rate of 8%. These loans are secured by a general
security interest in all our assets. On February 1, 2002, the parties agreed to
extend the maturity dates until the completion of the anticipated Series H
financing. On September 18, 2002, the respective promissory note maturity dates
were extended by agreement of the parties to December 31, 2002. On September 18,
2002, we agreed to extend the expiration dates of warrants issued in connection
with our Series D and F preferred until September 17, 2005 and to reduce the
exercise price of certain of those warrants to $1.00, in partial consideration
for the maturity date extension. The holders of these notes have agreed to
extend the maturity dates, and the notes are now payable on a demand basis.

On August 27, 2003, we received the proceeds of a loan from Mid-Am
Capital, L.L.C., in the amount of $150,000. The note was payable November 25,
2003 and bears interest at the annual rate of 10%. This loan was secured by a
general security interest in all our assets. On April 2, 2004, this note was
paid and cancelled.

On January 28, 2004, we converted accounts payable in the amount of
$1,128,386 by the issuance of a 10% short term promissory note to Jasper
Products, LLC, dated January 1, 2004, in the principal amount of $1,128,386 for
amounts owed to Jasper in connection with Jasper's processing and sale of our
products. As of March 31, 2004, we paid $200,000 in principal and was credited
an additional $11,350. On April 20, 2004, we paid an additional $200,000. On May
7, 2004, we paid $717,036 in full payment of the note's principal and accrued
interest.

On May 6, 2004, we issued a secured promissory note to Mid- Am Capital LLC
in the principal amount of $750,000. The note provides for 8% interest. The
note's original maturity date of September 4, 2004 has been extended to January
31, 2005. We issued warrants to purchase 3,000,000 shares of our common stock to
Mid-Am in connection with this promissory note. The warrants are exercisable for
one year from issue at an exercise price of $0.25 per share. We used the
proceeds of this promissory note to pay the promissory note issued to Jasper
Products in January 2004.

Convertible Debentures

To obtain funding for our ongoing operations, we entered into the
following financing transactions in 2004.

April 2004

In April 2004, we entered into a Subscription Agreement with two
accredited investors for the sale of (i) $500,000 in convertible debentures and
(ii) warrants to buy 3,000,000 shares of our common stock at $0.15 per share. In
connection with this financing, we paid a fee, which included an aggregate of
convertible debentures in the amount of $50,000.

The debentures issued in connection with the April 2004 financing bear
interest at 10%. The principal on the notes is due in equal monthly installments
commencing on November 1, 2004 until October 1, 2005. On October 1, 2005, all
principal and interest shall become due. In the event that our common stock has
a closing price in excess of $.20 for the five days preceding the monthly
payment, then, within our discretion, the monthly payment may be deferred. The
notes are convertible into our common stock at $0.10 per share. Based on this
conversion price, the $550,000 convertible debentures, excluding interest, were
convertible into 5,500,000 shares of our common stock.

The note holders have contractually agreed to restrict their ability to
convert or exercise their warrants and receive shares of our common stock such
that the number of shares of common stock held by them and their affiliates
after such conversion or exercise does not exceed 9.99% of the then issued and
outstanding shares of common stock.

June 2004

In June 2004, we entered into a Subscription Agreement with Longview Fund,
LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited, Stonestreet
Limited Partnership and Mid-Am Capital L.L.C for the issuance of convertible 10%
notes in the aggregate amount of $1,300,000 and five-year "A" warrants for the
purchase of, in the aggregate, 5,200,000 shares of common stock, at $0.25 per
share, and five-year "B" warrants for the purchase of, in the aggregate,
13,000,000 shares of common stock, at $2.00 per share. In connection with the
October 2004 financing, we subsequently amended the exercise price to $.15 for
the "A" warrants issued to Longview Fund, LP, Alpha Capital Aktiengesellschaft,
Whalehaven Funds Limited and Stonestreet Limited Partnership. The notes are
convertible into shares of our common stock at $0.15 per common share. The notes
are payable in twelve equal monthly installments, commencing January 1, 2005.
The installment payments consist of principal and a "premium" of 20% of the
principal paid per installment. We have the option to defer such payment until
the note's maturity date on December 1, 2005, if our common stock trades above
$0.20 for the five trading days prior to the due date of an installment payment.
In connection with this transaction, we issued additional notes in the aggregate
amount of $40,000 to Gem Funding, LLC, Bi-Coastal Consulting Corp., Stonestreet
Limited Partnership and Libra Finance, S.A upon identical terms as the principal
notes, as a finder's fee, and paid $12,500 in legal fees. The common stock
underlying all notes and warrants carry registration rights.

October 2004

On October 29, 2004, we entered into Subscription Agreements with Longview Fund,
LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and Stonestreet
Limited Partnership for the issuance of convertible 10% notes in the aggregate
amount of $550,000 and five-year "C" warrants for the purchase of, in the
aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.

December 2004

In December 2004, we entered into Subscription Agreements with Momona
Capital Corp. and Ellis International Ltd. for the issuance of convertible 10%
notes in the aggregate amount of $200,000 and five-year "C" warrants for the
purchase of, in the aggregate, 800,000 shares of common stock, at $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in

the aggregate amount of $10,000 to Momona Capital Corp. and Ellis International
Ltd. upon identical terms as the principal notes, as a finders' fees. The common
stock underlying all notes and warrants carry registration rights.

EFFECTS OF INFLATION

We believe that inflation has not had any material effect on our net sales
and results of operations.

BUSINESS

Our company

Our company is a Delaware corporation, which was formed on April 27, 1996.
We formerly owned the majority interest in two Sino-American joint ventures in
China, known as Green Food Peregrine Children's Food Co. Ltd. and Hangzhou
Meilijian Dairy Products Co., Ltd. These two joint ventures processed milk
products for local consumption in the areas of Shanghai and Hangzhou, China,
respectively. We closed Green Food Peregrine in December 1999 and sold our
interest in Hangzhou Meilijian Dairy in December 2000.

In December 1999, we obtained Chinese government approval for the
registration of a new wholly owned subsidiary in the Wai Gao Qiao "free trade
zone" in Shanghai, China. We formed this import-export company to import, export
and distribute food products on a wholesale level in China. In addition, China
Premium (Shanghai) was our legal presence in China with respect to contractual
arrangements for the development, marketing and distribution of branded food
products. We ceased all activities of this Chinese subsidiary in April 2004,
owing to low sales volume and insufficient financial or logistic resources to
market our products profitably in mainland China.

In December 1999, we formed Bravo! Foods, Inc., a wholly owned Delaware
subsidiary, which we utilized to advance the promotion and distribution of
branded Looney Tunes(TM) products in the United States, through production
agreements with local dairy processors. At the end of 2001, we assumed this
business, and our U.S. subsidiary ceased functioning as an operating company at
that time.

On February 1, 2000, we changed our name from China Peregrine Food
Corporation to China Premium Food Corporation, and on March 16, 2001 we changed
our name to Bravo! Foods International Corp.

In January 2005, we formed Bravo! Brands (UK) Ltd., a United Kingdom
registered company that is wholly owned by Bravo! Brands International Ltd. We
will utilize Bravo! Brands (UK) Ltd. to advance the production, promotion and
distribution of licensed branded products in the United Kingdom through
production and sales agent agreements with local entities.

In March 2005, we formed Bravo! Brands International Ltd., a Delaware
subsidiary that will hold license rights for our branded products on an
international basis. We will utilize Bravo! Brands International Ltd. to hold
and exploit certain license rights for branded products developed by us in
international markets through local second-tier subsidiaries such as Bravo!
Brands (UK) Ltd.

The Business

Our business involves the development and marketing of our own Slammers(R)
trademarked brand, the obtaining of license rights from third party holders of
intellectual property rights to other trademarked brands, logos and characters
and the granting of production and marketing rights to processor dairies to
produce branded flavored milk utilizing our intellectual property. In the United
States, we generate revenue from the unit sales of finished branded flavored
milks to retail consumer outlets. Internationally, we generate revenue primarily
through the sale of "kits" to these processors.

"Kits" sold to processors consist of flavor ingredients that are developed
and refined by us and the grant of production rights to processors to produce
the flavored milks. The consideration paid to us under these production
contracts consists of fees charged for our grant of production rights for the
branded flavored milks plus a charge for flavor ingredients. The fees charged by
us for the production rights are set to match royalty fees for our intellectual
property licenses.

All of our licensing agreements recognize that we will use third party
production agreements for the processing of flavored milk products, and that the
milk products will be produced and may be sold directly by those processors. Our
responsibilities under our third party production agreements are to design and
provide approved packaging artwork, to help determine the best tasting flavors
for the particular market and to assist in the administration, promotion and
expansion of the respective branded milk programs. Ingredients for the flavored

milks are formulated to our specifications and supplied on an exclusive basis by
either Givaudan Roure or Mastertaste, both of which are flavor development and
production companies. In the United States, we assume the responsibility for
sales and marketing of our flavored milks produced by Jasper Products LLC.

Third Party Intellectual Property Licenses

Warner Bros. (Looney Tunes(TM))

In January 1999, we commenced a licensing agreement with Warner Bros.
Consumer Products, permitting us to produce and distribute a line of high
quality, flavored milks branded with the Warner Bros. Looney Tunes(TM) logos,
characters and names in the Shanghai and Hangzhou greater metropolitan areas. On
July 27, 2000, we executed a licensing agreement with Warner Bros. to use Looney
Tunes(TM) characters and names on milk products in the United States. The term
of these licenses expired December 31, 2003.

On November 7, 2001, we executed a licensing agreement with Warner Bros.
to use Looney Tunes(TM) characters and names on milk products in Mexico. This
licensing agreement granted us the right to use the Warner Bros. cartoon
characters on milk products for sale in specified retail outlets throughout
Mexico. The initial term of the agreement was for 3 years and expired May 31,
2004.

On May 28, 2002, we executed a licensing agreement with Warner Bros. to
use Looney Tunes(TM) characters and names on milk products in Canada. The
initial term of the agreement was for 25 months and expired March 31, 2004.

The history of all of our Warner Bros. licenses, as a function of sales of
the flavored milks, did not support the guaranteed royalty structure required by
Warner Bros. for its licenses. As a result, we developed our own Slammers(R)
brand in 2003 and, in the fourth quarter of that year, we decided not to seek
the renewal for the China license and not accept the offer of Warner Bros. to
renew the U.S. license. In addition, we decided not to renew our licenses with
Warner Bros. for Canada and Mexico. In 2004, we executed third party licenses
with Marvel Comics, Masterfoods and Moon Pie.

Marvel Enterprises, Inc. (Super Heroes(R) and Marvel Heroes(R))

In January 2004, we commenced a license agreement with Marvel Enterprises, Inc.
Under the terms of the license agreement, we have the right to use certain
Marvel Super Heroes for the packaging and promotion of our flavored milk
products in the United States (including its territories) and nine Middle East
countries for a one-year (renewable) term. We agreed to a royalty rate of 11% on
the amount invoiced to dairy processors for "kits" and 4% of net wholesale sales
in the United States.

On February 4, 2005, we entered into a two-year license agreement for the
utilization of Marvel Heroes characters on our flavored milks in the United
Kingdom and Ireland. We agreed to a royalty rate of 4% of net wholesale sales in
the territory against the prepayment of a guaranteed minimum royalty amount. We
have adopted the unit sales model currently used in the United States. We have
outsourced the infrastructure required for the production, promotion, marketing,
distribution and sale of our products through a production agreement with
Waterfront Corporation in the UK and through an exclusive sales agency agreement
with Drinks Brokers, Ltd. a UK registered company responsible for the launch and
growth of several major beverage brands in the licensed territory.

We currently are negotiating with Marvel to conclude a new one year license for
the United States, Mexico and Canada and a two year license for the Middle East.

Chattanooga Bakery, Inc.( Moon Pie(R) )

In October 2003, we commenced a two-year license agreement with MD Enterprises,
Inc. on behalf of Chattanooga Bakery. Under the terms of the license agreement,
we have the exclusive right to manufacture, distribute, market and sell Moon

Pie(R) flavored milk products in the United States. We agreed to a variable
royalty rate of 3% to 2% of net wholesale sales, depending upon volume.

Masterfoods USA (Starburst(R), Milky Way(R), 3 Musketeers(R))

On September 21, 2004, we entered into a licensing agreement with
Masterfoods USA, a division of Mars, Incorporated, for the use of Masterfood's
Milky Way(R), Starburst(R) and 3 Musketeers(R) trademarks in connection with the
manufacture, marketing and sale of single serve flavored milk drinks in the
United States, its Possessions and Territories, and US Military installations
worldwide. The license limits the relationship of the parties to separate
independent entities. The initial term of the license agreement expires December
31, 2007. We have agreed to pay a royalty based upon the total net sales value
of the licensed products sold and advance payments of certain agreed upon
guaranteed royalties. Ownership of the licensed marks and the specific milk
flavors to be utilized with the marks remains with Masterfoods. We have a right
of first refusal for other milk beverage products utilizing the Masterfoods
marks within the licensed territory.

In House Intellectual Property

In addition to our third-party licenses, we have developed and sell
flavored milks bearing trademarks developed by us, including "Slammers(R)" "Pro
Slammers(TM)" and "Slim Slammers(R)".

Production Contracts/Administration

Prior to 2000, our business primarily involved the production and
distribution of milk in China. In the third quarter of 2000, we began to refocus
our business away from the production - distribution aspect of the value chain
by implementing a business model that involved the branding, marketing,
packaging design and promotion of branded flavored fresh milk in the United
States. During the middle of 2001, this refocused business was implemented in
China, in December 2001 in Mexico and in the third quarter of 2002 in Canada.
Currently, operations in the United States, Mexico and Canada are run directly
by Bravo! Foods International Corp. Our international business, which had been
facilitated by AsheTrade, our international agent, will now be handled by the
company's subsidiary formed in 2005, Bravo! Brands International Ltd. Mr.
Ibrahim Ashemimry, the principal of AsheTrade, has joined Bravo! Brands
International Ltd. as an employee and officer.

United States

The initial dairy processors with which we had production contracts were
members of Quality Chekd Dairies, Inc., a national cooperative with over 40
member dairies that process fresh milk on a regional basis. This business, while
viable, proved to have limited sales expansion capabilities in the US owing to
the inherent regional distribution limitations of a "fresh" milk product with a
short shelf life.

The advent of extended shelf life (ESL) and aseptic long life milk
presented us with the opportunity to increase dramatically sales on a national
basis. In the third quarter of 2001 and the first quarter of 2002, we entered
into production contracts with Shamrock Farms, located in Phoenix, Arizona and
Jasper Products, of Joplin, Missouri, and began to market branded ESL and
aseptic flavored milks to large national chain accounts. Since 2003, we have our
ESL and aseptic milks produced by Jasper Products

Middle East

In December 2003, we entered into a third party production agreement with
Saudia Dairy & Foodstuff Company, (SADAFCO) one of the largest Middle East dairy
processors, headquartered in Jeddah, Saudi Arabia. SADAFCO processes our
Slammers (R) branded flavored milks, including the Marvel line, for distribution
in nine Middle East countries. Our international business is facilitated by
AsheTrade, our international agent, with offices in Miami, Florida and Jeddah,
Saudi Arabia.

Mexico

In December 2001, we commenced a contractual relationship with Neolac S.A,
a national dairy processor located in central Mexico. We sell kits to Neolac,
including production rights for our branded flavored milk for all of Mexico. Our
responsibilities are to design and provide approved packaging artwork, to help
determine the best tasting flavors for the particular market and to assist in
the administration, promotion and expansion of the branded flavored milk
program. Ingredients for the flavored milks are formulated to our specifications
and supplied on an exclusive basis by Mastertaste. We do not have any
responsibility for or participation in sales or distribution in Mexico.

Canada

In April 2002, we commenced a contractual relationship with Farmers Dairy,
a dairy processor located in Halifax, Nova Scotia, Canada. We sold kits to
Farmers Dairy, including production rights for our branded flavored milk
products. In early 2004, the relationship with this processor terminated.
Currently, we are negotiating with a large dairy processor for a third party
production contract, that will be administered by a newly formed subsidiary to
be known as Bravo! Brands (Canada) Ltd.

Products

Commencing in September of 2000, we implemented the "kit" sales program
with third party dairy processors in the United States, for the production and
sale of fresh branded flavored milk in single serve plastic bottles. This
product, as with all of our U.S. products up to September 2000, had a limited
shelf life of, generally, 21 days.

In early 2002, we developed branded extended shelf life and aseptic,
bacteria free, long life flavored milk products. The extended shelf life product
was sold in 11.5oz single serve plastic bottles and had to be refrigerated. The
shelf life of this product is 90 days. Our aseptic product does not require
refrigeration and has a shelf life of 8 months. This product was packaged in an
11.2oz Tetra Pak Prisma(TM) sterile paper container. Both of these products were
introduced to the public in the second and third quarters of 2002.

Commencing in May 2002, we developed a new branded fortified flavored milk
product under the "Slammers(R) Fortified Reduced Fat Milk" brand name. We use
our Slammers(R) brand in conjunction with our licensed third party trademarks.
Slammers(R) is made from 2 percent fat milk and is fortified with 11 essential
vitamins. The introduction of this new product and the phase out of our
"regular" branded milks occurred in the fourth quarter of 2002. Our Slammers(R)
flavored milks are sold in the United States in single serve extended shelf life
plastic bottles, as well as the long life aseptic Tetra Pak Prisma(TM) package.
Our Slammers(R) flavored milks are sold in Mexico and have been sold in Canada
in single serve extended shelf life plastic bottles.

In October 2002, Parmalat introduced Looney Tunes(TM) brand fortified
aseptic milk, packaged in an 8oz Tetra-Brik(TM) format under our Slammers
Fortified Reduced Fat Milk(R) logo pursuant to a production agreement that we
executed in June 2002. The 8oz Tetra Brik Slammers(R) does not require
refrigeration and has a shelf life of 6 months. Currently, this product is no
longer available.

In November 2002, we introduced Slim Slammers(R) Fortified Milk, a low
calorie version of our Slammers (R)Fortified Reduced Fat Milk. Slim Slammers(R)
Fortified Milk has no added sugar and is sweetened with sucralose, a natural
sweetener made from sugar. Slim Slammers(R) Fortified Milk is made from 1
percent fat milk, is fortified with 11 essential vitamins and is available in
the same flavors as our Slammers(R) brand. We reintroduced this product in the
United States with a new package and formulation during 2004.

In 2004, we announced our product development and brand strategy for seven
new, separate and distinct single serve product lines. Ultimate Slammers(TM),
Slim Slammers(R), Moon Pie Slammers(R), Pro-Slammers(TM), Starburst(R)
Slammers(R), 3 Musketeers(R) Slammers(R), and Milky Way(R) Slammers(R) are all
fortified and positioned to appeal directly to profiled demographic segments,
including teens and pre teens for Ultimate Slammers(TM), Starburst(R)
Slammers(R) and , Milky Way(R) Slammers(R), teens and sports enthusiasts for
Pro-Slammers(TM), young to old for Moon Pie(R) Slammers(R) and health conscious
adults for Slim Slammers(R) and3 Musketeers(R) Slammers(R).

We launched four brands in 2004, beginning with Ultimate Slammers(R) in
April and achieved national distribution of Ultimate Slammers(R) through both
retail grocers and convenience stores by mid- summer. Roughly 10,000 retail

supermarket stores carried this brand nationwide in 2004. This was followed by
our June launch of Slim Slammers(R) and Moon Pie (R)Slammers(R) and the July
release of our Pro-Slammers(TM) line.

Industry Trends

The flavored milk industry has grown from approximately $750 million in
1995 to $2.5 billion in 2004. The single serve portion of this category is
difficult to measure, since approximately 2/3 of the sales in the single serve
milk industry are sold in immediate consumption channels or other channels that
do not report scan-data. For example, Wal-Mart, has become the largest retailer
in the USA for milk, selling an estimated 15% of total milk sales. Wal-Mart does
not report sales for the industry data resources embodied in A.C. Neilson or IRI
analyses. Similarly, most convenience stores and "up-and-down-the-street"
retailers in the immediate consumption sales channels do not report either, and
neither do vending and schools.

We have analyzed the industry using reports available from milk and
beverage industry sources. These include the total, segmented and rate of growth
sales that are reported, the immediate consumption sales rates for all
consumables compared to retail grocery buying patterns and opinions of experts
in the milk industry as to the relative size of reported versus non-reported
sales. Based upon these reports and analysis, we believe the current size of the
single serve flavored milk industry (packaging 16 oz. or smaller) is
approximately $1.5 billion domestically. The industry grew at annual rates of
between 5 and 15 percent during the last five years but was virtually flat in
the last two years while it digested the remarkable 10-year growth rates. We
believe that this space is positioned for growth now and will continue to be in
the immediate consumption channels such as vending, convenience stores and food
service market segments.

Market Analysis

The flavored milk business is a relatively new category in the dairy
field. The flavored "refreshment" segment is both the fastest growing and most
profitable category in the industry and is receiving the most attention in the
industry today. Pioneered by Nestle with the NesQuik line and Dean Foods with
its Chug brand, this "good for you" segment is in demand both in the U.S. and
internationally.

The International Dairy Foods Association reports that, although flavored
milk currently amounts to only 5 to 6 percent of milk sales, it represents over
59% of the growth in milk sales. With the total milk category exceeding $9.3
billion in 2004, the flavored milk segment was approximately $2.5 billion in
2004, with single serve flavored milk growing to approximately $1.5 billion for
the same period. Statistically, as the flavored segment grows, the entire
category grows as well. In the past ten years, selling more flavored milks has
resulted in more sales of white milk as well.

In addition, the International Dairy Foods Association and Dairy
Management Inc. have reported on studies suggesting that dairy products may help
in weight loss efforts when coupled with a reduced calorie diet, based on data
associating adequate calcium intake with lower body weight and reduced body fat.
We continue to develop a niche in the single serve flavored milk business by
utilizing strong, national branding as part of the promotion of our Slammers(R),
Pro Slammers(TM) and Slim Slammers(R) products. This niche has as its focus the
increased demand for single serve, healthy and refreshing drinks.

Market Segment Strategy

The Bravo! product model addresses a very clear and concise target market.
We know from experience that the largest retailers of milk products are
demanding new and more diverse refreshment drinks, specifically in the dairy
area, in response to consumer interest and demand. To that end, we have and will
continue to differentiate our products from those of our competitors through
innovative product formulations and packaging designs, such as those implemented
in our Slammers(R) and Pro Slammers(TM) fortified milk product lines and our
Slim Slammers(R) low calorie, no sugar added products.

Our Slammers(R) milk products have had promising results penetrating this
arena as consumers continue to look for healthy alternatives to carbonated
beverages. The positioning of our products as a healthy, fun and great tasting
alternative refreshment drink at competitive prices to more traditional
beverages creates value for the producer and the retailer alike. This "profit

orientation" for the trade puts old-fashioned milk products in a whole new
light. The consumer is happy, the retailer is happy and the producer is able to
take advantage of the value added by the brand and the resulting overall
increase in milk sales.

We currently are implementing a very important "first-to-market" strategy
that we feel will dramatically reposition our brands and company. Until now, all
single served flavored milk in plastic bottles required refrigeration for
storage, distribution, and shelf placement. Our strategic partner, Jasper
Products, became America's first processor with FDA approval to offer a "shelf
stable" re-sealable plastic bottle for ambient milk products that do not require
refrigeration.

The tactical advantage of distributing our milk products at ambient
temperatures enables us to side-step a major entry barrier in our immediate
consumption strategy. Most beverages are distributed ambient either through
beverage distribution channels or warehouse "candy and tobacco" distributors.
Refrigerated milk was relegated to dairy direct-store-delivery systems that are
controlled by either regional dairy processors or larger national dairy holding
companies such as Dean Foods or H.B. Hood. We avoid the roadblock of being
reliant upon our competition for chilled distribution since we are now in the
unique position to use the more traditional distribution network that
accommodates non-refrigerated beverages. We currently are converting all of our
products into ambient "shelf stable" re-sealable plastic bottles.

We have been and continue to pursue a strategic goal of placing
Slammers(R) milks in elementary, middle and high schools through ala carte lunch
programs and vending facilities in school cafeterias and we are promoting our
Slim Slammers(R) milks as low calorie, non-sugar added alternatives to
traditional soft drinks. Penetration of this market segment has been limited by
logistic and economic concerns of school administrators in the push to remove
traditional carbonated soft drinks from schools in favor of milk and milk based
products.

Competition

Nestle pioneered the single serve plastic re-sealable bottle which has
become the standard for this industry, and they currently enjoy a dominant
market share. Dean Foods owns a number of regional single serve brands that are
sold in this format, and they also have an exclusive license to produce Hershey
brand flavored milk nationwide. Our analysis indicates that the Nestle's Nesquik
brand accounts for approximately 30-35 percent of the U.S. single serve milk
category, while Hershey's market share is approximately half that, at around
15%. The other competition comes from private label and regional dairy brands.
Our Slammers(R) milks are the only other single serve brand distributed
nationally in America in plastic re-sealable containers.

Our resources for promotions have been limited, and we run significantly
less promotional activities in comparison to our competitors. Where we are in
direct competition with Nestle and Hershey, however, we have been able to
maintain competitive sales levels.

Employees

We have twelve full time employees located at our North Palm Beach
corporate offices. China Premium Food Corp (Shanghai) Co. Ltd., ceased
operations and does not maintain any employees in China.

Description of Property

Neither our company nor our subsidiaries currently own any real property. As of
February 1, 1999, we moved our corporate offices from West Palm Beach to 11300
US Highway 1, Suite 202, North Palm Beach, Florida, pursuant to a lease with HCF
Realty, Inc., having an initial term of five years. The current aggregate
monthly rent amounts to approximately $7,468, which includes an expansion of our
office space from 2,485 square feet to 3,490 square feet. The term of this lease
has been extended for six years to October 30, 2010.

We do not have a policy to acquire property for possible capital gains or
income generation. In addition, we do not invest in securities of real estate
entities or developed or underdeveloped properties.

MANAGEMENT

DIRECTORS AND EXECUTIVE OFFICERS

The directors, executive officers and significant employees/advisors are as of
December 15, 2004, as follows. Our directors serve for staggered terms of two
years or until their successors are elected. On March 6, 2003, the Board voted
to reduce the board positions by one to nine.

Name of Officer and Age Position with the Company Year Appointed
----------------------- ------------------------- --------------

Bravo! Foods International Corp.

Stanley A. Hirschman 58 Chairman and Director 2000
Roy G. Warren 49 Director, Chief Executive Officer 1997/1999
Tommy E. Kee 56 Chief Financial Officer, Treasurer 2003
Roy D. Toulan, Jr 59 Vice President, Corporate Secretary, General Counsel 2003
Michael Edwards 45 Vice President Sales 2000
Benjamin Patipa 49 Vice President, Schools/Vending 2002
Arthur W. Blanding 77 Director 1999
Robert Cummings 62 Director 1997
Paul Downes 43 Director 1997
John McCormack 46 Director 1997
Phillip Pearce 76 Director 1997

The experience and background of the Company's executive officers follow:

Mr. Stanley A. Hirschman - Chairman and Director since September 2000

Mr. Hirschman is president of CPointe Associates, Inc., an executive
management and consulting firm specializing in solutions for emerging companies
with technology-based products. CPointe was formed in 1996. In addition, he is a
director of Redwood Grove Capital Management, LLC, Global Marketing Partners,
Inc. and AirNET Wireless, LLC. Prior to establishing CPointe Associates, Mr.
Hirschman was vice president of operations of Software, Etc., Inc., a retail
software chain, from 1989 until 1996. Mr. Hirschman has also held senior
management positions with retailers T.J. Maxx, Gap Stores and Banana Republic.
Mr. Hirschman currently serves on the Audit Committee of the Company's board of
directors.

Mr. Roy G. Warren - Chief Executive Officer since May 1999; Director since 1997

Mr. Warren serves as our Chief Executive Officer and as a director. As
Chief Executive Officer, Mr. Warren continues to develop strategy for our growth
and external financial matters.

For 15 years from 1981 through 1996, Mr. Warren was in the securities
brokerage industry. During those years, Mr. Warren acted as executive officer,
principal, securities broker and partner with brokerage firms in Florida, most
notably Kemper Financial Companies, Alex Brown & Sons and Laffer Warren &
Company. Mr. Warren currently serves on the Executive Committee of the Company's
board of directors.

Mr. Warren also serves as a director of our U.S. subsidiary, Bravo! Foods,
Inc. and our wholly owned Chinese subsidiary, China Premium Food Corp (Shanghai)
Co., Ltd.

Mr. Tommy E. Kee - Chief Financial Officer, Treasurer since 2003

Tommy Kee joined our company in March 2003 as Chief Financial Officer. He
graduated with an MBA from the University of Memphis and a BS degree in
accounting from the University of Tennessee. Before joining us, he served for
several years as CFO for Allied Interstate, Inc. in the West Palm Beach area.

Prior to that, Mr. Kee served as CFO and Treasurer for Hearx Ltd. a West Palm
Beach, Florida public company. He also served 18 years as International
Controller and Financial Director with the Holiday Inns Inc. organization in
Memphis and Orlando. Mr. Kee handles all financial management and reporting for
the Company and works closely with our external auditors and general counsel for
financial reporting and SEC compliance.

Roy D. Toulan, Jr. - Vice President, Corporate Secretary, General Counsel since
2003

Roy Toulan began with the original founders as outside corporate counsel
in 1997 and has been responsible for all of our corporate and business legal
work, including securities matters. Mr. Toulan became Corporate Counsel in
October 2002, when he left his private legal practice in Boston, and Vice
President in January 2003. He received his law degree from Catholic University
in Washington D.C., and for the first 15 years of his career practiced corporate
and securities litigation with large law firms in New York and Boston. Before
joining our company full time, he spent the last 18 years in private practice in
Boston, Massachusetts in general corporate and securities law helping companies
with corporate structure and funding, both domestically and internationally.

Mr. Michael Edwards - Vice President Sales since 2003

Mr. Edwards has been with our company in a sales and marketing capacity
since 2000. Prior to that time, he worked for 5 years in beverage marketing
research for Message Factors, Inc., a Memphis, Tennessee marketing research
firm. Mr. Edwards has a BS degree from Florida State University in Management
and Marketing and spent 13 years in the banking industry, leaving CitiBank to
join Message Factors in 1995.

Dr. Benjamin Patipa - Vice President, Schools/Vending since 2002

Dr. Patipa is a pediatrician with over fifteen years of experience in
directing operations, marketing, sales and facilitating growth in both public
and private companies. In 1987, Dr. Patipa founded and served as the chairman
and CEO of Weight For Me, Inc., a company that developed a proprietary program
which pioneered the delivery of weight control and nutrition services to the
over 12 million obese children and adolescents in America. Weight For Me earned
national and international recognition as the premier program for the control of
obesity in children and adolescents. Dr. Patipa also served at HEARx Ltd. as a
member of the Executive Operating Committee and Sonus USA, Inc., where he lead
the company's franchise licensing and buying group business in the Southeast
United States. Most recently, Dr. Patipa served as Senior Vice President and
Operational Head of eHDL/HealthNet Data Link, Inc., a national electronic
healthcare information company.

Mr. Arthur W. Blanding - Director Since November 1999

Mr. Blanding is president of The Omega Company, an international dairy
industry consulting company. Mr. Blanding has over 50 years experience in
management of dairy processing, sales and strategic planning consulting. He
graduated from Michigan State University in 1956, with a degree in food science,
and in 1964 from Oregon State University with a degree in Food Microbiology and
attended Harvard Business School.

As President of The Omega Company for the past 20 years, Mr. Blanding has
completed over 200 projects successfully, both in the U.S. and abroad. Clients
of The Omega Company include Abbott International, Cumberland Farms, Dairy Gold,
Farm Fresh, Inc., Haagen Dazs, Labatt, Ross Laboratories and Stop & Shop
Company, among others. Mr. Blanding was a consultant for the design and
construction of the dairy processing facility built in Shanghai by Green Food
Peregrine. The Omega Company is a party to a consulting contract with the
Company concerning technical and production issues.

Mr. Robert J. Cummings - Director Since 1997

Mr. Cummings' work experience includes ten years in purchasing at Ford
Motor Company. In 1975, he founded and currently operates J & J Production
Service, Inc., a manufacturing representative business, which is currently
responsible for over $300 million in annual sales.

Mr. Paul Downes - Director Since 1997

Mr. Downes is a director and, from August of 1997 to April of 1998, served
as our Chairman. For the past 12 years, Mr. Downes has managed his personal
diverse portfolio of international investments with concentration in the United
Kingdom, Eastern Europe, North Africa and Asia. In 1985, he founded a group of
nursing homes for the elderly in Great Britain, which he sold in 1990. Prior to
that time, Mr. Downes spent several years organizing golf tournaments and
international golf matches in Malaysia, Singapore, Thailand, Philippines,
Indonesia and Hong Kong, spending two years living in Southeast Asia. Mr. Downes
is one of our "founders" and played a leading role in our initial raising
efforts. From 2001, Mr. Downes has served as the Chairman of a start up software
company located in Delray Beach, Florida.

Mr. Phillip Pearce - Director Since 1997

Mr. Pearce is a "retired" member of the securities industry. Mr. Pearce
served as Chairman of the NASD during which time he was instrumental in the
founding of NASDAQ. Additionally, Mr. Pearce was a former Director of E.F.
Hutton and has served as Governor of the New York Stock Exchange. Since his
retirement in 1988, Mr. Pearce has remained active in the securities industry as
a corporate financial consultant. Mr. Pearce serves on the compensation
committee of our board of directors. Mr. Pearce also serves on our audit
committee. Mr. Pearce serves as a director of Xybernaut Corporation, a reporting
company, and Redwood Grove Capital Management, LLC.

Based upon a review of the appropriate Forms 3, 4 and 5 and any amendments
to such forms filed pursuant to Section 16(a), we report the following
delinquent filings. Senior management and our Directors filed Form 4 reports on
January 28, 2005 for common stock issued on December 31, 2005, owing to a
misunderstanding as to when the delivery of such shares by us to the individual
recipients was to occur.

During 2004, our directors and executive officers have not filed Form 4s
for options that have been authorized pursuant to compensation plans but not
issued.

EXECUTIVE COMPENSATION

Compensation of directors

We compensated Directors for their travel expenses to and from board of
directors' meetings in 2001, 2002, 2003 and 2004. In 2003, there were three in
person meetings and four telephonic board meetings. In 2004, there were three in
person meetings and four telephonic board meetings. Directors received options
for 35,000 shares of common stock for each year as a director through 2001. Each
member of the executive committee has received options for an additional 40,000
shares of common stock for their services from 1998 through 2001. Directors
received additional options for 25,000 shares for 2002 and 2003. On January 13,
2004, the Directors unanimously voted to convert the options to common stock on
a one for one basis. The common shares so converted were issued pursuant to a
Form S-8 registration statement filed December 23, 2004.

Compensation of executive officers

The following table sets forth the compensation paid during the last three
fiscal years to our Chief Executive Officer and the other executive officers of
our company:

Summary Compensation

Annual Compensation Long-Term Compensation
--------------------------------------------------- -------------------------
Restricted Stock Awards All Other
Name & Position Year Salary Bonus 2004 (1) Other and Options Compensation (2)

------------------------- ------ ---------- ------------------ -------------- ------------------------- -----------------

Roy G. Warren President 2001 $180,000 $137,750 value $12,000 2,500,000 employment $220,000 salary
& CEO 2002 $180,000 of converted Medical contract options and $12,000
Director 2003 $220,000 options; $8,462 insurance 255,000 Director (insurance)
2004 $220,000 cash bonus options converted to
common stock per
January 13, 2004 vote
of Directors

Tommy E. Kee 2003 120,000 $15,000 value of $12,000 300,000 employment $60,000 salary
Chief financial; Officer 2004 120,000 converted Medical contract options $12,000
options; $4,615 insurance converted to common (insurance)
cash bonus stock per January 13,
2004 vote of Directors

Roy D. Toulan, Jr. 2003 180,000 $15,000 value $8,900 300,000 employment $180,000 salary
Vice President Secretary 2004 180,000 converted Medical contract options $8,900
Corporate Counsel options; $6,923 (part) converted to common (insurance)
cash bonus Life & stock per January 13,
disability 2004 vote of Directors
insurance

(1) Mr. Warren has waived a 4% EBITDA bonus provision in his employment
contract. Mr. Toulan was granted 100,000 shares of common stock in
2003 as a signing bonus, valued at $28, 000. The reported values of
options converted in 2004 are pursuant to a January 13, 2004 vote of
Directors authorizing conversion, and are valued $0.05 per share.

(2) Amount paid for termination of employment owing to change of
control.

Option Grants

The following table sets forth individual grants of stock options made
during the last completed fiscal year to each of the named executive officers.

Option Grants In Last Fiscal Year
Individual Grants

None.

Aggregated Options Exercised in Last Fiscal Year
And Fiscal Year-End Option Values

------------------------- ------------ ------------ -------------------------------- ----------------------------
Name Shares Value Number of Securities Value of Unexercised
Acquired Realized Underlying Unexercised Options In-the-Money Options at 2004
on Exercise at 2004 Fiscal Year-End Fiscal Year-End

Exercisable / Unexercisable Exercisable / Unexercisable

------------------------- ------------ ------------ ---------------- --------------- ----------------------------

Roy G. Warren President
& CEO 2,755,000 $220,400 -0- -0- -0- -0-
Director (1) (3)

------------------------- ------------ ------------ ---------------- --------------- ----------------------------
Tommy E. Kee
Chief Financial Officer 300,000 $24,000 -0- -0- -0- -0-
Treasurer (2) (3)
------------------------- ------------ ------------ ---------------- --------------- ----------------------------
Roy D. Toulan, Jr.
Vice President Secretary 300,000 $24,000 -0- -0- -0- -0-
Corporate Counsel (2) (3)

------------------------- ------------ ------------ ---------------- --------------- ----------------------------

(1) 2,500,000 employment contract options and 255,000 Director options
converted to common stock per January 13, 2004 vote of Directors

(2) 300,000 employment contract options converted to common stock per January
13, 2004 vote of Directors

(3) The reported value of options converted in 2004 are at market ($0.08 per
share) at January 13, 2004 vote of Directors authorizing conversion, and
at $0.05 per share for income tax reporting purposes

Compensation Plans

Directors

On March 27, 2001, we issued options to our directors, including Roy
Warren, to purchase the aggregate of 925,000 shares of our common stock. The
options have an exercise price of $0.75 and expire March 26, 2006. Directors
received options for 35,000 shares for each full year of service and an
additional 40,000 shares for service on a board committee. On July 1, 2002, we
issued 250,000 options to the Board of Directors, including Roy Warren, for
services rendered as directors. Each director received options for 25,000 shares
of common stock at an exercise price of $0.60. The options can be exercised for
five years.

On January 13, 2004, the Board of Directors adopted a plan to convert on a
one for one basis the options granted to the present employees of our and the
directors currently serving on the Board into a like number of our restricted
shares of common stock. The issuance of such common stock to any individual
director or employee is conditioned upon the execution of the "lockup" agreement
by such director or employee, pursuant to which the recipients of such common
stock shall not sell, transfer, pledge or hypothecate such common stock for a
six month period, commencing on the issue date of such common stock. The
conversion plan adopted by the Board of Directors will result in the issuance of
5,200,000 shares of our restricted common stock to our present directors and
employees.

Employment contracts

o Roy G. Warren Chief Executive Officer

We had a one-year contract with Mr. Warren commencing January 1, 2003, at
an annual base salary of $220,000. The contract provides for the grant of
options for 1,000,000 shares of common stock at $0.50 per share, options for
1,000,000 shares of common stock at $1.50 per share and options for 100,000
shares of common stock at $0.75 per share. During his employment, he also will
receive five-year incentive options for an additional 400,000 shares in tranches
of 100,000, as the public trading price for our stock reaches $2.00, $3.00,
$4.00 and $5.00, respectively. The exercise price for these options will track
the market price for our common stock when granted. Mr. Warren's employment
contract provides for the payment of one year's salary plus medical insurance
costs for termination of employment owing to change of control in our company.
Mr. Warren's employment contract provides for the payment of one year's salary
plus medical insurance costs for termination of employment owing to change of
control. We converted these employment contract options to common stock pursuant
to a vote of the Board of Directors on January 13, 2004. Our Board of Directors
has extended this contract pending the execution of a replacement employment
contract.

Tommy E. Kee, Chief Financial Officer, Treasurer

Mr. Kee has an eighteen-month contract with our company commencing July 1,
2003 at an annual salary of $120,000. We granted options for 300,000 shares of
common stock as an incentive bonus pursuant to an employment contract. The first
100,000 share options tranche vested on July 1, 2003 at an exercise price of
$0.10 per share. The remaining options for 200,000 shares of common stock vest
as follows: options for 100,000 shares on each of December 31, 2003 and 2004,
respectively. All of these options expire five years from vesting. Mr. Kee's
employment contract provides for the payment of six months' salary plus medical
insurance costs for termination of employment owing to change of control in the

Company. We converted these employment contract options to common stock pursuant
to a vote of the Board of Directors on January 13, 2004. Our Board of Directors
has extended this contract pending the execution of a replacement employment
contract.

Roy D. Toulan, Jr., Vice President, General Counsel and Corporate
Secretary

Mr. Toulan has a two-year contract with our company commencing January 1,
2003 at an annual salary of $180,000. An incentive bonus of 100,000 common stock
shares was granted to Mr. Toulan in January 2003, valued at $0.28 per share. In
addition, we granted options for 100,000 shares of common stock as part of the
pursuant to an employment contract. These options vested immediately, expire on
December 30, 2007 and have an exercise price of $0.40 per share. We also granted
options for 200,000 shares of common stock at an exercise price of $0.40 per
share, which vest as follows: options for 100,000 shares on each of December 31,
2003 and 2004. Options for 100,000 shares expire on each of December 30, 2008
and 2009, respectively. Mr. Toulan's employment contract provides for the
payment of one year's salary plus medical insurance costs for termination of
employment owing to change of control in our company. We converted these
employment contract options to common stock pursuant to a vote of the Board of
Directors on January 13, 2004. Our Board of Directors has extended this contract
pending the execution of a replacement employment contract.

Securities authorized for issuance under equity compensation plans

-------------------------- -------------------------- ------------------------------ --------------------------------
Compensation Plan Number of securities to Weighted average price of Number of securities remaining
Category be issued upon exercise outstanding options, for future issuance under
of options, warrants and warrants and rights equity compensation plans
rights

-------------------------- -------------------------- ------------------------------ ------------ -------------------

Directors (former) 335,000 $0.71 0 individual plans
-------------------------- -------------------------- ------------------------------ ------------ -------------------
Employees (former) 591,167 $0.87 60,000 individual plans
-------------------------- -------------------------- ------------------------------ ------------ -------------------
Consultants 1,460,714 $0.30 0 individual plans
-------------------------- -------------------------- ------------------------------ ------------ -------------------
Lender 25,000 $0.40 0 individual plan
-------------------------- -------------------------- ------------------------------ ------------ -------------------
Total 2,412,381 $0.77 60,000
-------------------------- -------------------------- ------------------------------ ------------ -------------------

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth the beneficial ownership of our company's common
stock as of March 4, 2005, as to

o each person known to beneficially own more than 5% of the Company's
common stock
o each of our directors
o each executive officer
o all directors and officers as a group

The following conditions apply to all of the following tables:

o except as otherwise noted, the named beneficial owners have direct
ownership of the stock and have sole voting and investment power with respect to
the shares shown
o the class listed as "common" includes the shares of common stock
underlying the Company's issued convertible preferred stock, options and
warrants

Beneficial Owners

---------------------- ----------------------------------- ------------------------- ------------
Title of Name and Address of Amount and Percent of
Class Beneficial Owner (1) Nature of Class (2)
Beneficial
Ownership

---------------------- ----------------------------------- ------------------------- ------------

Common Amro International, SA (3) 5,985,787 9.99%
Grossmuenster Platz 26
P.O. Box 4401 Zurich, Switzerland
CH 8022
Austinvest Anstalt Balzers
Landstrasse 938
9494 Furstentums Balzers,
Liechtenstein Esquire
Trade & Finance Inc.
Trident Chambers
P.O. Box 146
Road Town,
Tortola, B.V.I.
---------------------- ----------------------------------- ------------------------- ------------
Common The Keshet Fund LP (4) 5,985,787 9.99%
Keshet L.P.
Nesher Ltd
Talbiya B. Investments Ltd.
Ragnall House, 18 Peel Road
Douglas, Isle of Man
1M1 4L2, United Kingdom
---------------------- ----------------------------------- ------------------------- ------------
Common Alpha Capital 5,985,787 9.99%
Aktiengesellschaft (5)
Pradafant 7, Furstentums
9490, Vaduz,
Liechtenstein
---------------------- ----------------------------------- ------------------------- ------------
Common Mid-Am Capital, L.L.C. (5) 5,985,787 9.99%
Northpointe Tower
10220 North Ambassador Drive
Kansas City, MO 64190
---------------------- ----------------------------------- ------------------------- ------------
Common Explorer Fund Management, LLC (5) 5,985,787 9.99%
444 N. Michigan Ave.
Chicago, IL 60611
---------------------- ----------------------------------- ------------------------- ------------
Common Longview Fund LP 3,633,333 6.06%
1325 Howard Avenue #422
Burlingame, CA 94010
Attn: S. Michael Rudolph

---------------------- ----------------------------------- ------------------------- ------------
Common Stonestreet Limited Partnership 5,985,787 9.99%
C/o Canaccord Capital Corporation
320 Bay Street, Suite 1300
Toronto, Ontario M5H 4A6, Canada

---------------------- ----------------------------------- ------------------------- ------------
Common Whalehaven Funds Limited 3,816,667 6.37%

3rd Floor, 14 Par-Laville Road
Hamilton, Bermuda HM08

---------------------- ----------------------------------- ------------------------- ------------
Common Dale Reese (6) 3,305,985 5.52%
125 Kingston Road
Media, PA
---------------------- ----------------------------------- ------------------------- ------------
Common Longview Fund LP(5) 5,985,787 9.99%
1325 Howard Avenue #422
Burlingame, CA 94010
---------------------- ----------------------------------- ------------------------- ------------
Common Gamma Opportunity (5) 5,985,787 9.99%
Capital Partners LP
British Colonial Centre
of Commerce
One Bay Street, Suite 401
Nassau, The Bahamas
---------------------- ----------------------------------- ------------------------- ------------

(1) Beneficial Ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or
investment power with respect to securities. Shares of common stock
subject to options or warrants currently exercisable or convertible, or
exercisable or convertible within 60 days of March 3, 2005 are deemed
outstanding for computing the percentage of the person holding such option
or warrant but are not deemed outstanding for computing the percentage of
any other person.

(2) Percentage based on 59,917,797 shares of common stock outstanding with
respect to the common stock.

(3) Amro International, S.A., Austinvest Anstalt Balzers and Esquire Trade &
Finance Inc. share a common investment representative, attorney and
subscription agreements for the Series D and Series F convertible
preferred stock and are treated as a group for beneficial ownership
purposes. This group is contractually limited to a beneficial ownership of
our equity not to exceed 9.99%. All of the equity listed consists of
convertible preferred and warrants.

(4) The Keshet Fund L.P., Keshet L.P., Nesher Ltd. and Talbiya B. Investments
Ltd. share a common investment representative, attorney and subscription
agreements for the Series G convertible preferred stock and are treated as
a group for beneficial ownership purposes. This group is contractually
limited to a beneficial ownership of our equity not to exceed 9.99%. All
of the equity listed consists of convertible preferred and warrants.

(5) This owner is contractually limited to a beneficial ownership of our
equity not to exceed 9.99%. All of the equity listed consists of
convertible preferred and warrants.

(6) The beneficial owner has the right to convert 107,440 shares of stock
preferred to 107,440 shares of common stock within 60 days.

Management Owners

-------------- ----------------------------- ------------------------- ---------------
Title of Class Name and Address Amount and Percent of
of Management Nature of Class (2)
Owner (1) Ownership

-------------- ----------------------------- ------------------------- ---------------

Common Roy G. Warren 3,321,764 5.54%
11300 US Highway No.1

N. Palm Beach, FL
-------------- ----------------------------- ------------------------- ---------------
Common Paul Downes 288,000 Less than 1%
Tamarind Management Ltd.
20579 S. Charlestown
Boca Raton, FL
33434
-------------- ----------------------------- ------------------------- ---------------
Common Robert Cummings 565,000 Less than 1%
2829 N.E. 44th Street
Lighthouse Point,
FL 33064
-------------- ----------------------------- ------------------------- ---------------
Common John McCormack 787,500 1.31%
8750 South Grant
Burridge, IL 60521
-------------- ----------------------------- ------------------------- ---------------
Common Mr. Arthur W. 452,889 Less than 1%
Blanding
Janesville, WI
53545
-------------- ----------------------------- ------------------------- ---------------
Common Phillip Pearce 256,000 Less than 1%
6624 Glenleaf Court
Charlotte, NC 28270
-------------- ----------------------------- ------------------------- ---------------
Common Stanley Hirschman 369,670 Less than 1%
2600 Rutgers Court
Plano, Texas 75093
-------------- ----------------------------- ------------------------- ---------------
Common Roy D. Toulan, Jr. 1,015,121 1.696%
VP, General Counsel
6 Wheelers Pt. Rd
Gloucester, MA
-------------- ----------------------------- ------------------------- ---------------
Common Tommy Kee 442,385 Less than 1%
CFO, Treasurer
11300 US Highway 1
N. Palm Beach, FL
-------------- ----------------------------- ------------------------- ---------------
Common Executive officers 7,498,329 12.52%
and directors as a
group
-------------- ----------------------------- ------------------------- ---------------

(1) Beneficial Ownership is determined in accordance with the rules of the
Securities and Exchange Commission and generally includes voting or
investment power with respect to securities. Shares of common stock
subject to options or warrants currently exercisable or convertible, or
exercisable or convertible within 60 days of April 2, 2004 are deemed
outstanding for computing the percentage of the person holding such option
or warrant but are not deemed outstanding for computing the percentage of
any other person.

(2) Percentage based on 59,917,797 shares of common stock outstanding with
respect to the common stock.

There currently are no arrangements that may result in a change of
ownership or control.

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

In April 2004, we entered into a Subscription Agreement with two
accredited investors for the sale of (i) $500,000 in convertible debentures and
(ii) warrants to buy 3,000,000 shares of our common stock. Longview Fund LP
purchased a convertible debenture in the amount of $250,000 and warrants to buy
1,500,000 shares of common stock. In June 2004 and October 2004, Longview Fund
LP purchased a convertible debenture in the aggregate amount of $200,000 and
received an warrants to purchase an aggregate of 2,050,000 shares of common
stock. Phillip Pearce, a director of our company and Stanley Hirschman, our
Chairman, serve on the Board of Directors of Redwood Grove Capital Management,
LLC, which has a management agreement with Longview Fund LP. In addition, Mr.
Pearce and Mr. Hirschman each own .05% of the outstanding membership interest of
Redwood Grove Capital Management, LLC.

DESCRIPTION OF SECURITIES TO BE REGISTERED

COMMON STOCK

We are authorized to issue up to 300,000,000 shares of Common Stock, par
value $.001. As of March 4, 2005, there were 59,917,797 shares of common stock
outstanding. Holders of the common stock are entitled to one vote per share on
all matters to be voted upon by the stockholders. Holders of common stock are
entitled to receive ratably such dividends, if any, as may be declared by the
Board of Directors out of funds legally available therefor. Upon the
liquidation, dissolution, or winding up of our company, the holders of common
stock are entitled to share ratably in all of our assets which are legally
available for distribution after payment of all debts and other liabilities and
liquidation preference of any outstanding common stock. Holders of common stock
have no preemptive, subscription, redemption or conversion rights. The
outstanding shares of common stock are validly issued, fully paid and
nonassessable.

We have engaged American Stock Transfer & Trust Company located at 59
Maiden Lane, Plaza Level, New York, NY 10038, as independent transfer agent or
registrar.

INDEMNIFICATION FOR SECURITIES ACT LIABILITIES

Our Articles of Incorporation, as amended, provide to the fullest extent
permitted by Delaware law, our directors or officers shall not be personally
liable to us or our shareholders for damages for breach of such director's or
officer's fiduciary duty. The effect of this provision of our Articles of
Incorporation, as amended, is to eliminate our rights and our shareholders
(through shareholders' derivative suits on behalf of our company) to recover
damages against a director or officer for breach of the fiduciary duty of care
as a director or officer (including breaches resulting from negligent or grossly
negligent behavior), except under certain situations defined by statute. We
believe that the indemnification provisions in our Articles of Incorporation,
as amended, are necessary to attract and retain qualified persons as directors
and officers.

Insofar as indemnification for liabilities arising under the Securities
Act of 1933 (the "Act" or "Securities Act") may be permitted to directors,
officers or persons controlling us pursuant to the foregoing provisions, or
otherwise, we have been advised that in the opinion of the Securities and
Exchange Commission, such indemnification is against public policy as expressed
in the Act and is, therefore, unenforceable.

PLAN OF DISTRIBUTION

The selling stockholders and any of their respective pledgees, donees,
assignees and other successors-in-interest may, from time to time, sell any or
all of their shares of common stock on any stock exchange, market or trading
facility on which the shares are traded or in private transactions. These sales
may be at fixed or negotiated prices. The selling stockholders may use any one
or more of the following methods when selling shares:

o ordinary brokerage transactions and transactions in which the
broker-dealer solicits the purchaser;
o block trades in which the broker-dealer will attempt to sell the
shares as agent but may position and resell a portion of the block

as principal to facilitate the transaction;
o purchases by a broker-dealer as principal and resale by the
broker-dealer for its account;
o an exchange distribution in accordance with the rules of the
applicable exchange;
o privately-negotiated transactions;
o short sales that are not violations of the laws and regulations of
any state or the United States;
o broker-dealers may agree with the selling stockholders to sell a
specified number of such shares at a stipulated price per share;
o through the writing of options on the shares
o a combination of any such methods of sale; and
o any other method permitted pursuant to applicable law.

The selling stockholders may also sell shares under Rule 144 under the
Securities Act, if available, rather than under this prospectus. The selling
stockholders shall have the sole and absolute discretion not to accept any
purchase offer or make any sale of shares if they deem the purchase price to be
unsatisfactory at any particular time.

The selling stockholders may also engage in short sales against the box,
puts and calls and other transactions in our securities or derivatives of our
securities and may sell or deliver shares in connection with these trades.

The selling stockholders or their respective pledgees, donees, transferees
or other successors in interest, may also sell the shares directly to market
makers acting as principals and/or broker-dealers acting as agents for
themselves or their customers. Such broker-dealers may receive compensation in
the form of discounts, concessions or commissions from the selling stockholders
and/or the purchasers of shares for whom such broker-dealers may act as agents
or to whom they sell as principal or both, which compensation as to a particular
broker-dealer might be in excess of customary commissions. Market makers and
block purchasers purchasing the shares will do so for their own account and at
their own risk. It is possible that a selling stockholder will attempt to sell
shares of common stock in block transactions to market makers or other
purchasers at a price per share which may be below the then market price. The
selling stockholders cannot assure that all or any of the shares offered in this
prospectus will be issued to, or sold by, the selling stockholders. The selling
stockholders and any brokers, dealers or agents, upon effecting the sale of any
of the shares offered in this prospectus, may be deemed to be "underwriters" as
that term is defined under the Securities Act of 1933, as amended, or the
Securities Exchange Act of 1934, as amended, or the rules and regulations under
such acts. In such event, any commissions received by such broker-dealers or
agents and any profit on the resale of the shares purchased by them may be
deemed to be underwriting commissions or discounts under the Securities Act.

We are required to pay all fees and expenses incident to the registration
of the shares, including fees and disbursements of counsel to the selling
stockholders, but excluding brokerage commissions or underwriter discounts.

The selling stockholders, alternatively, may sell all or any part of the
shares offered in this prospectus through an underwriter. No selling stockholder
has entered into any agreement with a prospective underwriter and there is no
assurance that any such agreement will be entered into.

The selling stockholders may pledge their shares to their brokers under
the margin provisions of customer agreements. If a selling stockholders defaults
on a margin loan, the broker may, from time to time, offer and sell the pledged
shares. The selling stockholders and any other persons participating in the sale
or distribution of the shares will be subject to applicable provisions of the
Securities Exchange Act of 1934, as amended, and the rules and regulations under
such act, including, without limitation, Regulation M. These provisions may
restrict certain activities of, and limit the timing of purchases and sales of
any of the shares by, the selling stockholders or any other such person. In the
event that the selling stockholders are deemed affiliated purchasers or
distribution participants within the meaning of Regulation M, then the selling
stockholders will not be permitted to engage in short sales of common stock.
Furthermore, under Regulation M, persons engaged in a distribution of securities
are prohibited from simultaneously engaging in market making and certain other
activities with respect to such securities for a specified period of time prior
to the commencement of such distributions, subject to specified exceptions or
exemptions. In regards to short sells, the selling stockholder can only cover
its short position with the securities they receive from us upon conversion. In
addition, if such short sale is deemed to be a stabilizing activity, then the
selling stockholder will not be permitted to engage in a short sale of our
common stock. All of these limitations may affect the marketability of the
shares.

We have agreed to indemnify the selling stockholders, or their transferees
or assignees, against certain liabilities, including liabilities under the
Securities Act of 1933, as amended, or to contribute to payments the selling
stockholders or their respective pledgees, donees, transferees or other
successors in interest, may be required to make in respect of such liabilities.

If the selling stockholders notify us that they have a material
arrangement with a broker-dealer for the resale of the common stock, then we
would be required to amend the registration statement of which this prospectus
is a part, and file a prospectus supplement to describe the agreements between
the selling stockholders and the broker-dealer.

PENNY STOCK

The Securities and Exchange Commission has adopted Rule 15g-9 which
establishes the definition of a "penny stock," for the purposes relevant to us,
as any equity security that has a market price of less than $5.00 per share or
with an exercise price of less than $5.00 per share, subject to certain
exceptions. For any transaction involving a penny stock, unless exempt, the
rules require:

In order to approve a person's account for transactions in penny stocks,
the broker or dealer must

The broker or dealer must also deliver, prior to any transaction in a
penny stock, a disclosure schedule prescribed by the Commission relating to the
penny stock market, which, in highlight form:

SELLING STOCKHOLDERS

The table below sets forth information concerning the resale of the shares
of common stock by the selling stockholders. We will not receive any proceeds
from the resale of the common stock by the selling stockholders. We will receive
proceeds from the exercise of the warrants. Assuming all the shares registered
below are sold by the selling stockholders, none of the selling stockholders
will continue to own any shares of our common stock.

The following table also sets forth the name of each person who is
offering the resale of shares of common stock by this prospectus, the number of
shares of common stock beneficially owned by each person, the number of shares
of common stock that may be sold in this offering and the number of shares of
common stock each person will own after the offering, assuming they sell all of
the shares offered.

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Total
Shares of
Common
Stock
issuable Total Shares of
Upon Percentage Common Percentage Percentage
Conversion of Common Stock Beneficial of Common of Common
of Stock, Included Ownership Stock Beneficial Stock
Debentures Assuming in Included in Owned Ownership Owned
and/or Full Prospectus Prospectus Before After the After
Name(2) Warrants Conversion (1) ** Offering Offering(3) Offering (3)
------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------

Alpha Capital 6,916,667 15.35% Up to 5,076,557 9.99% -- --
Aktiengesellschaft 8,375,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Longview Fund LP 3,633,333 8.74% Up to 4,425,000 8.74% -- --
4,425,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Stonestreet Limited 7,283,333 16.42% Up to 5,076,557 9.99% -- --
Partnership 9,075,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Whalehaven Funds 3,816,667 9.37% Up to 4,775,000 9.37% -- --
Limited 4,775,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Gamma Opportunity 2,583,333 6.10% Up to 3,000,000 6.10% -- --
Capital Partners, LP 3,000,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
MID-AM Capital, L.L.C. 10,333,333 20.62% Up to 5,076,557 9.99% -- --
12,000,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Libra Finance, S.A 218,750 *** Up to 218,750 *** -- --
218,750
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Bi-Coastal Consulting 120,833 *** Up to 181,250 *** -- --
Corp. 181,250

shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Stonestreet Corporation 179,167 *** Up to 268,750 *** -- --
268,750
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Gem Funding LLC 95,833 *** Up to 143,750 *** -- --
143,750
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Momona Capital Corp. 2,450,000 7.00% Up to 3,475,000 7.00* -- --
3,475,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------
Ellis International 2,450,000 7.00% Up to 3,475,000 7.00* -- --
Ltd. 3,475,000
shares of
common
stock

------------------------ ------------ ------------- ------------ ------------- ------------ ------------- ------------

* This column represents an estimated number based on a conversion price as of a
recent date of March 25, 2005 of $.15 with respect to the convertible debentures
issued in June 2004 and $.10 with respect to the convertible debentures issued
in October 2004 and December 2004, divided into the principal amount.

** These columns represents the aggregate maximum number and percentage of
shares that the selling stockholders can own at one time (and therefore, offer
for resale at any one time) due to their 9.99% limitation.

*** Less than one percent.

The number and percentage of shares beneficially owned is determined in
accordance with Rule 13d-3 of the Securities Exchange Act of 1934, and the
information is not necessarily indicative of beneficial ownership for any other
purpose. Under such rule, beneficial ownership includes any shares as to which
the selling stockholders has sole or shared voting power or investment power and
also any shares, which the selling stockholders has the right to acquire within
60 days. The actual number of shares of common stock issuable upon the
conversion of the convertible debentures is subject to adjustment depending on,
among other factors, the future market price of the common stock, and could be
materially less or more than the number estimated in the table.

(1) The actual number of shares of common stock offered in this prospectus, and
included in the registration statement of which this prospectus is a part,
includes such additional number of shares of common stock as may be issued or
issuable upon conversion of the convertible debentures and exercise of the
related warrants by reason of any stock split, stock dividend or similar
transaction involving the common stock, in accordance with Rule 416 under the
Securities Act of 1933. However the selling stockholders have contractually
agreed to restrict their ability to convert their convertible debentures or
exercise their warrants and receive shares of our common stock such that the
number of shares of common stock held by them in the aggregate and their
affiliates after such conversion or exercise does not exceed 9.9% of the then
issued and outstanding shares of common stock as determined in accordance with
Section 13(d) of the Exchange Act. Accordingly, the number of shares of common
stock set forth in the table for the selling stockholders exceeds the number of
shares of common stock that the selling stockholders could own beneficially at
any given time through their ownership of the convertible debentures and the
warrants. In that regard, the beneficial ownership of the common stock by the
selling stockholder set forth in the table is not determined in accordance with
Rule 13d-3 under the Securities Exchange Act of 1934, as amended.

(2) Seymour Braun has investment authority and voting power over all securities,
including the shares of common stock underlying any convertible debenture,
convertible preferred stock and warrants held by Libra Finance, S.A. Among other
investment activities, Libra advises investors on financially assisting small
companies in need of capital. Gamma Capital Advisors, Ltd., an Anguilla, British
West Indies company, is the general partner to the stockholder Gamma Opportunity
Capital Partners, LP, a Cayman Islands registered limited partnership, with the
power to vote and dispose of the common shares being registered on behalf of the
stockholder. As such, Gamma Capital Advisors, Ltd. may be deemed the beneficial
owner of said shares. Jonathan P. Knight, PhD. is a Director to Gamma Capital
Advisors, Ltd., possessing the power to act on its behalf. Gamma Capital
Advisors, Ltd., and Jonathan P. Knight, PhD. disclaim beneficial ownership of
the shares of common stock being registered hereto. Mid-Am, a limited liability
company headquartered in Kansas City, Missouri, is a finance affiliate of Dairy
Farmers of America, Inc. Gerald L. Bos, the CEO and Treasurer of Mid-Am, has
voting and dispositive control over securities held by Mid-Am. Longview Fund LP
is a California limited partnership. S. Michael Rudolph may be deemed the
control person of the shares owned by such entity, with final voting power and
investment control over such shares. Alpha Capital Aktiengesellschaft is a
private investment fund that is owned by all its investors and managed by Mr.
Konrad Ackerman. Mr. Konrad Ackerman may be deemed the control person of the
shares owned by such entity, with final voting power and investment control over
such shares. Bicoastal Consulting Corp is a New Jersey corporation. Peter Benz
may be deemed the control person of the shares owned by such entity, with final
voting power and investment control over such shares. Stonestreet Limited
Partnership is a private investment fund that is owned by all its investors and
managed by Ms. Libby Leonard and Mr. Michael Finkelstein. Ms. Libby Leonard and
Mr. Michael Finkelstein may be deemed control persons of the shares owned by
such entity, with final voting power and investment control over such shares.
Whalehaven Funds Limited is a professional hedge fund incorporated in Bermuda.
The control persons are Evan Schemenauer, Arthur Jones, and Jennifer Kelly,
directors. Michael Finklestein, the President of Stonestreet Corporation, may be
deemed the control person of the shares owned by Stonestreet Corporation with
final voting power and investment control over such shares. Gem Funding LLC is a
Limited Liability Company, and Cory Weisblum, President may be deemed the
control person of the shares owned by such entity, with final voting power and
investment control over such shares. Arie Rabinovitz, the President of Momona
Capital Corp., may be deemed the control person of the shares owned by Momona
Capital Corp. with final voting power and investment control over such shares..
Wilhelm Ungar may be deemed the control person of the shares owned by Ellis
International Ltd. with final voting power and investment control over such
shares.

(3) Assumes that all securities registered will be sold.

Terms of Convertible Debentures

November 2003

To obtain funding for our ongoing operations, we entered into a
Subscription Agreement with an accredited investor on November 21, 2003 for the
sale of (i) $400,000 in convertible debentures, (ii) class A warrants to buy
2,000,000 shares of our common stock and (iii) class B warrants to buy
10,000,000 shares of common stock. In connection with this financing, we paid a
fee, which included (i) 400,000 shares of common stock, (ii) class A warrant to
purchase 2,000,000 shares of common stock and (iii) 10% of the proceeds received
by us in connection with the exercise of the class B warrants, which is payable
in shares of common stock at the rate of one share of common stock for every ten
shares of common stock actually issued upon exercise of the class B warrants.

This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.

The debentures bear interest at 8%, mature on two years from the date of
issuance, and are convertible into our common stock, at the selling
stockholders' option, at the lower of (i) $0.05 or (ii) 75% of the average of
the three lowest intraday trading prices for the common stock on a principal
market for the 30 trading days before but not including the conversion date.
However, during the six months after the issuance of the convertible debenture,
the conversion price shall not be less than $.03 per share unless an event of
default exists. The conversion floor price of $.03 per share shall be extended
indefinitely, if during the six months after the issuance of the convertible
debenture (i) the closing trading price of our common stock for any consecutive
15 day trading period is $.20 or higher, (ii) the daily trading volume for each
such 15 trading days is 300,000 or more shares of common stock and (iii) the

registration statement registering the shares issuable under the convertible
debenture is effective for each such 15 trading days, unless an event of default
exists. Accordingly, the above factors are not satisfied, there is in fact no
limit on the number of shares into which the debentures may be converted. As of
April 27, 2004, the trading prices for our common stock during the preceding 30
trading days as reported on the Over-The-Counter Bulletin Board was $.14 and,
therefore, the conversion price for the convertible debentures was $.05. Based
on this conversion price, the $400,000 convertible debentures, excluding
interest, were convertible into 8,000,000 shares of our common stock. The full
principal amount of the convertible debentures are due upon default under the
terms of convertible debentures.

In connection with a Securities Purchase Agreement dated November 2003, we
have issued 4,000,000 class A and 10,000,000 class B warrants to purchase shares
of common stock. The A warrants are exercisable until three years from the date
of issuance at a purchase price of $0.05 per share. The B warrants are
exercisable until three years from the date of issuance at a purchase price of
$1.00 per share. In 2004, we entered into an agreement with holders of the B
warrants whereby we amended 5,000,000 of the B Warrants to have an exercise
price of $.10 per share.

The conversion price of the debentures and the exercise price of the
warrants may be adjusted in certain circumstances such as if we pay a stock
dividend, subdivide or combine outstanding shares of common stock into a greater
or lesser number of shares, or take such other actions as would otherwise result
in dilution of the selling stockholder's position.

The selling stockholders have contractually agreed to restrict their
ability to convert their convertible debentures or exercise their warrants and
receive shares of our common stock such that the number of shares of common
stock held by them in the aggregate and their affiliates after such conversion
or exercise does not exceed 9.9% of the then issued and outstanding shares of
common stock.

April 2004

The debentures issued in connection with the April 2004 financing bear
interest at 10%. The principal on the notes is due in equal monthly installments
commencing on November 1, 2004 until October 1, 2005. On October 1, 2005, all
principal and interest shall become due. In the event that our common stock has
a closing price in excess of $.20 for the five days preceding the monthly
payment, then, within our discretion, the monthly payment may be deferred. and
the notes are convertible into our common stock at $0.10 per share. Based on
this conversion price, the $500,000 convertible debentures, excluding interest,
were convertible into 5,000,000 shares of our common stock.

June 2004

share. The notes are payable in twelve equal monthly installments, commencing
January 1, 2005. The installment payments consist of principal and a "premium"
of 20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on December 1, 2005, if our common stock
trades above $0.20 for the five trading days prior to the due date of an
installment payment. In connection with this transaction, we issued additional
notes in the aggregate amount of $40,000 to Gem Funding, LLC, Bi-Coastal
Consulting Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon
identical terms as the principal notes, as a finder's fee, and paid $12,500 in
legal fees. The common stock underlying all notes and warrants carry
registration rights.

This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.

October 2004

On October 29, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and
Stonestreet Limited Partnership for the issuance of convertible 10% notes in the
aggregate amount of $550,000 and five-year "C" warrants for the purchase of, in
the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical
terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.

December 2004

affiliates after such conversion or exercise does not exceed 9.99% of the then
issued and outstanding shares of common stock. See the "Selling Stockholders"
and "Risk Factors" sections for a complete description of the convertible
debentures.

This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.

Sample Conversion Calculation

The number of shares of common stock issuable upon conversion of the
debentures is determined by dividing that portion of the principal of the
debenture to be converted and interest, if any, by the conversion price. For
example, assuming conversion of $400,000 of debentures issued in November 2003
on March 4,2 005, a conversion price of $0.05 per share, the number of shares
issuable upon conversion would be:

$400,000/$.05 = 8,000,000 shares

LEGAL MATTERS

Sichenzia Ross Friedman Ference LLP, New York, New York will issue an
opinion with respect to the validity of the shares of common stock being offered
hereby.

EXPERTS

Lazar Levine & Felix LLP , Certified Public Accountants, have audited, as
set forth in their report thereon appearing elsewhere herein, our financial
statements at December 31, 2004 and 2003 and for the year then ended that
appears in the prospectus.

AVAILABLE INFORMATION

We have filed a registration statement on Form SB-2 under the Securities
Act of 1933, as amended, relating to the shares of common stock being offered by
this prospectus, and reference is made to such registration statement. This
prospectus constitutes the prospectus of Bravo! Foods International Corp., filed
as part of the registration statement, and it does not contain all information
in the registration statement, as certain portions have been omitted in
accordance with the rules and regulations of the Securities and Exchange
Commission.

We are subject to the informational requirements of the Securities
Exchange Act of 1934 which requires us to file reports, proxy statements and
other information with the Securities and Exchange Commission. Such reports,
proxy statements and other information may be inspected at public reference
facilities of the SEC at Judiciary Plaza, 450 Fifth Street N.W., Washington D.C.
20549. Copies of such material can be obtained from the Public Reference Section
of the SEC at Judiciary Plaza, 450 Fifth Street N.W., Washington, D.C. 20549 at
prescribed rates. Because we file documents electronically with the SEC, you may
also obtain this information by visiting the SEC's Internet website at
http://www.sec.gov.

INDEX TO FINANCIAL STATEMENTS

BRAVO! FOODS INTERNATIONAL CORP. AND SUBSIDIARY

FINANCIAL STATEMENTS

For the Years Ended December 31, 2004 and December 31, 2003

Report of Independent Registered Public Accounting Firm F-1
Consolidated Balance Sheets F-2
Consolidated Statements of Operations F-4
Consolidated Statement of Capital Deficit F-5
Consolidated Statements of Cash Flow F-6
Notes to Consolidated Financial Statements F-7

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Shareholders
Bravo! Foods International Corp.
North Palm Beach, Florida

We have audited the accompanying consolidated balance sheets of Bravo! Foods
International Corp. as of December 31, 2003 and 2004 and the related statements
of operations and comprehensive loss, shareholders' deficit and cash flows for
the years then ended. These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on these
financial statements based on our audits.

We conducted our audits in accordance with the standards of the Public Company
Accounting Oversight Board (U.S.). Those standards require that we plan and
perform the audits to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes consideration of
internal control over financial reporting as a basis for designing audit
procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the effectiveness of the Company's internal control
over financial reporting. Accordingly, we express no such opinion. An audit also
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits provide a
reasonable basis for our opinion.

In our opinion, the financial statements referred to above present fairly, in
all material respects, the financial position of Bravo! Foods International
Corp. as of December 31, 2003 and 2004 and the results of its operations and its
cash flows for the years then ended in conformity with accounting principles
generally accepted in the United States of America.

The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As shown in the financial statements,
the Company has incurred a net loss of $3,799,926 for the year ended December
31, 2004 and as of that date had a working capital deficiency of $2,365,969 and
a shareholders' deficit of $3,029,694. The Company is also delinquent in payment
of certain debts. These conditions raise substantial doubt about their ability
to continue as a going concern. The financial statements do not include any
adjustments relating to the recoverability and classification of recorded
assets, or the amounts and classification of liabilities that might be necessary
in the event the Company cannot continue in existence. Management's actions in
regard to these matters are more fully described in Note 1.

/s/LAZAR LEVINE & FELIX LLP

New York, New York
March 4, 2005

F-1

BRAVO! FOODS INTERNATIONAL CORP.

CONSOLIDATED BALANCE SHEETS

December 31,
------------
2003 2004
---- ----
Assets

Current assets:

Cash and cash equivalents $ 58,859 $ 113,888
Accounts receivable, net 25,921 51,968
Other receivables 6,331 --
Inventories 54,995 11,656
------------ ------------
Prepaid expenses 201,617 551,510

Total current assets 347,723 729,022

Furniture and equipment, net 68,623 111,206
License rights, net of accumulated amortization 24,065 67,301
Trademarks, net -- 10,249
Deferred product development costs 41,711 162,169
Deposits 10,736 13,900
------------ ------------
Total assets $ 492,858 $ 1,093,847
============ ============
Liabilities and Capital Deficit

Current liabilities:
Note payable to International Paper $ 187,743 $ 187,743
Notes payable to Alpha Capital 100,000 217,954
Notes payable to Mid-Am Capital LLC 150,000 111,262
Notes Payable to Libra Finance -- 40,106
Notes Payable to Longview -- 54,086
Notes Payable to Stonestreet -- 47,014
Notes Payable to Whalehaven -- 17,082
Notes Payable to Bi-Coastal -- 13,649
Notes Payable to Gem Funding -- 8,231
License fee payable to Warner Brothers 147,115 147,115
Note Payable to Gamma -- 59,678
Note Payable to Momona -- 25,885
Note Payable to Ellis -- 25,885
Accounts payable 2,123,705 1,763,339
Accrued liabilities 610,665 375,962
------------ ------------
Total current liabilities 3,319,228 3,094,991

Dividends payable 582,823 928,379
Other notes payable 310,098 100,171
------------ ------------
Total liabilities 4,212,149 4,123,541
------------ ------------

F-2

BRAVO! FOODS INTERNATIONAL CORP.

CONSOLIDATED BALANCE SHEETS

December 31,
------------
2003 2004
---- ----

Commitments and contingencies

Capital Deficit:

Series B convertible, 9% cumulative, and redeemable preferred stock,
stated value $1.00 per share, 1,260,000 shares authorized, 107,440 107,440
Series F convertible and redeemable preferred stock, stated value
$10.00 per share, 130,515 and 55,515 shares issued and outstanding 1,205,44 512,740
Series G convertible, 8% cumulative and redeemable preferred
stock, stated value $10.00 per share, 58,810 shares issued
and outstanding in 2003 520,604 --
Series H convertible, 7% cumulative and redeemable preferred stock,
stated value $10.00 per share, 165,500 shares issued
and outstanding 895,591 895,591
Series I convertible, 8% cumulative and redeemable preferred stock, st 72,192 72,192
Series J convertible, 8% cumulative and redeemable preferred stock, st 854,279 1,854,279
Series K convertible, 8% cumulative and redeemable preferred stock,
stated value $10.00 per share, 95,000 shares issued
and outstanding -- 950,000
Common stock, par value $0.001 per share, 300,000,000 shares
authorized, 28,047,542 and 57,793,501 shares issued
and outstanding 28,045 57,791
Additional paid-in capital 21,144,896 26,257,302
Accumulated deficit (29,548,471) (33,737,029)
Accumulated other comprehensive loss - translation adjustment 689 --
------------ ------------
Total capital deficit (3,719,291) (3,029,694)
------------ ------------

Total liabilities and capital deficit $ 492,858 $ 1,093,847
============ ============

See accompanying notes

F-3

BRAVO! FOODS INTERNATIONAL CORP.

CONSOLIDATED STATEMENTS OF OPERATIONS
AND COMPREHENSIVE LOSS

Years ended December 31,
------------------------
2003 2004
---- ----

Revenue - unit sales $ 356,985 $ 2,726,702

Revenue - net kit sales 2,737 --
Revenue - gross kit sales 840,420 617,997
------------ ------------
Total revenue 1,200,142 3,344,699
Cost of sales (192,498) (2,374,805)
------------ ------------
Gross margin 1,007,644 969,894
Selling expense 1,739,850 1,804,617
Product development 5,570 85,671
General and administrative expense 2,249,678 2,639,085
------------ ------------
Loss from operations (2,987,454) (3,559,479)
Other income (expense):
Interest expense, net 29,533 240,447
------------ ------------
Loss before income taxes (3,016,987) (3,799,926)
Provision for income taxes -- --
------------ ------------
Net loss (3,016,987) (3,799,926)

Dividends accrued for Series B preferred stock (9,669) (9,696)
Dividends accrued for Series G preferred stock (46,457) (15,633)
Dividends accrued for Series H preferred stock (120,818) (116,168)
Dividends accrued for Series I preferred stock (24,000) (24,066)
Dividends accrued for Series J preferred stock (138,960) (160,438)
Dividends accrued for Series K preferred stock -- (62,631)
Deemed dividend on Series J preferred stock (367,211) --
Deemed dividend on Series F preferred stock (195,353) --
------------ ------------
Net loss applicable to common shareholders $ (3,919,455) $ (4,188,558)
============ ============

Weighted average number of common shares outstanding 26,779,222 40,229,738
============ ============

Basic and diluted loss per share $ (0.15) $ (0.10)
============ ============
Comprehensive loss and its components consist of the following:

Net loss $ (3,016,987) $ (3,799,926)

Foreign currency translation adjustment 930 (689)
------------ ------------
Comprehensive loss $ (3,016,057) $ (3,800,615)
============ ============

See accompanying notes

F-4

BRAVO! FOODS INTERNATIONAL CORP.

STATEMENTS OF CAPITAL DEFICIT

FOR THE YEARS ENDED DECEMBER 31, 2003 and 2004

Preferred Stock Common Stock Additional
--------------- ------------ Paid In
Shares Amount Shares Amount Capital
------ ------ ------ ------ -------

Balance, December 31, 2002 613,663 $ 3,803,156 25,732,854 $ 25,730 $ 20,266,464
Issuance of common stock for services -- -- 100,000 100 27,900
Conversion preferred stock (21,398) (147,606) 1,814,688 1,815 169,538
Issuance of Series J preferred stock 100,000 1,000,000 -- -- 367,211
Finders' fees for financing -- -- 400,000 400 65,029
Issuance of warrants for convertible notes -- -- -- -- 49,474
Beneficial conversion feature of convertible notes -- -- -- -- 40,427
SEC registration costs for financing -- -- -- -- (36,500)
Conversion price changes for warrants -- -- -- -- 195,353
Accrued Dividends - Series B -- -- -- -- --
Accrued Dividends - Series G -- -- -- -- --
Accrued Dividends - Series H -- -- -- -- --
Accrued Dividends - Series I -- -- -- -- --
Accrued Dividends - Series J -- -- -- -- --
Net loss for 2003 -- -- -- -- --
Translation adjustment -- -- -- -- --
------------ ------------ ------------ ------------ ------------
Balance, December 31, 2003 692,265 $ 4,655,550 28,047,542 $ 28,045 $ 21,144,896

Issuance of common stock for services -- -- 9,332,300 9,332 666,300

Conversion preferred stock (133,810) (1,213,308) 15,897,701 15,898 1,240,485
Conversion notes payable -- -- 4,265,958 4,266 132,917
Issuance of Series K preferred stock 95,000 950,000 -- -- --
Private Placement financing -- -- 250,000 250 29,750
Issuance of warrants for convertible notes -- -- -- -- 2,778,557
Beneficial conversion feature of convertible notes -- -- -- -- 141,277
SEC registration costs for financing -- -- -- -- (40,656)
Conversion price changes for warrants -- -- -- -- 105,911
Beneficial conversion price changes for warrants -- -- -- -- 373
Stock option expense for consultants -- -- -- -- 57,492
Accrued Dividends - Series B -- -- -- -- --
Accrued Dividends - Series G -- -- -- -- --
Accrued Dividends - Series H -- -- -- -- --
Accrued Dividends - Series I -- -- -- -- --
Accrued Dividends - Series J -- -- -- -- --
Accrued Dividends - Series K -- -- -- -- --
Net loss for 2004 -- -- -- -- --
Translation adjustment -- -- -- -- --
------------ ------------ ------------ ------------ ------------
Balance, December 31, 2004 653,455 $ 4,392,242 57,793,501 $ 57,791 $ 26,257,302
============ ============ ============ ============ ============

Accumulated
Accumulated Comprehensive
Deficit Loss Total
------- ---- -----

Balance, December 31, 2002 $(25,629,015) $ (241) $ (1,533,906)
Issuance of common stock for services -- -- 28,000
Conversion preferred stock -- -- 23,747
Issuance of Series J preferred stock (367,211) -- 1,000,000
Finders' fees for financing -- -- 65,429
Issuance of warrants for convertible notes -- -- 49,474
Beneficial conversion feature of convertible notes -- -- 40,427
SEC registration costs for financing -- -- (36,500)
Conversion price changes for warrants (195,353) -- --
Accrued Dividends - Series B (9,669) -- (9,669)
Accrued Dividends - Series G (46,457) -- (46,457)
Accrued Dividends - Series H (120,818) -- (120,818)
Accrued Dividends - Series I (24,000) -- (24,000)
Accrued Dividends - Series J (138,961) -- (138,961)
Net loss for 2003 (3,016,987) -- (3,016,987)
Translation adjustment -- 930 930
------------ ------------ ------------
Balance, December 31, 2003 $(29,548,471) $ 689 $ (3,719,291)

Issuance of common stock for services -- -- 675,632

Conversion preferred stock -- -- 43,075
Conversion notes payable -- -- 137,183
Issuance of Series K preferred stock -- -- 950,000
Private Placement financing -- -- 30,000
Issuance of warrants for convertible notes -- -- 2,778,557
Beneficial conversion feature of convertible notes -- -- 141,277
SEC registration costs for financing -- -- (40,656)
Conversion price changes for warrants -- -- 105,911
Beneficial conversion price changes for warrants -- -- 373
Stock option expense for consultants -- -- 57,492
Accrued Dividends - Series B (9,696) -- (9,696)
Accrued Dividends - Series G (15,633) -- (15,633)
Accrued Dividends - Series H (116,168) -- (116,168)
Accrued Dividends - Series I (24,066) -- (24,066)
Accrued Dividends - Series J (160,438) -- (160,438)
Accrued Dividends - Series K (62,631) -- (62,631)
Net loss for 2004 (3,799,926) -- (3,799,926)
Translation adjustment -- (689) (689)
------------ ------------ ------------
Balance, December 31, 2004 $(33,737,029) $ -- $ (3,029,694)
============ ============ =============

See accompanying notes

F-5

BRAVO! FOODS INTERNATIONAL CORP.
STATEMENTS OF CASH FLOWS

Years ended December 31,
------------------------
2003 2004
---- ----
Cash flows from operating activities:

Net loss $(3,016,987) $(3,799,926)
Adjustments to reconcile net loss to net cash used in
operating activities:
Depreciation and amortization 101,207 374,215
Stock issuance for compensation and financing finders' fees 93,428 600,632
Options issued for compensation -- 57,492
Registration costs for financing (36,500) (40,656)
Loss on disposal of fixed assets 15,134 6,216
Increase (decrease) from changes in:
Accounts receivable 210,228 (26,047)
Other receivable 8,331 6,331
Advance to vendors 8,719 --
Inventories 67 43,339
Prepaid expenses (189,748) (353,057)
Accounts payable and accrued expenses 1,285,443 (593,475)
Deferred product and development costs (41,711) (397,894)
----------- -----------
Net cash used in operating activities (1,562,389) (4,122,830)
----------- -----------
Cash flows from investing activities:
Purchase of equipment (31,323) (78,952)
----------- -----------
Net cash used in investing activities (31,323) (78,952)
----------- -----------

Cash flows from financing activities:
Proceeds from issuance of Series J preferred stock 1,000,000 --
Borrowings 150,000 --
Proceeds of Series K preferred stock -- 950,000
Convertible notes payable 400,000 3,427,500
Private placement financing -- 30,000
Payment of note payable, bank loan and license fee payable (122,938) (150,000)
----------- -----------
Net cash provided by financing activities 1,427,062 4,257,500
----------- -----------

Effect of changes in exchange rate on cash 930 (689)
----------- -----------
Net (decrease) / increase in cash and cash equivalents (165,720) 55,029
Cash and cash equivalents, beginning of period 224,579 58,859
----------- -----------
Cash and cash equivalents, end of period $ 58,859 $ 113,888
=========== ===========

Cash paid during the year for interest $ -- $ 51,301

Non-cash investing and financing activities:
Stock granted in exchange of debt and payables and services $ 93,428 $ 600,632
Preferred stock and accrued dividends converted to common stock $ 171,353 $ --
Beneficial conversion feature $ 133,611 $ 141,650

See accompanying notes

F-6

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 1 - Organization, Businesses and Going Concern Uncertainty

Bravo! Foods International Corp., formerly known as China Premium Food
Corporation, was incorporated under the laws of the State of Delaware on April
26, 1996. We are engaged in the sale of branded flavored milk products and
flavor ingredients in the United States, the Middle East, Canada and Mexico.

In December 1999, we obtained Chinese government approval for the registration
of China Premium Food Corp (Shanghai) Co. Ltd., a wholly owned subsidiary, in
the Wai Gao Qiao free trade zone in Shanghai, China. This subsidiary was formed
to import, export and distribute food products and flavored milk ingredients on
a wholesale level in China. We ceased all business activities of this Chinese
subsidiary in the second quarter 2004 and did not generate revenue in 2004 from
our China operation.

In January 2005, we formed Bravo! Brands (UK) Ltd., a registered United Kingdom
subsidiary. The company formed this subsidiary to operate our branded flavored
milk business in the United Kingdom. On February 4, 2005, we executed a license
agreement with Marvel Enterprises, Inc., for the use of Marvel Heroes(R) comic
book characters on our products.

Going Concern Uncertainty

As shown in the accompanying consolidated financial statements, we have suffered
operating losses and negative cash flow from operations since inception and have
an accumulated deficit of $33,737,029, a capital deficit of $3,029,694, negative
working capital of $2,365,969 and are delinquent on certain of our debts at
December 31, 2004. Further, our auditors stated in their report on our
Consolidated Financial Statements for the year ended December 31, 2004, that
these conditions raise substantial doubt about our ability to continue as a
going concern. Management plans to increase gross profit margins in our U.S.
business and obtain additional financing and is continuing to reposition our
products with the launch of three new product lines in the first and second
quarters of 2005. While there is no assurance that funding will be available or
that the Company will be able to improve its profit margins, management is
continuing to actively seek equity and/or debt financing, and the Company
received $1,150,000 in the first quarter 2005 as part of a $2,300,000
convertible debt financing. No assurances can be given that the Company will be
successful in carrying out our plans. The consolidated financial statements do
not include any adjustments that might result from the outcome of this
uncertainty.

Use of Estimates

The preparation of financial statements in conformity with accounting principles
generally accepted in the United States of America requires management to make
estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. Among the more significant estimates included in
these financial statements are the estimated allowance for doubtful accounts
receivable and the deferred income tax asset valuation allowance. Actual results
could differ materially from those estimates.

Fair Value of Financial Instruments

The carrying amount of cash, receivables, accrued liabilities and notes payable
are reasonable estimates of their fair value because of the short maturity of
these items.

F-9

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Cash and Cash Equivalents

We consider all highly liquid investments purchased with a remaining maturity of
three months or less to be cash equivalents.

Accounts Receivable and Concentration of Credit Risk

Our financial instruments that are exposed to concentrations of credit risk
primarily consist of cash and accounts receivable.

During the normal course of business, we extend unsecured credit to our
customers who are located in various geographical areas. Typically credit terms
require payments to be made by the thirtieth day following the sale. We
regularly evaluate and monitor the creditworthiness of each customer on a
case-by-case basis. We provide an allowance for doubtful accounts based on our
continuing evaluation of our customers' credit risk. As of December 31, 2004,
the allowance of doubtful accounts aggregated $90,396. We maintain cash accounts
with high credit quality financial institutions. The FDIC insures total cash
balances up to $100,000 per bank. Cash balances in any one financial institution
were not in excess of this limit at December 31, 2004.

Inventory

Inventory, which consists primarily of packing materials and flavor ingredients,
is stated at the lower of cost on the first in, first-out method or market.

Furniture and Equipment

Furniture and equipment are stated at cost. Depreciation is computed primarily
utilizing the straight-line method over a period of seven years for furniture
and five years for equipment.

Maintenance, repairs and minor renewals are charged directly to expenses as
incurred. Additions and betterments to property and equipment are capitalized.
When assets are disposed of, the related cost and accumulated depreciation
thereon are removed from the accounts, and any resulting gain or loss is
included in the statement of operations.

Impairment of Long-Lived Assets

Effective January 1, 2002, we began applying the provisions of Statement of
Financial Accounting Standard No. 144, "Accounting for the Impairment or
Disposal of Long-Lived Assets" ("SFAS No. 144"). SFAS No. 144 requires that
long-lived assets be reviewed for impairment whenever events or changes in
circumstances indicate that the carrying amount of an asset may not be
recoverable through the estimated undiscounted cash flows expected to result
from the use and eventual disposition of the assets. Whenever any such
impairment exists, an impairment loss will be recognized for the amount by which
the carrying value exceeds the fair value.

F-10

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Revenue Recognition

We sell flavor ingredients and production rights (collectively referred to as
"kits") to processor dairies in Mexico and nine Middle East counties and also
sell flavored milk products in the U.S. We recognize revenue when goods are
shipped, and title and the risk and reward of ownership have been passed to the
customer and possible return of goods can be reasonably estimated. The criteria
to meet this guideline are: 1) persuasive evidence of an arrangement exists, 2)
delivery has occurred or services have been rendered, 3) the price to the buyer
is fixed or determinable and 4) collectibility is reasonably assured.

We follow the final consensus reached by the Emerging Issues Task Force (EITF)
99-19, "Reporting Revenue Gross as a Principal versus Net as an Agent". Pursuant
to EITF 99-19, our sales of kits made directly to customers are reflected in the
statement of operations on a gross basis, whereby the total amount billed to the
customer is recognized as revenue. Sales of kits made through intermediaries, in
whom our role is similar to that of an agent, are reflected on a net basis,
which represents the amount earned by us in the transaction.

We have production agreements with processors of dairy products pursuant to
which we sell flavored milk products to retail stores (referred to as "unit
sales"). We benefit from the difference between the prices charged by the dairy
processor to produce the product for us and the price paid by retail stores to
purchase the product. We bear the responsibility for paying food brokers fees,
transportation and delivery expenses and sample expense, etc. We recognize
revenue on the gross basis and recognize the aforementioned expenses as selling
expenses.

Shipping and Handling Costs

Shipping and handling costs incurred by us are included in selling expenses and
aggregated $504,971 and $ 498,313 for 2003 and 2004, respectively.

Advertising and Promotion Costs

Advertising and promotion costs, which are included in selling expenses, are
expensed as incurred and aggregated $342,367 and $656,614 for 2003 and 2004,
respectively.

Income Taxes

We account for income taxes using the liability method, which requires an entity
to recognize deferred tax liabilities and assets. Deferred income taxes are
recognized based on the differences between the tax bases of assets and
liabilities and their reported amounts in the financial statements that will
result in taxable or deductible amounts in future years. Further, the effects of
enacted tax laws or rate changes are included as part of deferred tax expense or
benefit in the period that covers the enactment date. A valuation allowance is
recognized if it is more likely than not that some portion, or all, of a
deferred tax asset will not be realized.

Earnings (Loss) Per Share

Basic earnings (loss) per common share is computed by dividing the loss
applicable to common stockholders by the weighted average number of common
shares outstanding for the period.

For the years ended December 31, 2003 and 2004, potential common shares arising
from our stock options, stock warrants and convertible preferred stock of
39,611,363 and 65,089,658, respectively, were not included in the computation of
diluted earnings per share because their effect was antidilutive.

F-11

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Stock-based Compensation

We have adopted the intrinsic value method of accounting for employee stock
options as permitted by Statement of Financial Accounting Standards No. 123,
"Accounting for Stock-based Compensation" (SFAS No. 123) and disclose the pro
forma effect on net loss and loss per share as if the fair value based method
had been applied. For equity instruments, including stock options, issued to
non-employees, the fair value of the equity instruments or the fair value of the
consideration received, whichever is more readily determinable, is used to
determine the value of services or goods received and the corresponding charge
to operations. (SFAS 123 was amended further in December 2004; see below -
Recent Accounting Pronouncements).

The following table illustrates the effect on net loss and loss per share as if
we had applied the fair value recognition provision of SFAS No. 123 to
stock-based employee compensation.

Year ending December 31,
------------------------
2003 2004
---- ----
Net loss applicable to common
shareholders: as reported $ (3,919,455) $(4,188,558)

Add: total stock based employee
compensation expense determined
under fair value method for all awards -- --
------------- -------------
Pro forma net loss $ (3,919,455) $ (4,188,558)
============= =============

Loss per share:

As reported $ (0.15) $ (0.10)
Pro forma $ (0.15) $ (0.10)

Recent Accounting Pronouncements

In December 2004, the FASB issued Statement No. 152, "Accounting for Real Estate
Time-Sharing Transactions". This statement amends SFAS No. 66 (Accounting for
Sales of Real Estate) and SFAS No. 67 (Accounting for Costs and Initial Rental
Operations of Real Estate Projects). This standard, which is effective for
financial statements for fiscal years beginning after June 15, 2005, is not
applicable to the Company's current operations.

In December 2004, the FASB issued SFAS No. 153 "Exchange of Non-Monetary Assets
- an amendment of APB Opinion No. 29". Statement 153 eliminates the exception to
fair value for exchanges of similar productive assets and replaces it with a
general exception for exchange transactions that do not have commercial
substance, defined as transactions that are not expected to result in
significant changes in the cash flows of the reporting entity. This statement is
effective for exchanges of non-monetary assets occurring after June 15, 2005.
The application of this statement is not expected to have an impact on the
Company's financial statements considering the Company's intermittent
participation in exchanges of non-monetary assets.

In December 2004, the FASB issued a revision of SFAS No. 123 "Share-Based
Payment" (No. 123R). The statement establishes standards for the accounting for
transactions in which an entity exchanges its equity instruments for goods and
services. It also addresses transactions in which an entity incurs liabilities
in exchange for goods or services that are based on the fair value of the
entity's equity instruments or that may be settled by the issuance of those
equity instruments. The statement does not change the accounting guidance for
share-based payments with parties other than employees. The statement requires a
public entity to measure the cost of employee service received in exchange for
an award of equity instruments based on the grant-date fair value of the award
(with limited exception). That cost will be recognized over the period during
which an employee is required to provide service in exchange for the award
(usually the vesting period). A public entity will initially measure the cost of
employee services received in exchange for an award of a liability instrument
based on its current fair value; the fair value of that award will be remeasured
subsequently at each reporting date through the settlement date. Changes in fair
value during the requisite service period will be recognized as compensation
over that period. The grant-date fair value of employee share options and
similar instruments will be estimated using option-pricing models adjusted for
the unique characteristics of these instruments. According to management, this
pronouncement, which becomes effective for the Company for periods beginning
after December 15, 2005, is not expected to have a material effect on their
financial position.

F-12

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 2 - Fixed Assets

Fixed assets are comprised of the following:

2003 2004
---- ----
Furniture and fixtures $ 79,841 $ 150,871
Office equipment 166,179 151,577
Leasehold improvements 21,321 23,714
Purchased software -- 3,223
--------- ---------
267,341 329,385
Less: accumulated depreciation and
amortization (198,718) (218,179)
--------- ---------
$ 68,623 $ 111,206
========= =========

Depreciation and amortization expense of fixed assets aggregated $37,168 and
$30,153 for 2003 and 2004, respectively.

Note 3 - Licensing Agreements

Warner Brothers Consumer Products Co.

On January 1, 1999, we entered into a licensing agreement (the Original
Agreement) with Warner Brothers Consumer Products Co. (Warner) for the right to
utilize Looney Tunes(TM) images and names, as defined in the Agreement, on our
products in Shanghai and Hangzhou, China. We recorded license rights of $300,000
and amortized the rights over a period of three years. On November 21, 2000, we
entered into an amendment of the Original Agreement with Warner. Per the
amendment, the term of the agreement was extended to June 30, 2003 with the
guaranteed consideration being increased to $400,000. The Original Agreement, as
amended, was extended to October 29, 2003, at which time it expired. As of
December 31, 2003, the outstanding obligation under this agreement was $147,115.

We decided not to seek another license from Warner Bros. for China beyond the
October 2003 expiration based upon the lack of sales in our China markets and
what we perceived to be the licensor's continuing overall lack of brand support
in China. The Company and Warner Bros. dispute the contractual necessity of the
payment of the balance owed on the China license as a result of the above
circumstances. As of December 31, 2004, we reserved and continue to reserve
$147,116 for this obligation, representing a total $183,343 balance of
guaranteed royalties, which includes $36,227 for the legally allowed default
penalty.

On July 26, 2000, we entered into a license agreement with Warner Bros. and
obtained rights to utilize Looney Tunes(TM) character images and names in the
United States in connection with specified categories of products sold by
Bravo!. The license agreement was originally effective from January 1, 2000 to
December 31, 2002 and was extended to December 31, 2003. We recorded total
license rights for this U.S. license of $750,000.

F-13

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

In September 2001, we entered into a licensing agreement with Warner for the
right to utilize Looney Tunes(TM) character images and names, as defined in the
agreement, on our products sold in Mexico, with a minimum total guaranteed
consideration of $145,000, which we amortized over a period of three years. This
licensing agreement was effective through May 31, 2004.

In May 2002, we entered into a licensing agreement with Warner to utilize Looney
Tunes(TM) characters and names on milk products sold in specified retail outlets
throughout Canada, for the period March 1, 2002 to March 31, 2004. We recorded a
license right of $32,720 upon execution of the agreement.

Our experience with Warner Bros. licenses, as a function of sales of the
flavored milks, has not supported the guaranteed royalty structure required by
Warner Bros. for its licenses. As a result, we decided to exploit our own
Slammers(R) brand, which was developed in 2003, and commenced negotiations for
licenses with Marvel Comics and Moon Pie. For these reasons, we decided not to
accept the offer of Warner Bros. to renew the U.S. license.

Marvel Enterprises, Inc.

In January 2004, we commenced a license agreement with Marvel Enterprises, Inc.
for the right to use certain Marvel Super Heroes in the United States (including
its territories) and nine Middle East countries for a one-year (renewable) term.
We agreed to a royalty rate of 11% on the amount invoiced to dairy processors
for "kits" and 4% of net wholesale sales in the United States. We have recorded
$100,000 and $75,000 for 750,000 shares and options for an additional 750,000
shares as license fees.

We currently are negotiating with Marvel to conclude a new one-year license for
the United States, Mexico and Canada and a two-year license for the Middle East.

Chattanooga Bakery, Inc.( Moon Pie(R) )

In October 2003, we commenced a two-year license agreement with MD Enterprises,
Inc. on behalf of Chattanooga Bakery for the right to manufacture, distribute,
market and sell Moon Pie(R) flavored milk products in the United States. We
agreed to a variable royalty rate of 3% to 2% of net wholesale sales, depending
upon volume.

Masterfoods USA (Starburst(R), Milky Way(R), 3 Musketeers(R))

F-14

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 4 - Default of Note Payable to International Paper

In 1999, we issued a promissory note to assume existing debt owed by our then
Chinese joint venture subsidiary to a supplier, International Paper. The face
value of that unsecured note was $282,637 at an interest rate of 10.5% per
annum. The note originally required 23 monthly payments of $7,250 and a balloon
payment of $159,862 due on July 15, 2000. During 2000, we negotiated an
extension of this note to July 1, 2001. International Paper imposed a charge of
$57,000 to renegotiate the note, which amount represents interest due through
the extension date. The current balance due on this note is $187,743 at December
31, 2004, all of which is delinquent. We have not had any communication with
International Paper during the last three years. Although International Paper
has not pursued collection of the note, it is possible that they could do so in
the future and, if they do, such collection effort may have a significant
adverse impact on the liquidity of the Company. We have not accrued interest as
of December 31, 2003 and December 31, 2004.

Note 5 - Notes Payable to Individual Lenders

On May 9, 2004 we received the proceeds of a $750,000 loan from Mid-Am Capital,
payable September 3, 2004, with an interest rate of 8%. This loan is secured by
a general security interest in all of our assets. Mid-Am has agreed to extend
the note to January 31, 2005. Interest accrued and unpaid as December 31, 2004
aggregated $10,121.

Note 6 - Capital Deficit

2003

On January 2, 2003, we issued 100,000 shares of common stock to an
employee. This common stock was registered under a Form S-8 registration
statement in December 2004. In January 2003, we recorded $28,000 of compensation
expense based upon a signing bonus for this grant. In addition, we granted
options for 100,000 shares of common stock to the employee pursuant to an
employment contract. These options vested immediately, expire on December 30,
2007 and have an exercise price of $0.40 per share. We also granted options for
200,000 shares of common stock at an exercise price of $0.40 per share and vest
as follows: options for 100,000 shares on each of December 31, 2003 and 2004,
and 100,000 expire on each of December 30, 2008 and 2009, respectively.

On February 4, 2003, we issued 30,000 shares of common stock to Keshet,
LP, upon the conversion of 480 shares of Series G Convertible Preferred stock,
at a conversion price of $0.196. The conversion included accrued and unpaid
dividends on the preferred converted.

F-15

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On February 21, 2003, we issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $500,000. Each preferred share is convertible to 40
shares of our common stock at a per common share conversion price of $0.25,
representing 2,000,000 shares of common stock underlying the preferred. The
issued warrants entitle the holder to purchase 33.33 shares of common stock for
each share of Series J Convertible Preferred stock issued at an exercise price
of $0.30 per common stock share, representing 1,666,667 shares of common stock
underlying the warrants. The warrants are exercisable for a five-year period.
The February 21, 2003 closing market trading price was $0.23 per share. This
private offering was made to Mid-Am, an accredited investor, pursuant to Rule
506 of Regulation D and Section 4(2) of the Securities Act of 1933. In
accordance with EITF 00-27, we recorded a deemed dividend of $274,720 related to
a beneficial conversion feature.

On April 14, 2003, we issued 50,000 shares of common stock to Keshet, LP,
upon the conversion of 596 shares of Series G Convertible Preferred, at a
conversion price of $0.148. The conversion included accrued and unpaid dividends
on the preferred converted.

On April 22, 2003, we issued 50,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 595 shares of Series G Convertible Preferred,
at a conversion price of $0.148. The conversion included accrued and unpaid
dividends on the preferred converted.

On May 22, 2003, we issued 100,000 shares of common stock to Keshet, LP,
upon the conversion of 607 shares of Series G Convertible Preferred, at a
conversion price of $0.076. The conversion included accrued and unpaid dividends
on the preferred converted.

On May 22, 2003, we issued 100,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 607 shares of Series G Convertible Preferred,
at a conversion price of $0.076. The conversion included accrued and unpaid
dividends on the preferred converted.

On May 29, 2003, we issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. for the aggregate
purchase price of $500,000. Each preferred share is convertible to 50 shares of
our common stock at a conversion price of $0.20, representing 2,500,000 shares
of common stock underlying the preferred. The issued warrants entitle the holder
to purchase 40 shares of common stock for each share of Series J Convertible
Preferred stock issued at an exercise price of $0.25 per common stock share,
representing 2,000,000 shares of common stock underlying the warrants. The
warrants are exercisable for a five-year period. The May 22, 2003 closing market
trading price was $0.12 per share. In addition, we made the following
adjustments to prior issued warrants for the purpose of facilitating future fund
raising by us arising out of the exercise of the warrants by Holder. The
purchase price, as defined in the Warrants No. 1 and 2, has been reduced to
$0.25, subject to further adjustment as described in the warrants. The warrant
stock provided for in Warrant No.1 has been increased by 1,500,000 shares. The
warrant stock provided for in Warrant No. 2 has been increased by 333,333
shares. The expiration date, as defined in the respective warrants, remains as
stated. The trading price call option trigger set forth in Section 9 (b) of the
warrants has been reduced from $1.75 to $0.75 per share. This private offering
was made to Mid-Am, an accredited investor, pursuant to Rule 506 of Regulation D
and Section 4(2) of the Securities Act of 1933. The value of the warrants,
$92,491, was determined using the Black-Scholes model.

On August 12, 2003, we issued 1,200,000 shares of common stock based upon
Series G notices of conversion received in June and July 2003. The issuance of
common stock was delayed in order to determine the accuracy of the conversion
variables contained in the respective notices of conversion, as follows:

We issued 200,000 shares of common stock to Keshet, LP, upon the
conversion of 1,209 shares of Series G Convertible Preferred, at a conversion
price of $0.076. The conversion included accrued and unpaid dividends on the
preferred converted.

We issued 200,000 shares of common stock to The Keshet Fund, LP, upon the
conversion of 1,209 shares of Series G Convertible Preferred, at a conversion
price of $0.076. The conversion included accrued and unpaid dividends on the
preferred converted.

F-16

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

We issued 150,000 shares of common stock to The Keshet Fund, LP, upon the
conversion of 773 shares of Series G Convertible Preferred, at a conversion
price of $0.0653. The conversion included accrued and unpaid dividends on the
preferred converted.

We issued 250,000 shares of common stock to Keshet, LP, upon the
conversion of 1,289 shares of Series G Convertible Preferred, at a conversion
price of $0.0653. The conversion included accrued and unpaid dividends on the
preferred converted.

We issued 200,000 shares of common stock to Talbiya B. Investments, Ltd.,
upon the conversion of 1,031 shares of Series G Convertible Preferred, at a
conversion price of $0.0653. The conversion included accrued and unpaid
dividends on the preferred converted.

We issued 200,000 shares of common stock to Nesher. Ltd., upon the
conversion of 1,031 shares of Series G Convertible Preferred, at a conversion
price of $0.0653. The conversion included accrued and unpaid dividends on the
preferred converted.

On September 15, 2003, we issued 213,750 shares of common stock to Michael
Willms, upon the conversion of 7,500 shares of Series H Convertible Preferred,
at the fixed conversion price of $0.40. The conversion included accrued and
unpaid dividends on the preferred converted.

On September 29, 2003, we issued 70,938 shares of common stock to The
Dennis H. Willms Irrevocable Trust, Michael Willms, Trustee, upon the conversion
of 2,500 shares of Series H Convertible Preferred, at the fixed conversion price
of $0.40. The conversion included accrued and unpaid dividends on the preferred
converted.

On November 21, 2003, we entered into a Subscription Agreement with Gamma
Opportunity Capital Partners, LP for the sale of a convertible note in the
amount of $200,000 and warrants to purchase 5,000,000 shares of common stock, at
$1.00 per share. The convertible note is convertible into shares of our common
stock at the lesser of $0.05 or 75% of the average of the three lowest closing
bid prices for the thirty trading days prior to but not including the conversion
date. During the 180 days following the issuance of the convertible note, the
conversion price shall not be less than $.03 per share if no event of default
exists. This 180 day period shall be extended indefinitely if no event of
default exists, the closing trading price for any 15 day consecutive trading
period is $0.20 or higher, the daily trading volume for the 15 days is at least
300,000 and a registration statement registering the convertible note is
effective. In connection with this transaction, we issued 400,000 shares of our
common stock and a warrant to purchase 2,000,000 shares of common stock at $.05
per share.

On November 21, 2003, we also entered into a Subscription Agreement with
Mid-Am Capital, LLC for the sale of a convertible note in the amount of $200,000
and warrants to purchase 5,000,000 shares of common stock, at $1.00 per share.
The convertible note is convertible into shares of our common stock at the
lesser of $0.05 or 75% of the average of the three lowest closing bid prices for
the thirty trading days prior to but not including the conversion date. During
the 180 days following the issuance of the convertible note, the conversion
price shall not be less that $.03 per share if no event of default exists. This
180 day period shall be extended indefinitely if no event of default exists, the
closing trading price for any 15 day consecutive trading period is $0.20 or
higher, the daily trading volume for the 15 days is at least 300,000 and a
registration statement registering the convertible note is effective.

F-17

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

2004

On February 1, 2004, we agreed to issue 750,000 shares of our common stock
and warrants to purchase an additional 750,000 shares of common stock to Marvel
Enterprises, Inc. We issued this equity in connection with the grant of an
intellectual property license by Marvel on January 17, 2004, giving us the right
to use certain Marvel Comics characters on our Slammers(R) line of flavored
milks. The warrants have an exercise price of $0.10 per share for the first year
and, upon the occurrence of certain conditions tied to the royalty performance
under the license, can be extended for an additional year with an exercise price
of $0.14 per share. We made this private offering to Marvel Enterprises, an
accredited investor, pursuant to Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933.

On February 12, 2004, we held a special meeting of shareholders at which
the shareholders approved an increase of our authorized common stock from
50,000,000 shares to 300,000,000 shares.

On February 17, 2004, we converted 875 shares of Series G Convertible
Preferred Stock into 215,164 shares of common stock pursuant to a January 12,
2004 notice of conversion from Nesher, LP, at a conversion price of $0.0407. The
conversion included accrued and unpaid dividends on the converted preferred. We
delayed processing this notice in light of our special meeting of shareholders
held February 12, 2004. The shares of common stock issued pursuant to this
conversion were retired and cancelled on March 5, 2004 and issued to third
parties on that date in accordance with the instructions of Nesher, LP.

On February 17, 2004, we converted 1,400 shares of Series G Convertible
Preferred Stock into 343,980 shares of common stock pursuant to a January 12,
2004 notice of conversion from Talbiya Investments, Ltd., at a conversion price
of $0.0407. The conversion included accrued and unpaid dividends on the
converted preferred. We delayed processing this notice in light of our special
meeting of shareholders held February 12, 2004. The shares of common stock
issued pursuant to this conversion were retired and cancelled on March 5, 2004
and issued to third parties on that date in accordance with the instructions of
Talbiya Investments, Ltd.

On February 17, 2004, we converted 700 shares of Series G Convertible
Preferred Stock into 172,162 shares of common stock pursuant to a January 12,
2004 notice of conversion from The Keshet Fund, LP, at a conversion price of
$0.0407. The conversion included accrued and unpaid dividends on the converted
preferred. We delayed processing this notice in light of our special meeting of
shareholders held February 12, 2004. The shares of common stock issued pursuant
to this conversion were retired and cancelled on March 5, 2004 and issued to
third parties on that date in accordance with the instructions of The Keshet
Fund, LP.

On February 17, 2004, we converted 2,025 shares of Series G Convertible
Preferred Stock into 497,951 shares of common stock pursuant to a January 12,
2004 notice of conversion from Keshet LP, at a conversion price of $0.0407. The
conversion included accrued and unpaid dividends on the converted preferred. We
delayed processing this notice in light of our special meeting of shareholders
held February 12, 2004. The shares of common stock issued pursuant to this
conversion were retired and cancelled on March 5, 2004 and issued to third
parties on that date in accordance with the instructions of Keshet, LP.

On March 1,2004, we issued 80,000 shares of non-voting Series K 8%
Convertible Preferred stock, to Mid-Am Capital, LLC, having a stated value of
$10.00 per Preferred K share, for the aggregate purchase price of $800,000. Each
preferred share is convertible to 100 shares of our common stock at a conversion
price of $0.10, representing 8,000,000 shares of common stock underlying the
preferred. In addition, we made the following adjustments to prior issued
warrants for the purpose of facilitating future fund raising by us arising out
of the exercise of the warrants by Holder. The purchase price, as defined in the
Warrant No. 2003-B-002, has been reduced to $0.10, subject to further adjustment
as described in the warrant. The expiration date, as defined in the warrant,
remains as stated. This private offering was made to Mid-Am, an accredited
investor, pursuant to Rule 506 of Regulation D and Section 4(2) of the
Securities Act of 1933.

F-18

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On March 9, 2004, we converted 5,000 shares of Series F Convertible
Preferred Stock into 1,315,789 shares of common stock pursuant to a January 8,
2004 notice of conversion from Esquire Trade & Finance Inc., at a conversion
price of $0.038. The conversion did not include accrued and unpaid dividends on
the converted preferred. We delayed processing this notice in light of our
special meeting of shareholders held February 12, 2004. The shares of common
stock issued pursuant to this conversion were issued to third parties on that
date in accordance with the instructions of Esquire Trade & Finance Inc.

On April 1 2004, we converted 5,000 shares of Series F Convertible
Preferred Stock into 1,315,789 shares of common stock pursuant to a January 27,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.038. The conversion did not include accrued and unpaid dividends on the
converted preferred. We delayed processing this notice in light of our special
meeting of shareholders held February 12, 2004. The shares of common stock
issued pursuant to this conversion were issued to third parties on that date in
accordance with the instructions of Austinvest Anstalt Balzers. We issued the
preferred and the underlying common stock upon conversion to an accredited
investor, pursuant to a Regulation D offering.

On April 2, 2004, the Comoany and Mid-Am Capital, LLC entered into
Supplement No.1 to the Series K Convertible Preferred Subscription Agreement, by
which we sold an additional 15,000 shares of our Series K Convertible Preferred
Stock utilizing the proceeds from a certain promissory note issued by us to
Mid-Am in the face amount of $150,000. With the consummation of this sale, the
$150,000 promissory note was deemed paid by us in full. We issued the preferred
and the underlying common stock upon conversion to an accredited investor,
pursuant to a Regulation D offering.

On April 8, 2004, we converted 4,862 shares of Series G Convertible
Preferred Stock into 700,000 shares of common stock pursuant to a March 25, 2004
notice of conversion from Nesher, LP, at a conversion price of $0.0853. The
conversion included accrued and unpaid dividends of $11,089 on the preferred
converted. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

On April 8, 2004, we converted 4,478 shares of Series G Convertible
Preferred Stock into 650,000 shares of common stock pursuant to a March 25, 2004
notice of conversion from Talbiya B. Investments, Ltd., at a conversion price of
$0.0853. The conversion included accrued and unpaid dividends of $10,662 on the
preferred converted. We issued the preferred and the underlying common stock
upon conversion to an accredited investor, pursuant to a Regulation D offering.

On April 8, 2004, we converted 1,919 shares of Series G Convertible
Preferred Stock into 275,000 shares of common stock pursuant to a March 25, 2004
notice of conversion from The Keshet Fund, LP, at a conversion price of $0.0853.
The conversion included accrued and unpaid dividends of $4,265 on the preferred
converted. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

On April 8, 2004, we converted 7,677 shares of Series G Convertible
Preferred Stock into 1,100,000 shares of common stock pursuant to a March 25,
2004 notice of conversion from Keshet, LP, at a conversion price of $0.0853. The
conversion included accrued and unpaid dividends of $17,060 on the preferred
converted. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

F-19

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On April 20, 2004, we entered into a Subscription Agreement with Longview
Fund, LP and Alpha Capital Aktiengesellschaft for the issuance of two
convertible 10% notes in the amount of $250,000 each and five-year warrants for
the purchase of, in the aggregate, 3,000,000 shares of common stock, at $0.15
per share. The notes are convertible into shares of our common stock at $0.10
per common share. Conversions are limited to a maximum ownership of 9.99% of the
underlying common stock at any one time. The notes are payable in twelve equal
monthly installments, commencing November 1, 2004. The installment payments
consist of principal and a "premium" of 20% of the principal paid per
installment. We have the option to defer such payment until the note's maturity
date on October 1, 2005, if our common stock trades above $0.20 for the five
trading days prior to the due date of an installment payment. In connection with
this transaction, we issued two additional notes in the aggregate amount of
$50,000, upon identical terms as the principal notes, as a finder's fee, and
paid $20,000 in legal fees. The common stock underlying all notes and warrants
carry registration rights. We issued the convertible notes and warrants to
accredited investors, pursuant to a Regulation D offering.

On April 30, 2004, we converted 20,000 shares of Series F Convertible
Preferred Stock into 1,945,525 shares of common stock pursuant to an April 27,
2004 notice of conversion from Esquire Trade & Finance Inc., at a conversion
price of $0.1028. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

On April 30, 2004, we converted 20,000 shares of Series F Convertible
Preferred Stock into 1,945,525 shares of common stock pursuant to an April 27,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.1028. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

On April 30, 2004, we converted 2,500 shares of Series F Convertible
Preferred Stock into 243,191 shares of common stock pursuant to an April 27,
2004 notice of conversion from Esquire Trade & Finance Inc., at a conversion
price of $0.1028. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

On April 30, 2004, we converted 2,500 shares of Series F Convertible
Preferred Stock into 243,191 shares of common stock pursuant to an April 27,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.1028. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

On May 20, 2004, we converted 9,226 shares of Series G Convertible
Preferred Stock into 620,578 shares of common stock pursuant to a May 19, 2004
notice of conversion from Nesher, LP, at a conversion price of $0.148. The
conversion did not include accrued and unpaid dividends on the converted
preferred. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

On May 20, 2004, we converted 13,972 shares of Series G Convertible
Preferred Stock into 939,782 shares of common stock pursuant to a May 19, 2004
notice of conversion from Keshet, LP, at a conversion price of $0.148. The
conversion did not include accrued and unpaid dividends on the converted
preferred. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering.

F-20

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On June 17, 2004, we issued 87,195 of our common stock to Stephen Nollau,
a former consultant, for services rendered. We issued the common stock pursuant
to a Form S-8 registration statement, filed by us on June 16, 2004.

On June 29, 2004, we converted 234 shares of Series G Convertible
Preferred Stock into 13,604 shares of common stock pursuant to a June 15, 2004
notice of conversion from Nesher, LP, at a conversion price of $0.172. The
conversion did not include accrued and unpaid dividends on the converted
preferred. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering. This
conversion exhausted the outstanding Series G convertible preferred held by this
investor.

On June 29, 2004, we converted 1,850 shares of Series G Convertible
Preferred Stock into 107,558 shares of common stock pursuant to a June 15, 2004
notice of conversion from Keshet, LP, at a conversion price of $0.172. The
conversion did not include accrued and unpaid dividends on the converted
preferred. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering. This
conversion exhausted the outstanding Series G convertible preferred held by this
investor.

On June 29, 2004, we converted 3,472 shares of Series G Convertible
Preferred Stock into 201,860 shares of common stock pursuant to a June 15, 2004
notice of conversion from The Keshet Fund, LP, at a conversion price of $0.172.
The conversion did not include accrued and unpaid dividends on the converted
preferred. We issued the preferred and the underlying common stock upon
conversion to an accredited investor, pursuant to a Regulation D offering. This
conversion exhausted the outstanding Series G convertible preferred held by this
investor.

On June 29, 2004, we converted 8,091 shares of Series G Convertible
Preferred Stock into 470,406 shares of common stock pursuant to a June 15, 2004
notice of conversion from Talbiya B. Investments, Ltd, at a conversion price of
$0.172. The conversion did not include accrued and unpaid dividends on the
converted preferred. We issued the preferred and the underlying common stock
upon conversion to an accredited investor, pursuant to a Regulation D offering.
This conversion exhausted the outstanding Series G convertible preferred held by
this investor.

On June 30, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited,
Stonestreet Limited Partnership and Mid-Am Capital L.L.C for the issuance of
convertible 10% notes in the aggregate amount of $1,300,000 and five-year "A"
warrants for the purchase of, in the aggregate, 5,200,000 shares of common
stock, at $0.25 per share, and five-year "B" warrants for the purchase of, in
the aggregate, 13,000,000 shares of common stock, at $2.00 per share. The notes
are convertible into shares of our common stock at $0.15 per common share.
Conversions are limited to a maximum ownership of 9.99% of the underlying common
stock at any one time. The notes are payable in twelve equal monthly
installments, commencing January 1, 2005. The installment payments consist of
principal and a "premium" of 20% of the principal paid per installment. We have
the option to defer such payment until the note's maturity date on December 1,
2005, if our common stock trades above $0.20 for the five trading days prior to
the due date of an installment payment. In connection with this transaction, we
issued additional notes in the aggregate amount of $40,000 to Gem Funding, LLC,
Bi-Coastal Consulting Corp., Stonestreet Limited Partnership and Libra Finance,
S.A upon identical terms as the principal notes, as a finder's fee, and paid
$12,500 in legal fees. The common stock underlying all notes and warrants carry
registration rights. We issued the convertible notes and warrants to accredited
investors, pursuant to a Regulation D offering.

F-21

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On August 9, 2004, we converted $50,000 of our November 2003 Convertible
Promissory Note into 1,000,000 shares of common stock pursuant to an August 5,
2004 notice of conversion from Gamma Opportunity Capital Partners LP, at a fixed
conversion price of $0.05. The conversion did not include accrued and unpaid
interest on the converted amount. We issued the underlying common stock upon
conversion pursuant to our SB-2 registration statement, declared effective on
August 3, 2004.

On August 23, 2004, we converted $50,000 of our April 2004 Convertible
Promissory Note into 500,000 shares of common stock pursuant to an August 5,
2004 notice of conversion from Longview Fund LP, at a fixed conversion price of
$0.10. The conversion did not include accrued and unpaid interest on the
converted amount. We issued the underlying common stock upon conversion pursuant
to our SB-2 registration statement, declared effective on August 3, 2004.

On September 27, 2004, we converted $50,000 of our April 2004 Convertible
Promissory Note into 500,000 shares of common stock pursuant to a September 21,
2004 notice of conversion from Longview Fund LP, at a fixed conversion price of
$0.10. The conversion did not include accrued and unpaid interest on the
converted amount. We issued the underlying common stock upon conversion pursuant
to our SB-2 registration statement, declared effective on August 3, 2004.

On October 6, 2004, we converted $25,000 of our November 2003 Convertible
Promissory Note into 500,000 shares of common stock pursuant to a September 23,
2004 notice of conversion from Gamma Opportunity Capital Partners LP, at a fixed
conversion price of $0.05. The conversion did not include accrued and unpaid
interest on the converted amount. We issued the underlying common stock upon
conversion pursuant to our SB-2 registration statement, declared effective on
August 3, 2004.

On October 6, 2004, we issued 500,000 shares of our common stock to
Knightsbridge Holdings, LLC, pursuant to a consulting agreement dated November
10, 2003. We issued the common stock pursuant to our SB-2 registration
statement, declared effective on August 3, 2004. The issued and outstanding
equity reported in our Form 10QSB for the period ended March 31, 2004 reflects
these shares of common stock.

On October 13, 2004, we issued 250,000 restricted shares of our common
stock in a private placement to Arthur Blanding, at the market price of $0.12
per share, pursuant to Section 4(2) of the Securities Act of 1934. Mr. Blanding,
who solicited the purchase, is an accredited investor and has been a director of
the Company since 1999.

On October 15, 2004, we issued 750,000 shares of our common stock to
Marvel Enterprises, Inc., as partial compensation under a license agreement
dated February 1, 2004. We issued the common stock pursuant to our SB-2
registration statement, declared effective on August 3, 2004. The issued and
outstanding equity reported in our Form 10QSB for the period ended March 31,
2004 reflects these shares of common stock.

On October 29, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and
Stonestreet Limited Partnership for the issuance of convertible 10% notes in the
aggregate amount of $550,000 and five-year "C" warrants for the purchase of, in
the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of our common stock at $0.10 per
common share. Conversions are limited to a maximum ownership of 9.99% of the
underlying common stock at any one time. The notes are payable in twelve equal
monthly installments, commencing May 1, 2005. The installment payments consist
of principal and a "premium" of 20% of the principal paid per installment. We
have the option to defer such payment until the note's maturity date on April
30, 2006, if our common stock trades above $0.15 for the five trading days prior
to the due date of an installment payment and the underlying common stock is
registered. In connection with this transaction, we issued additional notes,
without attached warrants, in the aggregate amount of $27,500 to Gem Funding,
LLC, Bi-Coastal Consulting Corp., Stonestreet Limited Partnership and Libra
Finance, S.A upon identical terms as the principal notes, as a finder's fee, and
paid $12,500 in legal fees. The common stock underlying all notes and warrants
carry registration rights. We issued the convertible notes and warrants to
accredited investors, pursuant to a Regulation D offering.

F-22

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On December 17, 2004, we converted $50,000 of our April 2004 Convertible
Promissory Note into 500,000 shares of common stock pursuant to a December 8,
2004 notice of conversion from Longview Fund LP, at a fixed conversion price of
$0.10. The conversion did not include accrued and unpaid interest on the
converted amount. We issued the underlying common stock upon conversion pursuant
to our SB-2 registration statement, declared effective on August 3, 2004.

On December 20, 2004, we converted $25,000 of our April 2004 Convertible
Promissory Note into 265,958 shares of common stock pursuant to a December 9,
2004 notice of conversion from Bi Coastal Consulting Corp., at a fixed
conversion price of $0.10. The conversion included $1,595.89 accrued and unpaid
interest on the converted amount. We issued the underlying common stock upon
conversion pursuant to our SB-2 registration statement, declared effective on
August 3, 2004.

On December 20, 2004, we converted $50,000 of our November 2003
Convertible Promissory Note into 1,000,000 shares of common stock pursuant to a
December 8, 2004 notice of conversion from Gamma Opportunity Capital Partners
LP, at a fixed conversion price of $0.05. The conversion did not include accrued
and unpaid interest on the converted amount. We issued the underlying common
stock upon conversion pursuant to our SB-2 registration statement, declared
effective on August 3, 2004.

On December 27, 2004, we converted 10,000 shares of Series F Convertible
Preferred Stock into 1,290,323 shares of common stock pursuant to a December 27,
2004 notice of conversion from Austinvest Anstalt Balzers, at a conversion price
of $0.0775. The conversion did not include accrued and unpaid dividends on the
converted preferred. We issued the preferred and the underlying common stock
upon conversion to an accredited investor, pursuant to a Regulation D offering
and Rule 144.

On December 27, 2004, we converted 10,000 shares of Series F Convertible
Preferred Stock into 1,290,323 shares of common stock pursuant to a December 27,
2004 notice of conversion from Esquire Trade & Finance Inc., at a conversion
price of $0.0775. The conversion did not include accrued and unpaid dividends on
the converted preferred. We issued the preferred and the underlying common stock
upon conversion to an accredited investor, pursuant to a Regulation D offering
and Rule 144.

On December 29, 2004, we closed a funding transaction with Momona Capital
Corp. and Ellis International Ltd. for the issuance of convertible 10% notes in
the aggregate amount of $200,000 and five-year "C" warrants for the purchase of,
in the aggregate, 800,000 shares of common stock, at $0.15 per share. The notes
are convertible into shares of our common stock at $0.10 per common share.
Conversions are limited to a maximum ownership of 9.99% of the underlying common
stock at any one time. The notes are payable in twelve equal monthly
installments, commencing May 1, 2005. The installment payments consist of
principal and a "premium" of 20% of the principal paid per installment. We have
the option to defer such payment until the note's maturity date on April 30,
2006, if our common stock trades above $0.15 for the five trading days prior to
the due date of an installment payment, and the underlying common stock is
registered. In connection with this transaction, we issued additional notes,
without attached warrants, in the aggregate amount of $10,000 to the investors
upon identical terms as the principal notes, as a finder's fee, and paid $3,500
in legal fees. The common stock underlying all notes and warrants carry
registration rights. We issued the convertible notes and warrants to accredited
investors, pursuant to an amendment to an October 29, 2004 Regulation D
offering.

F-23

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On December 31, 2004, we issued 8,095,105 shares of our common stock and
options for 150,000 shares at an exercise price of $0.25 per share, pursuant to
a Form S-8 registration statement filed December 23, 2004, as follows:

Description Employee / Consultant Common Shares

Compensation Plan: issue
common for existing options
Arthur W. Blanding - Director 170,000
Robert J. Cummings - Director 255,000
Paul Downes - Director 205,000
Michael Edwards - VP 600,000
Stanley A. Hirschman - Director 100,000
Tommy E. Kee - CFO 300,000
John J. McCormack - Director 205,000
Benjamin Patipa - VP 300,000
Phillip Pearce - Director 205,000
Roy D. Toulan, Jr. VP-
General Counsel 300,000
Roy Warren - CEO, Director 2,755,000

Compensation Plan: issue
common in lieu of 10% of
salary Roy Warren - CEO 291,282
Tommy E. Kee - CFO 87,385
Roy D. Toulan, Jr. VP-
General Counsel 196,615
Michael Edwards - VP 149,282
Benjamin Patipa - VP 87,385
Bryce Boynton 29,128
Nicole Warren 21,486

Employment Contract Roy D. Toulan, Jr. VP-
General Counsel 100,000

Employment Contract Michael Edwards - VP 116,189

Common in lieu of cash -
consultants and non-fund
raising service providers Joseph Zappulla - public 111,111
relations
Stanley Harris - marketing 75,227
David Uhlman - operations 40,000
Timothy Preuniger - operations 50,000
Roy D. Toulan, Jr. - legal 303,506
Marc J. Ross - legal 250,000

Option for common stock in Options for 150,000
lieu of cash - consultants) Tim Ransom shares @ $0.25/share

Consultant Agreements Knightsbridge Capital, LLC,
alter ego for Robert Press,
financial advisor; corporate 250,000
planning

F-24

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Black Dog Communications
Group, Inc., alter ego for
Shep Doniger, public relations 41,509

Geoffrey Eiten, strategic
planning; part of 1,500,000
shares registered under Form
S-8 500,000

Note 7 - Stock Warrants and Options

2003

On January 2, 2003, we granted options for 100,000 shares of common stock
to an employee pursuant to an employment contract. These options vested
immediately, expire on December 30, 2007 and have an exercise price of $0.40 per
share. We also granted options for 200,000 shares of common stock at an exercise
price of $0.40 per share and vest as follows: options for 100,000 shares on each
of December 31, 2003 and 2004, and 100,000 expire on each of December 30, 2008
and 2009, respectively.

On February 21, 2003, we issued a warrant for 1,666,667 shares of common
stock to Mid-Am, in connection with the issuance of 50,000 shares of non-voting
Series J 8% Convertible Preferred stock, having a stated value of $10.00 per
Preferred J share, for the aggregate purchase price of $500,000. The warrants
have an exercise price of $0.30 per common stock share, and are exercisable for
a five-year period. The February 21, 2003 closing market trading price was $0.23
per share. In accordance with EITF 00-27, we recorded a deemed dividend of
$274,720 related to a beneficial conversion feature.

On May 29, 2003, we issued a warrant for 2,000,000 shares of common stock
to Mid-Am, in connection with the issuance of 50,000 shares of non-voting Series
J 8% Convertible Preferred stock, having a stated value of $10.00 per Preferred
J share, for the aggregate purchase price of $500,000. The warrants entitle the
holder to purchase 40 shares of common stock for each share of Series J
Convertible Preferred stock issued at an exercise price of $0.25 per common
stock share, and are exercisable for a five-year period. The May 22, 2003
closing market trading price was $0.12 per share. In addition, we made the
following adjustments to prior issued warrants for the purpose of facilitating
future fund raising by us arising out of the exercise of the warrants by Holder.
The purchase price, as defined in the Warrants No. 1 (issued September 2002) and
2 (issued February 2003), was reduced to $0.25, subject to further adjustment as
described in the warrants. The warrant stock provided for in Warrant No.1 was
increased by 1,500,000 shares. The warrant stock provided for in Warrant No. 2
was increased by 333,333 shares. The expiration date, as defined in the
respective warrants, remains as stated. The trading price call option trigger
set forth in Section 9 (b) of all of the warrants has been reduced from $1.75 to
$0.75 per share. The value of the warrants, $92,491, was determined using the
Black-Scholes model.

On November 21, 2003, we issued two "A" warrants for the aggregate amount
of 2,000,000 shares of common stock, and two "B" warrants for the aggregate
amount of 10,000,000 shares of common stock to Mid-Am Capital, L.L.C. and Gamma
Opportunity Capital Partners, LP, in connection with the issuance of two
convertible notes in the aggregate face amount of $400,000. The "A" warrants
have an exercise price of $0.05 per share and the "B" warrants have an exercise
price of $1.00 per share. In connection with this transaction, we issued a
warrant to purchase 2,000,000 shares of common stock at $0.05 per share, as a
finder's fee. All warrants issued in connection with this transaction are
exercisable for five years.

F-25

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

2004

On February 1, 2004, we agreed to issue warrants to purchase 750,000
shares of common stock to Marvel Enterprises, Inc. We issued this equity in
connection with the grant of an intellectual property license by Marvel on
January 17, 2004, giving us the right to use certain Marvel Comics characters on
our Slammers(R) line of flavored milks. The warrants have an exercise price of
$0.10 per share for the first year and, upon the occurrence of certain
conditions tied to the royalty performance under the license, can be extended
for an additional year with an exercise price of $0.14 per share. We made this
private offering to Marvel Enterprises, an accredited investor, pursuant to Rule
506 of Regulation D and Section 4(2) of the Securities Act of 1933.

On May 9, 2004 we received the proceeds of a $750,000 loan from Mid-Am
Capital, payable September 3, 2004, with an interest rate of 8%. This loan is
secured by a general security interest in all of our assets. Mid-Am has agreed
to extend the note without to January 31, 2005. We issued one-year warrants for
3,000,000 shares of common stock at $0.25 per share to Mid-Am Capital in
connection with this loan.

On November 19, 2004, we agreed to grant incentive stock options to
National Financial Communications Corp. for the purchase of the aggregate of
1,000,000 shares of our common stock at an exercise price of $.25 per share in
connection with a public relations and corporate communications services
agreement. The options are exercisable during the period commencing on the
agreement date and ending three years subsequent to the termination date of the
agreement. The grant of options shall be as follows: (i) options for 250,000
shares upon the execution of the agreement, and (ii) beyond the first ninety
(90) days of the agreement, the balance of 750,000 shares on a pro rata
quarterly basis at the rate of 250,000 per quarter, conditioned upon the
continuation of the agreement.

F-26

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On December 31, 2004, we issued five-year options for 150,000 shares of
common stock at an exercise price of $0.25 per share to Tim Ransom for graphic
design services, pursuant to a Form S-8 registration statement

The assumptions used in the Black Scholes option pricing model in 2003 and 2004
were as follows:
December 31,
------------
2003 2004
---- ----
Discount rate - bond yield rate 2.35 - 4.9% 2.33 - 3.25%
Volatility 69 - 88% 110 - 120%
Expected life 2.25 - 3.75 years 0.75 - 3.75 years
Expected dividend yield -- --

A summary of the status of our stock options and warrants as of December 31,
2003 and 2004 with changes during the years then ended are presented below:

Weighted
Average
Shares Price
------ -----
Total warrants and options outstanding
at December 31, 2002 21,157,803 $ 0.70

Warrants and options granted 18,668,337 0.13
Warrants and options exercised --
Warrants and options expired (214,777) (1.03)
---------- ----------
Total warrants and options outstanding
at December 31, 2003 39,611,363 0.28

Warrants and options granted 33,565,000 .87
Warrants and options exercised (5,895,000) (.06)
Warrants and options expired (2,191,705) (1.03)

Total warrants and options outstanding
at December 31, 2004 65,089,658 $ 0.56
========== ==========

The following table summarizes information about stock options and warrants
outstanding at December 31, 2004:

Warrants/Options Outstanding Options/Warrants Exercisable
---------------------------- ----------------------------
Weighted Weighted Weighted
Average Average Average
Number Remaining Exercise Number Exercise
Exercise Price Outstanding Life (Years) Price Exercisable Price
$0.00 to $0.75 46,724,658 3.0 $ 0.31 46,724,658 $ 0.31
$0.75 to 2.00 18,365,000 1.0 $ 1.56 18,365,000 $ 1.56
----------- ----------- ----------- ----------- -----------
65,089,658 2.6 $ 0.56 65,089,658 $ 0.56
=========== =========== =========== =========== ===========

F-27

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 8 - Income Taxes

We are subject to Federal income taxes. As we have experienced operating losses
for the years of 2003 and 2004, we have not provided for income tax .

We have gross deferred tax assets of approximately $6.8 million and $8.1 million
at December 31, 2003 and 2004, respectively, relating principally to tax effects
of net operating loss carry forwards. In assessing the recoverability of
deferred tax assets, management considers whether it is more likely than not
that the assets will be realized. The ultimate realization of deferred tax
assets is dependent upon the generation of future taxable income during the
periods in which those temporary differences become deductible. Management
considers projected future taxable income and tax planning strategies in making
this assessment. Based upon the level of historical taxable loss and projections
for future taxable income over the periods in which the deferred tax items are
recognizable for tax reporting purposes, it is more likely than not that we will
not realize the benefits of these deferred tax assets existing at December 31,
2003 and 2004. As such, management has recorded a valuation allowance for the
full amount of deferred tax assets at December 31, 2003 and 2004.

At December 31, 2004, we had available net operating losses of approximately $19
million for federal income tax purposes, to offset future taxable income, if
any, which will expire at various dates through the year 2023 for federal income
tax purposes. The utilization of net operating losses, however, may be subject
to certain limitations as prescribed by Section 382 of the Internal Revenue
Code.

Note 9 - Business Segment and Geographic Information

We operate principally in one industry segment. The following sales information
is based on customer location rather than subsidiary location.

United Middle
2004 States Canada Mexico East Total Company
------ ------ ------ ---- -------------

Revenue - unit sales $ 2,726,702 $ -- $ -- $ -- $ 2,726,702
Revenue - gross kit sales 44,379 -- 119,968 453,650 617,997
----------- ----------- ----------- ----------- -----------
Total revenue 2,771,081 -- 119,968 453,650 3,344,699
Cost of goods sold (2,262,055) -- (55,609) (57,141) (2,374,805)
----------- ----------- ----------- ----------- -----------
Gross margin $ 509,026 $ -- $ 64,359 $ 396,509 $ 969,894
----------- ----------- ----------- ----------- -----------

United Middle
2003 States Canada Mexico East Total Company
------ ------ ------ ---- -------------
Revenue - unit sales $ 356,985 $ -- $ -- $ -- $ 356,985
Revenue - net kit sales 2,737 -- -- -- 2,737
Revenue - gross kit sales 629,999 43,745 145,362 21,314 840,420
----------- ----------- ----------- ----------- -----------
Total revenue 989,721 43,745 145,362 21,314 1,200,142
Cost of goods sold (127,647) (10,403) (45,247) (9,201) (192,498)
----------- ----------- ----------- ----------- -----------

Gross margin $ 862,074 $ 33,342 $ 100,115 $ 12,113 $ 1,007,644
----------- ----------- ----------- ----------- -----------

F-28

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Note 10 - Commitments and Contingencies

Commitments

We lease office space at our corporate office in Florida under an original
operating lease that expired March 8, 2004. We have renewed the operating lease
for an additional six-year period that will expire October 30, 2010.

Future minimum rental payments required under the operating lease as of December
31, 2004 are as follows:

Years ending December 31, Amount
------------------------- ------
2005 $ 89,616
2006 $ 89,616
2007 $ 89,616
2008 $ 89,616
2009 $ 89,616
2010 Partial year $ 74,680

Rental expense for the years ended December 31, 2003 and 2004 was $75,270 and
$68,784, respectively.

Note 11 - Subsequent Events

On January 18, 2005, we converted $35,931 of our April 2004 Convertible
Promissory Note into 500,000 shares of common stock pursuant to a January 14,
2005 notice of conversion from Longview Fund LP, at a fixed conversion price of
$0.10. The conversion included $14,068 of accrued and unpaid interest on the
converted amount. We issued the underlying common stock upon conversion pursuant
to our SB-2 registration statement, declared effective on August 3, 2004.

On January 19, 2005, we converted $64,068 of our April 2004 Convertible
Promissory Note into 641,387 shares of common stock pursuant to a January 19,
2005 notice of conversion from Longview Fund LP, at a fixed conversion price of
$0.10. The conversion included $70 of accrued and unpaid interest on the
converted amount. We issued the underlying common stock upon conversion pursuant
to our SB-2 registration statement, declared effective on August 3, 2004.

On January 31, 2005, we closed a funding transaction with Longview Fund,
LP, Longview Equity Fund, LP, Longview International Equity Fund, LP, Alpha
Capital Aktiengesellschaft and Whalehaven Funds Limited, five institutional
accredited investors, for the issuance and sale to the Subscribers of up to
$2,300,000 of principal amount of promissory notes convertible into shares of
our common stock, and Warrants to purchase shares of common stock at 100%
coverage of the common stock issuable in accordance with the principal amount of
the notes. One Million One Hundred Fifty Thousand Dollars ($1,150,000) of the
purchase price was paid on the initial closing date, and One Million One Hundred
Fifty Thousand Dollars ($1,150,000) of the purchase price will be payable within
five (5) business days after the actual effectiveness of an SB-2 Registration
Statement as defined in the Subscription Agreement. The initial closing notes
were at prime plus 4% interest in the aggregate amount of $1,150,000, plus
five-year Warrants for the purchase of, in the aggregate, 9,200,000 shares of
common stock, at the lesser of (i) $0.16, or (ii) 101% of the closing bid price
of the Common Stock as reported by Bloomberg L.P. for the OTC Bulletin Board for
the trading day preceding the Closing Date. The notes are convertible into
shares of common stock of we at $0.125 per common share. Conversions are limited
to a maximum ownership of 9.99% of the underlying common stock at any one time.
The notes have a maturity date two yeas from closing and are payable in twelve
equal monthly installments, commencing June 1, 2005. The installment payments
consist of principal equal to 1/20th of the initial principal amount which,
subject to certain conditions concerning trading volume and price, can be paid
in cash at 103% of the monthly installment, or common stock or a combination of
both. The notes have an acceleration provision upon the change in a majority of
the present Board of Directors except as the result of the death of one or more
directors, or a change in the present CEO. In connection with this transaction,
we issued restricted common stock in the aggregate amount of 460,000 shares plus
the aggregate cash amount of $57,500 for due diligence fees to the investors in
this transaction

F-29

BRAVO! FOODS INTERNATIONAL CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

On February 14, 2005, we converted $41,666 of our June 2004 Convertible
Promissory Note into 430,327 shares of restricted common stock pursuant to a
February 9, 2005 notice of conversion from Longview Fund LP, at a fixed
conversion price of $0.15. The conversion included $22,882 of accrued and unpaid
interest on the converted amount. We issued the Convertible Promissory Note and
the underlying common stock upon conversion to an accredited investor, pursuant
to a Regulation D offering

On February 16, 2005, we converted $25,000 of our November 2003
Convertible Promissory Note into 549,340 shares of common stock pursuant to a
February 15, 2005 notice of conversion from Gamma Opportunity Capital Partners
LP, at a fixed conversion price of $0.05. The conversion included $2,467 of
accrued and unpaid interest on the converted amount. We issued the underlying
common stock upon conversion pursuant to our SB-2 registration statement,
declared effective on August 3, 2004.

F-30

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

ITEM 24. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

Our Articles of Incorporation, as amended, provide to the fullest extent
permitted by Delaware law, our directors or officers shall not be personally
liable to us or our shareholders for damages for breach of such director's or
officer's fiduciary duty. The effect of this provision of our Articles of
Incorporation, as amended, is to eliminate our right and our shareholders
(through shareholders' derivative suits on behalf of our company) to recover
damages against a director or officer for breach of the fiduciary duty of care
as a director or officer (including breaches resulting from negligent or grossly
negligent behavior), except under certain situations defined by statute. We
believe that the indemnification provisions in its Articles of Incorporation, as
amended, are necessary to attract and retain qualified persons as directors and
officers.

Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors, officers and controlling persons of
the registrant pursuant to the foregoing provisions, or otherwise, the
registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the
Securities Act and is, therefore, unenforceable. In the event that a claim for
indemnification against such liabilities (other than the payment by the
registrant of expenses incurred or paid by a director, officer or controlling
person of the registrant in the successful defense of any action, suit or
proceeding) is asserted by such director, officer or controlling person in
connection with the securities being registered, the registrant will, unless in
the opinion of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.

ITEM 25. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION.

The following table sets forth an itemization of all estimated expenses,
all of which we will pay, in connection with the issuance and distribution of
the securities being registered:

NATURE OF EXPENSE AMOUNT

SEC Registration fee $ 3,726.60
Accounting fees and expenses 10,000.00*
Legal fees and expenses 35,000.00*
Miscellaneous 5,000.00
----------
TOTAL $53,726.60*
==========

* Estimated.

ITEM 26. RECENT SALES OF UNREGISTERED SECURITIES.

On January 2, 2002, we issued options for 3,714 shares of common stock having an
exercise price of $0.35 and exercisable for five years, pursuant to an
employment agreement.

On January 18, 2002, we issued 238,334 shares of common stock to Austinvest
Anstalt Balzers, upon the conversion of 5,000 shares of Series D Convertible
Preferred, at a conversion price of $0.2453. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $8,463.34.

On January 18, 2002, we issued 238,334 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 5,000 shares of Series D Convertible
Preferred, at a conversion price of $0.2453. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $8,463.34.

On January 28, 2002, we issued 40,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 883 shares of Series G Convertible Preferred, at a
conversion price of $0.2453. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $984.83.

On January 28, 2002, we issued 136,038 shares of common stock to Amro
International, S.A., upon the conversion of 2,840 shares of Series D Convertible
Preferred, at a conversion price of $0.2453. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $4,970.00.

On January 30, 2002, we issued 15,000 shares of its Series H convertible
preferred stock, having a conversion price of $0.40 per share of common stock,
and warrants for 375,000 shares at $0.50 per share. The Series H convertible
preferred stock and warrants were priced at $10.00 per unit, and resulted in
proceeds of $150,000 in cash.

On February 4, 2002, we issued 206,700 shares of common stock to Austinvest
Anstalt Balzers, upon the conversion of 4,375 shares of Series D Convertible
Preferred, at a conversion price of $0.2480. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $7,511.60.

On February 4, 2002, we issued 206,700 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 4,375 shares of Series D Convertible
Preferred, at a conversion price of $0.2480. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $7,511.60.

On February 5, 2002, we issued 20,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 492 shares of Series G Convertible Preferred, at a
conversion price of $0.2453. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $496.03.

On February 15, 2002, we issued 5,000 shares of its Series H convertible
preferred stock, having a conversion price of $0.40 per share of common stock,
and warrants for 125,000 shares at $0.50 per share to a sophisticated and
accredited investor. The Series H convertible preferred stock and warrants were
priced at $10.00 per unit, and resulted in proceeds of $50,000 in cash.

On February 20, 2002, we issued 35,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 832 shares of Series G Convertible Preferred, at a
conversion price of $0.2949. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $952.05.

On February 29, 2002, we issued 279,795 shares of common stock to Amro
International, S.A, upon the conversion of 7,160 shares of Series D Convertible
Preferred, at a conversion price of $0.3013. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $12,711.00.

On March 1, 2002, we issued 20,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 536 shares of Series G Convertible Preferred, at a
conversion price of $0.2993. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $630.20.

On March 1, 2002, we issued warrants for 25,000 shares of common stock, having
an exercise price of $0.40 per share. The warrants are immediately exercisable
and have an expiration date of February 28, 2007. These warrants were issued to
the lender in connection with a December 27, 2001 loan of $250,000 to us.

On March 15, 2002, we issued 20,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 532 shares of Series G Convertible Preferred, at a
conversion price of $0.2973. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $633.70.

On March 18, 2002, we issued 50,000 shares of its Series H convertible preferred
stock, having a conversion price of $0.40 per share of common stock, and
warrants for 1,250,000 shares at $0.50 per share to a sophisticated and
accredited investor. The Series H convertible preferred stock and warrants were
priced at $10.00 per unit, and resulted in proceeds of $500,000 in cash.

On April 19, 2002, we issued 10,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 252 shares of Series G Convertible Preferred, at a
conversion price of $0.2840. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $320.80.

On April 19, 2002, we issued 10,000 shares of common stock to The Keshet Fund
LP, upon the conversion of 234 shares of Series G Convertible Preferred, at a
conversion price of $0.2640. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $299.40.

On April 24, 2002 our Board of Directors voted to extend options for 1,383,705
shares of common stock issued on April 29 and December 15, 1997 to Tamarind
Management, Ltd. (an affiliate of Mr. Paul Downes, a founder of the Company) and
options for 700,000 shares of common stock issued on December 15, 1997 to Mr.
Dale Reese (a founder of the Company), for services rendered to us. These
extended options, which had original expiration dates of April 29 and December
15, 2002, respectively, retain an exercise price of $1.00 and are exercisable
upon the following conditions: The expiration dates for these options are
extended for a two year period, commencing upon the effective date of a
registration statement for the resale of the common stock underlying the
options; the options will not be exercised during a one year lockup period
commencing on the 1st day after our common stock trades during a 90 day period
at a moving average of at least $1.00; we have the option to call the options
commencing on the 1st day after our common stock trades during a 90 day period
at a moving average of at least $2.00.

On May 3, 2002, we issued 52,730 shares of common stock to Amro International,
S.A, upon the conversion of 1,000 shares of Series D Convertible Preferred, at a
conversion price of $0.22. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $1,811.51.

On May 7, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 215 shares of Series G Convertible Preferred, at a
conversion price of $0.2427. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $277.44.

On May 13, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 158 shares of Series G Convertible Preferred, at a
conversion price of $0.1787. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $207.77.

On May 13, 2002, we issued 20,000 shares of common stock to Keshet LP, upon the
conversion of 316 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $416.07.

On May 13, 2002, we issued 15,000 shares of common stock to Keshet LP, upon the
conversion of 237 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $312.45.

On May 17, 2002, we issued 131,239 shares of common stock to Amro International,
S.A, upon the conversion of 2,000 shares of Series D Convertible Preferred, at a
conversion price of $0.18. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $3,623.00.

On May 17, 2002, we issued 278,498 shares of common stock to Amro International,
S.A, upon the conversion of 4,000 shares of Series D Convertible Preferred, at a
conversion price of $0.17. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $7,344.00.

On May 20, 2002, we issued 10,000 shares of common stock to Keshet LP, upon the
conversion of 158 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $209.37.

On May 20, 2002, we issued 10,000 shares of common stock to Keshet LP, upon the
conversion of 131 shares of Series G Convertible Preferred, at a conversion
price of $0.1680. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $372.82.

On May 23, 2002, we issued 63,454 shares of common stock to Austinvest Anstalt
Balzers, upon the conversion of 1,000 shares of Series D Convertible Preferred,
at a conversion price of $0.1787. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $7,494.00.

On May 23, 2002, we issued 63,454 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 1,000 shares of Series D Convertible
Preferred, at a conversion price of $0.1787. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $7,494.00.

On May 24, 2002, we issued 15,000 shares of common stock to Keshet LP, upon the
conversion of 237 shares of Series G Convertible Preferred, at a conversion
price of $0.1787. The conversion included accrued and unpaid dividends on the
preferred converted in the amount of $312.85.

On May 24, 2002, we issued 15,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 157 shares of Series G Convertible Preferred, at a
conversion price of $0.1680. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $449.88.

On May 29, 2002, we issued 652,178 shares of common stock to Amro International,
S.A, upon the conversion of 9,642 shares of Series D Convertible Preferred, at a
conversion price of $0.168. The conversion included accrued and unpaid dividends
on the preferred converted in the amount of $13,146.

On May 29, 2002, we issued 652,178 shares of common stock to Esquire Trade &
Finance, Inc., upon the conversion of 9,642 shares of Series D Convertible
Preferred, at a conversion price of $0.168. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $13,146.

On May 30, 2002, we issued 652,178 shares of common stock to Austinvest Anstalt
Balzers, upon the conversion of 9,642 shares of Series D Convertible Preferred,
at a conversion price of $0.168. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $13,146.

On June 13, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 126 shares of Series G Convertible Preferred, at a
conversion price of $0.1627. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $366.70.

On June 13, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 130 shares of Series G Convertible Preferred, at a
conversion price of $0.1680. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $381.12.

On June 17, 2002, we received sufficient consents to file an amended certificate
of incorporation, which increased our authorized common stock from 20,000,000 to
50,000,000 shares.

On June 17, 2002, we issued 30,000 shares of its Series I 8% convertible
preferred stock and warrants for 2,000,000 shares at $0.50 per share,
exercisable within three years from issue, to two sophisticated and accredited
investors, pursuant to Rule 506, Regulation D and Section 4(2) of the Securities
Act of 1933. The conversion of the preferred into common stock shall be at a per
common share conversion price of 75% of the average of the three lowest closing
bid prices for the thirty day period immediately preceding conversion. The
conversion price is subject to a maximum of $0.50 per share and a minimum of
$0.30 per share, which minimum conversion price shall govern for the 270 days
immediately following the issue date of the Series I preferred shares. The
minimum conversion price shall be extended indefinitely upon the occurrence of
certain defined events, including the effectiveness of a registration statement
for the resale of the common stock underlying the preferred and a trading price
of our common stock at $0.50 or higher for fifteen consecutive days. We have the
ability to compel the exercise of the warrants in tranches of not more than
500,000 warrants each, if the trading price of our common stock equals or
exceeds $1.00 for thirty consecutive trading days and a registration statement
for the underlying common is effective. The Series I convertible preferred stock
and warrants were priced at $10.00 per unit, and resulted in gross cash proceeds
of $300,000, less expenses of $12,000.

On June 18, 2002, we agreed to extend the expiration dates of warrants issued in
connection with our Series D and F preferred until June 17, 2005 and to reduce
the exercise price of certain of those warrants to $1.00. In consideration for
this warrant modification, the holders of two promissory notes executed by us
aggregating $100,000, dated November 6 and 7, 2001, respectively, agreed to
extend the maturity dates of the notes to December 31, 2002. In addition, the
holders of our Series D and F preferred stock agreed to waive all potential
penalties associated with the Series D and F preferred, including the
abandonment of a certain SB-2 registration statement filed in connection with
the resale of the common stock underlying the Series D and F preferred. Below is
a table containing the warrant modifications.

WARRANT COMMON UNMODIFIED
ISSUE SHARES UPON PURCHASE
WARRANTHOLDER (Series) DATE EXERCISE PRICE
------------- -------- ------- ----------- ----------

Austinvest Anstalt Balzers (D) 3-9-99 16,250 $ 2.96
Austinvest Anstalt Balzers (D) 4-23-99 8,125 $ 2.96
Austinvest Anstalt Balzers (D) 2-1-00 422,500 $ 0.625*
Austinvest Anstalt Balzers (F) 4-7-00 1,000,000 $ 1.00
Austinvest Anstalt Balzers (F) 10-13-00 38,259 $ 0.9825*
Esquire Trade & Finance, Inc. (D) 3-9-99 16,250 $ 2.96
Esquire Trade & Finance, Inc. (D) 4-23-99 8,125 $ 2.96
Esquire Trade & Finance, Inc. (D) 2-1-00 422,500 $ 0.625*
Esquire Trade & Finance, Inc. (F) 4-7-00 1,000,000 $ 1.00
Esquire Trade & Finance, Inc. (F) 10-13-00 38,259 $ 0.9625*
Libra Finance, S.A . (F) 4-7-00 1,600,000 $ 0.84*
Amro International, S.A (D) 2-1-00 455,000 $ 0.625*
Amro International, S.A (F) 4-7-00 1,000,000 $ 1.00
Amro International, S.A (F) 10-13-00 38,259 $ 0.9625*
Amro International, S.A (D) 3-9-99 17,500 $ 2.96
Amro International, S.A (D) 4-23-99 8,750 $ 2.96

* Exercise price not adjusted

On June 19, 2002, we issued 33,333 shares of restricted common stock to
Tradersbloom Limited, as a finder fee in connection with the issuance of our
Series I preferred stock. Tradersbloom Limited is a sophisticated and accredited
investor.

On June 19, 2002, we issued 66,667 shares of restricted common stock to Libra
Finance, S.A., as a finder fee in connection with the issuance of our Series I
preferred stock. Libra Finance, S.A. is a sophisticated and accredited investor.

On June 21, 2002, we issued 10,000 shares of common stock to The Keshet Fund LP,
upon the conversion of 135 shares of Series G Convertible Preferred, at a
conversion price of $0.1760. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $402.29.

On July 1, 2002, the Company issued 500,000 shares of common stock to Esquire
Trade & Finance, Inc., upon the conversion of 8,250 shares of Series D
Convertible Preferred, at a conversion price of $0.165. The conversion did not
include accrued and unpaid dividends on the preferred converted.

On July 1, 2002, the Company issued 500,000 shares of common stock to Austinvest
Anstalt Balzers, upon the conversion of 8,250 shares of Series D Convertible
Preferred, at a conversion price of $0.165. The conversion did not include
accrued and unpaid dividends on the preferred converted.

On July 23, 2002, the Company issued 475,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 6,172 shares of Series G Convertible
Preferred, at a conversion price of $0.1680. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $18,083.72.

On July 23, 2002, the Company issued 475,000 shares of common stock to Keshet
LP, upon the conversion of 6,172 shares of Series G Convertible Preferred, at a
conversion price of $0.1680. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $18,083.72.

On September 26, 2002, the Company issued 154,171 shares of common stock to Amro
International, SA, upon the conversion of 2,500 shares of Series D Convertible
Preferred, at a conversion price of $0.187. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $3,830.

On September 26, 2002, the Company issued 396,053 shares of common stock to Amro
International, SA, upon the conversion of 7,108 shares of Series D Convertible
Preferred, at a conversion price of $0.208. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $11,299.

On September 30, 2002, the Company issued 100,000 shares of non-voting Series J
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $1,000,000. Each preferred share is convertible to
40 shares of the Company's common stock of at a per common share conversion
price of $0.25, representing 4,000,000 shares of common stock underlying the
preferred. The issued warrants entitle the holder to purchase 25 shares of
common stock for each share of Series J Convertible Preferred stock issued at an
exercise price of $0.40 per common stock share, representing 2,500,000 shares of
common stock underlying the warrants. The warrants are exercisable for a
five-year period . The blended per share price for the common stock underlying
the preferred and the warrants is $0.307; the September 30, 2002 closing market
trading price was $0.29 per share. This private offering was made to Mid-Am, an
accredited investor, pursuant to Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933.

The common stock issued by the Company in the fourth quarter 2002 resulted from
conversions by the holders of Series F and G convertible preferred stock. The
common stock and the preferred converted were issued to sophisticated and
accredited investors, who had appropriate access to information concerning the
Company's operations and financial condition in a rule 506 private offering.
Holders of the Series F and G preferred can convert such equity into common
shares at 75% of the average of the three lowest bid trading prices of the
Company's common shares measured during a 20 day lookback period.

On November 8, 2002, the Company issued 160,112 shares of common stock to
Austinvest Anstalt Balzers, upon the conversion of 2,642 shares of Series F
Convertible Preferred, at a conversion price of $0.165. The Series F preferred
does not include dividends.

On November 8, 2002, the Company issued 160,112 shares of common stock to
Esquire Trade & Finance, Inc., upon the conversion of 2,642 shares of Series F
Convertible Preferred, at a conversion price of $0.165. The Series F preferred
does not include dividends.

On November 18, 2002, the Company issued 26,000 shares of common stock to

Nesher, Ltd., upon the conversion of 377 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $1,333.92.

On November 18, 2002, the Company issued 11,240 shares of common stock to
Talbiya B. Investments, Ltd., upon the conversion of 163 shares of Series G
Convertible Preferred, at a conversion price of $0.1963. The conversion included
accrued and unpaid dividends on the preferred converted in the amount of
$577.16.

On November 18, 2002, the Company issued 10,000 shares of common stock to
Nesher, Ltd., upon the conversion of 145 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $515.68.

On November 18, 2002, the Company issued 6,000 shares of common stock to Talbiya
B. Investments, Ltd., upon the conversion of 87 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $309.67.

On November 18, 2002, the Company issued 8,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 116 shares of Series G Convertible
Preferred, at a conversion price of $0.1963. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $413.25.

On November 18, 2002, the Company issued 14,440 shares of common stock to
Keshet, LP, upon the conversion of 208 shares of Series G Convertible Preferred,
at a conversion price of $0.1960. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $747.92.

On November 18, 2002, the Company issued 6,000 shares of common stock to Keshet,
LP, upon the conversion of 93 shares of Series G Convertible Preferred, at a
conversion price of $0.2093. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $332.70.

On November 20, 2002, the Company issued 2,000,000 shares of common stock to
Amro International, SA, upon the conversion of 39,200 shares of Series F
Convertible Preferred, at a conversion price of $0.1960. The Series F preferred
does not include dividends.

On November 27, 2002, the Company issued 16,000 shares of common stock to
Keshet, LP, upon the conversion of 257 shares of Series G Convertible Preferred,
at a conversion price of $0.2093. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $931.69.

On November 27, 2002, the Company issued 15,000 shares of common stock to
Keshet, LP, upon the conversion of 273 shares of Series G Convertible Preferred,
at a conversion price of $0.2480. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $994.59.

On December 24, 2002, the Company issued 8,000 shares of common stock to The
Keshet Fund LP, upon the conversion of 144 shares of Series G Convertible
Preferred, at a conversion price of $0.2467. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $534.17.

On December 24, 2002, the Company issued 45,000 shares of common stock to
Nesher, LP, upon the conversion of 750 shares of Series G Convertible Preferred,
at a conversion price of $0.2293. The conversion included accrued and unpaid
dividends on the preferred converted in the amount of $2,815.26.

On December 24, 2002, the Company issued 90,000 shares of common stock to
Keshet, LP, upon the conversion of 1,501 shares of Series G Convertible
Preferred, at a conversion price of $0.2293. The conversion included accrued and
unpaid dividends on the preferred converted in the amount of $5,630.52.

On December 24, 2002, the Company issued 45,000 shares of common stock to
Talbiya B. Investments, Ltd, upon the conversion of 750 shares of Series G
Convertible Preferred, at a conversion price of $0.2293. The conversion included
accrued and unpaid dividends on the preferred converted in the amount of
$2,815.26.

On January 2, 2003 the Company granted options for 100,000 shares of common
stock to Mr. Toulan pursuant to an employment contract. These options vested
immediately, expire on December 30, 2007 and have an exercise price of $0.40 per
share.

On January 2, 2003 the Company granted options for 100,000 shares of common
stock to Mr. Toulan pursuant to an employment contract. These options vest on
December 31, 2003, expire on December 30, 2008 and have an exercise price of
$0.40 per share.

On January 2, 2003 the Company granted options for 100,000 shares of common
stock to Mr. Toulan pursuant to an employment contract. These options vest on
December 31, 2004, expire on December 30, 2009 and have an exercise price of
$0.40 per share.

On February 4, 2003, the Company issued 30,000 shares of common stock to Keshet,
LP, upon the conversion of 480 shares of Series G Convertible Preferred, at a
conversion price of $0.1960. The conversion included accrued and unpaid
dividends on the preferred converted.

On February 21, 2003, the Company issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $500,000. Each preferred share is convertible to 40
shares of the Company's common stock of at a per common share conversion price
of $0.25, representing 2,000,000 shares of common stock underlying the
preferred. The issued warrants entitle the holder to purchase 33.33 shares of
common stock for each share of Series J Convertible Preferred stock issued at an
exercise price of $0.30 per common stock share, representing 1,666,667 shares of
common stock underlying the warrants. The warrants are exercisable for a
five-year period. The February 21, 2003 closing market trading price was $0.23
per share. This private offering was made to Mid-Am, an accredited investor,
pursuant to Rule 506 of Regulation D and Section 4(2) of the Securities Act of
1933.

On April 14, 2003, the Company issued 50,000 shares of common stock to Keshet,
LP, upon the conversion of 596 shares of Series G Convertible Preferred, at a
conversion price of $0.148. The conversion included accrued and unpaid dividends
on the preferred converted.

On April 22, 2003, the Company issued 50,000 shares of common stock to The
Keshet Fund, LP, upon the conversion of 595 shares of Series G Convertible
Preferred, at a conversion price of $0.148. The conversion included accrued and
unpaid dividends on the preferred converted.

On May 22, 2003, the Company issued 100,000 shares of common stock to Keshet,
LP, upon the conversion of 607 shares of Series G Convertible Preferred, at a
conversion price of $0.076. The conversion included accrued and unpaid dividends
on the preferred converted.

On May 22, 2003, the Company issued 100,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 607 shares of Series G Convertible Preferred,
at a conversion price of $0.076. The conversion included accrued and unpaid
dividends on the preferred converted.

On May 29, 2003, the Company issued 50,000 shares of non-voting Series J 8%
Convertible Preferred stock, having a stated value of $10.00 per Preferred J
share, and common stock warrants to Mid-Am Capital, L.L.C. ("Mid-Am") for the
aggregate purchase price of $500,000. Each preferred share is convertible to 50
shares of the Company's common stock of at a per common share conversion price
of $0.20, representing 2,500,000 shares of common stock underlying the
preferred. The issued warrants entitle the holder to purchase 40 shares of
common stock for each share of Series J Convertible Preferred stock issued at an
exercise price of $0.25 per common stock share, representing 2,000,000 shares of
common stock underlying the warrants. The warrants are exercisable for a
five-year period. The May 22, 2003 closing market trading price was $0.22 per
share. In addition, the following adjustments were made to prior issued Warrants
for the purpose of facilitating future fund raising by the Company arising out
of the exercise of the Warrants by Holder. The Purchase Price, as defined in the
Warrants No. 1 and 2, has been reduced to $0.25, subject to further adjustment
as described in the Warrants. The Warrant Stock provided for in Warrant No.1 has
been increased by 1,500,000 shares. The Warrant Stock provided for in Warrant

No. 2 has been increased by 333,333 shares. The Expiration Date, as defined in
the respective Warrants, remains as stated. The aforementioned adjustments
resulted in a total of 6,000,000 shares of common stock underlying Warrant No. 1
and Warrant No. 2. Those warrants were valued using the Black-Scholes model as
of May 22, 2003. No adjustments resulted from that valuation. The trading price
Call Option trigger set forth in Section 9 (b) of the Warrants has been reduced
from $1.75 to $0.75 per share. This private offering was made to Mid-Am, an
accredited investor, pursuant to Rule 506 of Regulation D and Section 4(2) of
the Securities Act of 1933.

On August 12, 2003, the Company issued 1,200,000 shares of common stock upon the
conversion of 6,542 shares of Series G Convertible Preferred. The conversions
were based upon notices of conversion received in June and July 2003, and was
delayed in order to determine the accuracy of the conversion variables contained
in the respective notices of conversion. The conversion-based issuances of
common were as follows:

o The Company issued 200,000 shares of common stock to Keshet, LP,
upon the conversion of 1,209 shares of Series G Convertible
Preferred, at a conversion price of $0.076. The conversion included
accrued and unpaid dividends on the preferred converted.

o The Company issued 200,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 1,209 shares of Series G
Convertible Preferred, at a conversion price of $0.076. The
conversion included accrued and unpaid dividends on the preferred
converted.

o The Company issued 150,000 shares of common stock to The Keshet
Fund, LP, upon the conversion of 773 shares of Series G Convertible
Preferred, at a conversion price of $0.0653. The conversion included
accrued and unpaid dividends on the preferred converted.

o The Company issued 250,000 shares of common stock to Keshet, LP,
upon the conversion of 1,289 shares of Series G Convertible
Preferred, at a conversion price of $0.0653. The conversion included
accrued and unpaid dividends on the preferred converted.

o The Company issued 200,000 shares of common stock to Talbiya B.
Investments, Ltd., upon the conversion of 1,031 shares of Series G
Convertible Preferred, at a conversion price of $0.0653. The
conversion included accrued and unpaid dividends on the preferred
converted.

o The Company issued 200,000 shares of common stock to Nesher. Ltd.,
upon the conversion of 1,031 shares of Series G Convertible
Preferred, at a conversion price of $0.0653. The conversion included
accrued and unpaid dividends on the preferred converted.

On September 15, 2003, the Company issued 213,750 shares of common stock to
Michael Willms, upon the conversion of 7,500 shares of Series H Convertible
Preferred, at the fixed conversion price of $0.40. The conversion included
accrued and unpaid dividends on the preferred converted.

On September 29, 2003, the Company issued 70,938 shares of common stock to The
Dennis H. Willms Irrevocable Trust, Michael Willms, Trustee, upon the conversion
of 2,500 shares of Series H Convertible Preferred, at the fixed conversion price
of $0.40. The conversion included accrued and unpaid dividends on the preferred
converted.

To obtain funding for our ongoing operations, we entered into a Subscription
Agreement with two accredited investors in November 2003 for the sale of (i)
$400,000 in convertible debentures, (ii) class A warrants to buy 2,000,000
shares of our common stock and (iii) class B warrants to buy 10,000,000 shares
of common stock. In connection with this financing, we paid a finders fee to an
accredited investor, which included (i) 400,000 shares of common stock, (ii)
class A warrant to purchase 2,000,000 shares of common stock and (iii) 10% of
the proceeds received by us in connection with the exercise of the class B
warrants, which is payable in shares of common stock at the rate of one share of
common stock for every ten shares of common stock actually issued upon exercise
of the class B warrants.

The debentures issued in connection with the April 2004 financing bear interest
at 10%. The principal on the notes is due in equal monthly installments
commencing on November 1, 2004 until October 1, 2005. On October 1, 2005, all
principal and interest shall become due. In the event that our common stock has
a closing price in excess of $.20 for the five days preceding the monthly
payment, then, within our discretion, the monthly payment may be deferred. and
the notes are convertible into our common stock at $0.10 per share.

Marvel License

On February 1, 2004, we entered into a license agreement with Marvel
Enterprises, Inc. In consideration for the use of proprietary information, we
issued Marvel 750,000 shares of our common stock and a common stock purchase
warrant to purchase 750,000 shares of our common stock. The warrants have an
exercise price of $.10 per share for the first year and, upon the occurrence of
certain conditions tied to the royalty performance under the license, can be
extended for an additional year with an exercise price of $.14 per share.

June 2004

This prospectus relates to the resale of the shares of common stock and
the common stock underlying these convertible debentures and warrants.

October 2004

On October 29, 2004, we entered into Subscription Agreements with Longview
Fund, LP, Alpha Capital Aktiengesellschaft, Whalehaven Funds Limited and
Stonestreet Limited Partnership for the issuance of convertible 10% notes in the
aggregate amount of $550,000 and five-year "C" warrants for the purchase of, in
the aggregate, 2,200,000 shares of common stock, at $0.15 per share, and the
repricing of five-year "A" warrants, issued June 30, 2004 for the purchase of,
in the aggregate, 3,200,000 shares of common stock, from $0.25 to $0.15 per
share. The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $27,500 to Gem Funding, LLC, Bi-Coastal Consulting
Corp., Stonestreet Limited Partnership and Libra Finance, S.A upon identical

terms as the principal notes, as a finder's fee, and paid $12,500 in legal fees.
The common stock underlying all notes and warrants carry registration rights.

December 2004

In December 2004, we entered into Subscription Agreements with Momona
Capital Corp. and Ellis International Ltd. for the issuance of convertible 10%
notes in the aggregate amount of $400,000 and five-year "C" warrants for the
purchase of, in the aggregate, 800,000 shares of common stock, at $0.15 per
share The notes are convertible into shares of common stock at $0.10 per common
share. The notes are payable in twelve equal monthly installments, commencing
May 1, 2005. The installment payments consist of principal and a "premium" of
20% of the principal paid per installment. We have the option to defer such
payment until the note's maturity date on April 30, 2006, if our common stock
trades above $0.15 for the five trading days prior to the due date of an
installment payment and the underlying common stock is registered. In connection
with this transaction, we issued additional notes, without attached warrants, in
the aggregate amount of $10,000 to Momona Capital Corp. and Ellis International
Ltd. upon identical terms as the principal notes, as a finder's fee. The common
stock underlying all notes and warrants carry registration rights.

* All of the above offerings and sales were deemed to be exempt under rule
506 of Regulation D and Section 4(2) of the Securities Act of 1933, as amended.
No advertising or general solicitation was employed in offering the securities.
The offerings and sales were made to a limited number of persons, all of whom
were accredited investors, business associates of Bravo! Foods International
Corp. or executive officers of Bravo! Foods International Corp., and transfer
was restricted by Bravo! Foods International Corp. in accordance with the
requirements of the Securities Act of 1933. In addition to representations by
the above-referenced persons, we have made independent determinations that all
of the above-referenced persons were accredited or sophisticated investors, and
that they were capable of analyzing the merits and risks of their investment,
and that they understood the speculative nature of their investment.
Furthermore, all of the above-referenced persons were provided with access to
our Securities and Exchange Commission filings.

Except as expressly set forth above, the individuals and entities to whom
we issued securities as indicated in this section of the registration statement
are unaffiliated with the Company.

ITEM 27. EXHIBITS.

The following exhibits are included as part of this Form SB-2.
References to "the Company" in this Exhibit List mean Bravo! Foods
International Corp., a Delaware corporation.

Exhibit
No. Title of Document

3.1 Articles of Incorporation (1)

3.2 Amended Articles (name change) (1)

3.3 Restated Bylaws China Peregrine Food Corporation (1)

4.1 Preferred, Series B Designation (1)

4.2 Preferred, Series F Designation (2)

4.3 Preferred, Series G Designation (3)

4.4 Preferred, Series H Designation (6)

4.5 Preferred, Series I Designation (7)

4.6 Preferred, Series J Designation (8)

4.7 Preferred, Series K Designation (10)

4.8 Subscription Agreement dated November 2003 entered with Gamma
Opportunity Capital Partners, LP (11)

4.9 Class A Common Stock Purchase Warrant issued to Gamma Opportunity
Capital Partners, LP (11)

4.10 Class B Common Stock Purchase Warrant issued to Gamma Opportunity
Capital Partners, LP (11)

4.11 Convertible Note issued to Gamma Opportunity Capital Partners, LP dated
November 2003 (11)

4.12 Class A Common Stock Purchase Warrant issued to Libra Finance, S.A.
(11)

4.13 Subscription Agreement dated November 2003 entered with MID-AM CAPITAL,
L.L.C. (11)

4.14 Class A Common Stock Purchase Warrant issued to MID-AM CAPITAL, L.L.C.
(11)

4.15 Class B Common Stock Purchase Warrant issued to MID-AM CAPITAL, L.L.C.
(11)

4.16 Convertible Note issued to MID-AM CAPITAL, L.L.C. dated November 2003
(11)

4.17 Subscription Agreement dated April 2, 2004 entered with Alpha Capital
Aktiengesellschaft and Longview Fund LP (11)

4.18 Convertible Note issued to Alpha Capital Aktiengesellschaft dated April
2004 (11)

4.19 Convertible Note issued to Longview Fund LP dated April 2004 (11)

4.20 Common Stock Purchase Warrant issued to Alpha Capital
Aktiengesellschaft dated April 2004 (11)

4.21 Common Stock Purchase Warrant issued to Longview Fund LP dated April
2004 (11)

4.21 Subscription Agreement entered by and between the Company and Mid-AM
Capital LLC dated June 2004 (filed herewith)

4.22 Convertible Note issued to Mid-AM Capital LLC dated June 2004 (filed
herewith)

4.23 Common Stock Purchase Warrant A issued to Mid-AM Capital LLC dated June
2004 (filed herewith)

4.24 Common Stock Purchase Warrant B issued to Mid-AM Capital LLC dated June
2004(filed herewith)

4.25 Subscription Agreement entered by and between the Company and Alpha
Capital, Longview Fund LP, Stonestreet Limited Partnership, Whalehaven
Funds Limited and Gamma Opportunity Capital Partners LP dated June 2004
(filed herewith)

4.26 Form of Common Stock Purchase A issued to Alpha Capital, Longview Fund
LP, Stonestreet Limited Partnership, Whalehaven Funds Limited and Gamma
Opportunity Capital Partners LP dated June 2004 (filed herewith)

4.27 Form of Common Stock Purchase B issued to Alpha Capital, Longview Fund
LP, Stonestreet Limited Partnership, Whalehaven Funds Limited and Gamma
Opportunity Capital Partners LP dated June 2004 (filed herewith)

4.28
Form of Convertible Note issued to Alpha Capital, Longview Fund LP,
Stonestreet Limited Partnership, Whalehaven Funds Limited and Gamma
Opportunity Capital Partners LP dated June 2004 (filed herewith)

4.29 Subscription Agreement entered by and between the Company and Alpha
Capital, Longview Fund LP, Stonestreet Limited Partnership and
Whalehaven Funds Limited dated October 2004 (filed herewith)

4.30 Form of Common Stock Purchase C issued to Alpha Capital, Longview Fund
LP, Stonestreet Limited Partnership and Whalehaven Funds Limited dated
October 2004 (filed herewith)

4.31 Form of Convertible Note issued to Alpha Capital, Longview Fund LP,
Stonestreet Limited Partnership, Whalehaven Funds Limited and Gamma
Opportunity Capital Partners LP dated October 2004 (filed herewith)

4.32 Subscription Agreement entered by and between the Company and Momona
Capital Corp. and Ellis International Ltd. dated December 2004 (filed
herewith)

4.33 Form of Common Stock Purchase C issued to Momona Capital Corp. and
Ellis International Ltd. dated December 2004 (filed herewith)

4.34 Form of Convertible Note issued to Momona Capital Corp. and Ellis
International Ltd. dated December 2004 (filed herewith)

5.1 Sichenzia Ross Friedman Ference LLP Opinion and Consent (12)

10.1 Warner Bros China License Agreement (5)

10.2 Warner Bros China License Agreement (modified)(5)

10.3 Warner Bros. U.S. License Agreement(5)

10.4 Warner Bros. Mexico License Agreement(6)

10.5 Warner Bros. Cananda License Agreement(6)

10.6 MoonPie License Agreement(10)

10.7 Marvel License Agreement(10)

10.8 SADAFCO Production Agreement(10)

10.9 Real Estate Lease Amendment Extending Term (10)

21.1 Subsidiaries Certificate of Incorporation Bravo! Foods, Inc. (6)

21.2 Subsidiaries Articles of Association China Premium Food Corporation
(Shanghai) Co., Inc. (6)

23.1 Consent of Lazar Levine & Felix LLP (filed herewith).

23.2 Consent of legal counsel (see Exhibit 5.1).

--------------------------------------------------

(1) Filed with Form 10SB/A First Amendment
(2) Filed with Form 10QSB for 3-31-99
(3) Filed with Form 10QSB for 6-30-99
(4) Filed with Form 10K-SB for 12-31-99
(5) Filed with Form 10QSB for 6-30-00
(6) Filed with Form SB-2/A Second Amendment
(7) Filed with Form SB-2/A Third Amendment
(8) Filed with Form 10K-SB 2001
(9) Filed with Form 8K filed October 2, 2002
(10) Filed with Form 10-KSB for 12-31-03
(11) Filed with Form SB-2 filed June 4, 2004

(12) Filed with the Form SB-2 filed on January 19, 2005

ITEM 28. UNDERTAKINGS.

The undersigned registrant hereby undertakes to:

(1) File, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement to:

(i) Include any prospectus required by Section 10(a)(3) of the Securities Act of
1933, as amended (the "Securities Act");

(ii) Reflect in the prospectus any facts or events which, individually or
together, represent a fundamental change in the information in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of
securities offered (if the total dollar value of the securities offered would
not exceed that which was registered) and any deviation from the low or high end
of the estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) under the
Securities Act if, in the aggregate, the changes in volume and price represent
no more than a 20% change in the maximum aggregate offering price set forth in

the "Calculation of Registration Fee" table in the effective registration
statement, and

(iii) Include any additional or changed material information on the plan of
distribution.

(2) For determining liability under the Securities Act, treat each
post-effective amendment as a new registration statement of the securities
offered, and the offering of the securities at that time to be the initial bona
fide offering.

(3) File a post-effective amendment to remove from registration any of the
securities that remain unsold at the end of the offering.

(4) For purposes of determining any liability under the Securities Act, treat
the information omitted from the form of prospectus filed as part of this
registration statement in reliance upon Rule 430A and contained in a form of
prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4) or 497(h)
under the Securities Act as part of this registration statement as of the time
it was declared effective.

(5) For determining any liability under the Securities Act, treat each
post-effective amendment that contains a form of prospectus as a new
registration statement for the securities offered in the registration statement,
and that offering of the securities at that time as the initial bona fide
offering of those securities.

Insofar as indemnification for liabilities arising under the Securities
Act may be permitted to directors, officers and controlling persons of the
registrant pursuant to the foregoing provisions, or otherwise, the registrant
has been advised that in the opinion of the Securities and Exchange Commission
such indemnification is against public policy as expressed in the Securities Act
and is, therefore, unenforceable.

In the event that a claim for indemnification against such liabilities
(other than the payment by the registrant of expenses incurred or paid by a
director, officer or controlling person of the registrant in the successful
defense of any action, suit or proceeding) is asserted by such director, officer
or controlling person in connection with the securities being registered, the
registrant will, unless in the opinion of its counsel the matter has been
settled by controlling precedent, submit to a court of appropriate jurisdiction
the question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication
of such issue.

SIGNATURES

In accordance with the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements of filing on Form SB-2 and authorizes this registration
statement to be signed on its behalf by the undersigned, in the City of North
Palm Beach, State of Florida, on March 30, 2005.

BRAVO! FOODS INTERNATIONAL CORP.

By: /s/ Roy G. Warren
--------------------------------------
Roy G. Warren, CEO and
Secretary

In accordance with the requirements of the Securities Act of 1933, this
registration statement was signed by the following persons in the capacities and
on the dates stated.

Name Title Date
------------------------ -------------------------------------- --------------

/s/Stanley Hirschman Chairman and Director March 30, 2005
--------------------
Stanley Hirschman

/s/Roy G. Warren Director, CEO and Secretary March 30, 2005
----------------
Roy G. Warren

/s/Arthur W. Blanding Director March 30, 2005
---------------------
/s/Arthur W. Blanding
---------------------

/s/Robert Cummings Director March 30, 2005
------------------
Robert Cummings

/s/Paul Downes Director March 30, 2005
--------------
Paul Downes

/s/Phillip Pearce Director March 30, 2005
-----------------
Phillip Pearce

/s/John McCormack Director March 30, 2005
-----------------
John McCormack

/s/Tommy Kee Chief Financial/Accounting Officer March 30, 2005
------------
Tommy Kee

/s/Roy D. Toulan Vice President, Corporate Secretary March 30, 2005
------------------- and General Counsel
Roy D. Toulan